[CAS NO. 216974-75-3] Bevacizumab
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [216974-75-3]
Catalog
HY-P9906
Brand
MCE
CAS
216974-75-3
DESCRIPTION [216974-75-3]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 149 kDa(Average) |
| Molecular Formula | - |
| SMILES | [Bevacizumab] |
For research use only. We do not sell to patients.
15 Publications Citing Use of MCE
- [1]J Extracell Vesicles. 2019 Jun 17;8(1):1629865.
- [2]Cell Death Dis. 2020 Jan 23;11(1):55.
- [3]PLoS Pathog. 2023 Jan 18;19(1):e1011077.
- [4]Anal Chim Acta. 2021, 338306.
- [5]EBioMedicine. 2019 Sep.
- [6]Mol Carcinog. 2019 Dec;58(12):2316-2326.
- [7]Nucleic Acid Ther. 2020 Dec;30(6):365-378.
- [8]Int J Biol Sci. 2022; 18(3): 942-955.
- [9]Int J Biol Sci. 2022; 18(3):942-955.
- [10]Vascul Pharmacol. 2022 Nov 6;147:107126.
- [11]Sci Rep. 2019 Nov 18;9(1):16954.
- [12]J Ethnopharmacol. 2021 Sep 28;114667.
- [13]J Pharmaceut Biomed. 2021, 114015.
- [14]Research Square Print. 2022 Jun.
- [15]Research Square Preprint. 2020 Jun.
Summary
IC50 & Target
VEGF [1]
In Vitro
Bevacizumab, a humanized monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity, and inhibits its interaction with VEGFR-1 and VEGFR-2 [1] . Experimental analysis shows that the EC 50 of Bevacizumab to bind VEGF analyzed by ELISA is 0.18 μg/mL. Binding kinetics assays show similar results that Bevacizumab inhibits the VEGF-induced proliferation of HUVEC with an IC 50 value of 0.047±0.0081 μg/mL [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
It is demonstrated that the subconjunctival administration of FD006 and Bevacizumab can significantly inhibit CoNV in NaOH cauterized rats compared with the control group (p < 0.01) [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00482495 | Mayo Clinic|National Cancer Institute (NCI) |
Multiple Myeloma and Plasma Cell Neoplasm
|
April 2006 | Phase 2 |
| NCT04843943 | Fudan University |
Hepatocellular Carcinoma
|
May 1, 2021 | Phase 1|Phase 2 |
| NCT03476798 | University of Oklahoma|Clovis Oncology, Inc. |
Cervical Cancer|Endometrial Cancer
|
June 29, 2018 | Phase 2 |
| NCT04230187 | Yanhong Deng|Sun Yat-sen University |
Colorectal Cancer
|
June 1, 2020 | Phase 3 |
| NCT00445848 | Southwest Oncology Group|National Cancer Institute (NCI) |
Lung Cancer
|
July 2007 | Phase 2 |
| NCT03890952 | Ulrik Lassen|Herlev Hospital|University of Copenhagen|Rigshospitalet, Denmark |
Recurrent Adult Brain Tumor
|
October 1, 2018 | Phase 2 |
| NCT02069704 | mAbxience Research S.L.|Laboratorio Elea Phoenix S.A.|Libbs Farmacêutica LTDA |
Metastatic Colorectal Cancer (mCRC)
|
October 29, 2014 | Phase 1 |
| NCT00602329 | Abramson Cancer Center of the University of Pennsylvania|National Cancer Institute (NCI) |
Colorectal Cancer
|
February 2006 | Phase 2 |
| NCT01256580 | Massachusetts Eye and Ear Infirmary |
Choroidal Neovascularization|Myopia|Punctate Inner Choroidopathy (PIC)|Multifocal Choroiditis|Ocular Histoplasmosis Syndrome|Central Serous Chorioretinopathy (CSC)|Angioid Streaks|Trauma, or Hereditary Eye Diseases
|
August 2010 | Not Applicable |
| NCT01526837 | Brain & Spine Surgeons of New York |
Glioblastoma Multiforme
|
October 2011 | Phase 1 |
| NCT00741221 | Hellenic Oncology Research Group |
Non-small-cell Lung Cancer
|
June 2008 | Phase 2 |
| NCT00762034 | Eli Lilly and Company |
Non-small Cell Lung Cancer
|
December 2008 | Phase 3 |
| NCT00250978 | Memorial Sloan Kettering Cancer Center |
Carcinoma, Non-Small-Cell Lung
|
November 2005 | Phase 1 |
| NCT01891747 | Vanderbilt-Ingram Cancer Center |
Malignant Glioma
|
July 2013 | Phase 1 |
| NCT00479674 | Duke University|Genentech, Inc.|Celgene Corporation |
Breast Cancer
|
May 2007 | Phase 2 |
| NCT01506167 | Hoffmann-La Roche |
Colorectal Cancer
|
July 6, 2012 | |
| NCT00745498 | Seoul National University Bundang Hospital |
Proliferative Diabetic Retinopathy|Vitreous Hemorrhage
|
June 2008 | Not Applicable |
| NCT03394885 | Duke University|Johns Hopkins University|Genentech, Inc. |
Ovarian Cancer|Ovarian Neoplasms
|
June 19, 2018 | Phase 1|Phase 2 |
| NCT00703976 | University of Pittsburgh|Eli Lilly and Company|Genentech, Inc. |
Cancer
|
October 2008 | Phase 2 |
| NCT01010126 | National Cancer Institute (NCI) |
Adult Hepatocellular Carcinoma|Advanced Adult Hepatocellular Carcinoma|Endometrial Serous Adenocarcinoma|Localized Non-Resectable Adult Liver Carcinoma|Lung Carcinoid Tumor|Malignant Pancreatic Gastrinoma|Malignant Pancreatic Glucagonoma|Malignant Pancreatic Insulinoma|Malignant Pancreatic Somatostatinoma|Metastatic Digestive System Neuroendocrine Tumor G1|Ovarian Carcinosarcoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Surface Papillary Adenocarcinoma|Pancreatic Alpha Cell Adenoma|Pancreatic Beta Cell Adenoma|Pancreatic Delta Cell Adenoma|Pancreatic G-Cell Adenoma|Pancreatic Polypeptide Tumor|Recurrent Adult Liver Carcinoma|Recurrent Digestive System Neuroendocrine Tumor G1|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Neuroendocrine Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Carcinoma|Regional Digestive System Neuroendocrine Tumor G1|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IIIC Uterine Corpus Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer|Uterine Carcinosarcoma
|
September 8, 2009 | Phase 2 |
| NCT01661283 | Sarcoma Alliance for Research through Collaboration|Novartis Pharmaceuticals|Genentech, Inc.|United States Department of Defense |
Malignant Peripheral Nerve Sheath Tumors|MPNST|Sarcoma
|
September 2012 | Phase 2 |
| NCT00700102 | Hoffmann-La Roche |
Colorectal Cancer
|
February 2006 | Phase 3 |
| NCT02310295 | University of Sao Paulo |
Diabetic Macular Edema
|
January 2009 | Not Applicable |
| NCT01219205 | Hallym University Medical Center |
Macular Edema
|
March 2008 | Not Applicable |
| NCT01966003 | Amgen|Actavis Inc. |
Non-small Cell Lung Cancer Metastatic
|
November 11, 2013 | Phase 3 |
| NCT05410301 | Varun Monga, MD|University of Iowa |
Glioblastoma|Recurrent Glioblastoma
|
April 2023 | Not Applicable |
| NCT02330783 | Peking University Cancer Hospital & Institute |
Metastatic Renal Cell Carcinoma
|
December 2014 | Phase 2 |
| NCT00906685 | Anders Kvanta|St. Erik Eye Hospital |
Central Retinal Vein Occlusion
|
May 2009 | Phase 3 |
| NCT00217672 | Translational Oncology Research International|University of California, Los Angeles |
Breast Cancer
|
May 2005 | Phase 2 |
| NCT00240071 | University of Alabama at Birmingham|Genentech, Inc. |
Metastatic Breast Cancer
|
October 2005 | Phase 2 |
| NCT01677884 | Gustave Roussy, Cancer Campus, Grand Paris |
Colorectal Neoplasms
|
November 2012 | Phase 2 |
| NCT00307736 | Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute|Genentech, Inc. |
Rectal Cancer|Adenocarcinoma of the Rectum
|
May 2006 | Phase 1|Phase 2 |
| NCT00577031 | Hoffmann-La Roche |
Colorectal Cancer
|
February 2008 | Phase 4 |
| NCT05271240 | Northwell Health |
Glioblastoma|Glioblastoma Multiforme|Glioma, Malignant|GBM|Brain Cancer|Glioblastoma, IDH-wildtype|Glioblastoma Multiforme, Adult
|
April 27, 2022 | Phase 3 |
| NCT05062317 | M.D. Anderson Cancer Center |
Liver Metastases
|
April 26, 2022 | Phase 2 |
| NCT03872947 | Toray Industries, Inc |
Solid Tumor|Colorectal Cancer|Cholangiocarcinoma|Bladder Cancer|Ovarian Cancer|Gastric Cancer|Palpable Subcutaneous Malignant Lesions|Renal Cell Carcinoma|Melanoma|Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
|
April 26, 2019 | Phase 1 |
| NCT02086656 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
Colorectal Cancer Liver Metastases
|
June 2013 | Phase 2 |
| NCT01075464 | Genentech, Inc. |
Solid Cancers
|
February 2010 | Phase 1 |
| NCT00440973 | The Methodist Hospital Research Institute|Genentech, Inc. |
Carcinoma, Renal Cell
|
October 2006 | Phase 2 |
| NCT00898417 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Lung Cancer
|
March 14, 2008 | |
| NCT01081262 | National Cancer Institute (NCI)|NRG Oncology |
Borderline Ovarian Mucinous Tumor|Ovarian Mucinous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Stage IA Fallopian Tube Cancer AJCC v6 and v7|Stage IA Ovarian Cancer AJCC v6 and v7|Stage IB Fallopian Tube Cancer AJCC v6 and v7|Stage IB Ovarian Cancer AJCC v6 and v7|Stage IC Fallopian Tube Cancer AJCC v6 and v7|Stage IC Ovarian Cancer AJCC v6 and v7|Stage IIA Fallopian Tube Cancer AJCC v6 and v7|Stage IIA Ovarian Cancer AJCC V6 and v7|Stage IIB Fallopian Tube Cancer AJCC v6 and v7|Stage IIB Ovarian Cancer AJCC v6 and v7|Stage IIC Fallopian Tube Cancer AJCC v6 and v7|Stage IIC Ovarian Cancer AJCC v6 and v7|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7
|
October 12, 2010 | Phase 3 |
| NCT03577743 | Assiut University |
Metastatic Triple Negative Breast Cancer|Safety Issues|Efficacy
|
July 1, 2018 | Phase 2 |
| NCT02853318 | Roswell Park Cancer Institute |
Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carcinoma
|
September 1, 2016 | Phase 2 |
| NCT03176264 | Novartis Pharmaceuticals|Novartis |
Metastatic Colorectal Cancer
|
September 25, 2017 | Phase 1 |
| NCT02659384 | European Organisation for Research and Treatment of Cancer - EORTC |
Ovarian Neoplasms
|
December 2016 | Phase 2 |
| NCT00061178 | Genentech, Inc. |
Renal Cell Cancer
|
Phase 3 | |
| NCT00403442 | Vitreous -Retina- Macula Consultants of New York|QLT Inc. |
Macular Degeneration
|
September 2006 | Phase 1 |
| NCT03721653 | Gruppo Oncologico del Nord-Ovest|Roche Pharma AG |
Metastatic Colorectal Cancer
|
November 30, 2018 | Phase 2 |
| NCT00942331 | National Cancer Institute (NCI) |
Advanced Urothelial Carcinoma|Metastatic Bladder Urothelial Carcinoma|Metastatic Prostate Carcinoma|Metastatic Renal Pelvis Urothelial Carcinoma|Metastatic Ureter Urothelial Carcinoma|Metastatic Urethral Urothelial Carcinoma|Metastatic Urothelial Carcinoma|Stage IV Bladder Urothelial Carcinoma AJCC v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Pelvis Cancer AJCC v7|Stage IV Ureter Cancer AJCC v7|Stage IV Urethral Cancer AJCC v7|Unresectable Urothelial Carcinoma
|
July 15, 2009 | Phase 3 |
| NCT03186326 | Federation Francophone de Cancerologie Digestive |
Metastatic Colorectal Cancer|MSI
|
April 24, 2018 | Phase 2 |
| NCT00601900 | National Cancer Institute (NCI) |
Invasive Breast Carcinoma|Recurrent Breast Carcinoma|Stage III Breast Cancer AJCC v6|Stage IV Breast Cancer AJCC v6 and v7
|
May 15, 2008 | Phase 3 |
| NCT01139723 | Genentech, Inc. |
Solid Cancers
|
June 2010 | Phase 1 |
| NCT00344617 | Singapore National Eye Centre |
Choroidal Neovascularisation|Polypoidal Choroidal Vasculopathy
|
June 2006 | Phase 3 |
| NCT01399918 | Memorial Sloan Kettering Cancer Center|Novartis Pharmaceuticals |
Renal Cell Carcinoma
|
July 2011 | Phase 2 |
| NCT04683965 | The First Affiliated Hospital with Nanjing Medical University|Jiangsu Hansoh Pharmaceutical Co., Ltd. |
Colorectal Neoplasms
|
January 1, 2021 | Phase 2 |
| NCT05007132 | Dominik Paul Modest|Charite University, Berlin, Germany |
Metastatic Colorectal Cancer
|
December 17, 2021 | Phase 2 |
| NCT02921269 | National Cancer Institute (NCI) |
Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Recurrent Cervical Carcinoma|Stage IV Cervical Cancer AJCC v6 and v7|Stage IVA Cervical Cancer AJCC v6 and v7|Stage IVB Cervical Cancer AJCC v6 and v7
|
March 10, 2017 | Phase 2 |
| NCT00294359 | Australasian Gastro-Intestinal Trials Group |
Metastatic Colorectal Cancer
|
June 2005 | Phase 2|Phase 3 |
| NCT04854668 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Metastatic Colorectal Cancer
|
May 27, 2021 | Phase 3 |
| NCT04776655 | Azienda Unità Sanitaria Locale Reggio Emilia|Istituto Di Ricerche Farmacologiche Mario Negri|Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale |
Colorectal Cancer|Metastatic Colorectal Cancer|RAS Mutation
|
April 30, 2021 | Phase 3 |
| NCT00463073 | Rigshospitalet, Denmark|Aalborg University Hospital|Odense University Hospital |
Malignant Gliomas
|
August 2006 | Phase 2 |
| NCT01614509 | Yeungnam University College of Medicine |
Branch Retinal Vein Occlusion
|
January 2012 | Not Applicable |
| NCT01051583 | Cairo University|AL-Nour Eye Hospital|Kasr El Aini Hospital |
Neovascular Glaucoma
|
January 2006 | Phase 2 |
| NCT03743428 | Shenzhen People´s Hospital |
Colorectal Neoplasms
|
October 22, 2020 | Not Applicable |
| NCT00113230 | M.D. Anderson Cancer Center|Genentech, Inc. |
Rectal Cancer
|
February 2005 | Phase 2 |
| NCT03095001 | Chinese PLA General Hospital |
Peritoneal Adhesion
|
June 1, 2017 | Phase 2 |
| NCT00022048 | Stanford University|National Cancer Institute (NCI) |
Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms
|
August 2001 | Phase 1|Phase 2 |
| NCT00868192 | Washington University School of Medicine|Columbia University |
Ovarian Carcinoma|Primary Peritoneal Carcinoma
|
May 2008 | Phase 2 |
| NCT01397695 | University of California, San Diego |
Hereditary Hemorrhagic Telangiectasia (HHT)
|
June 2009 | Phase 2 |
| NCT01847677 | Grupo Español de Investigación en Cáncer de Ovario|Roche Pharma AG |
Cancer, Ovarian
|
May 6, 2013 | Phase 2 |
| NCT04607421 | Pfizer|Ono Pharmaceutical Co. Ltd|Merck KGaA, Darmstadt, Germany |
Neoplasms
|
December 21, 2020 | Phase 3 |
| NCT01375816 | GERCOR - Multidisciplinary Oncology Cooperative Group |
Colorectal Cancer
|
May 2011 | Phase 2 |
| NCT00255762 | National Cancer Institute (NCI) |
Recurrent Melanoma|Stage IV Melanoma
|
December 2005 | Phase 2 |
| NCT01327222 | IRCCS San Raffaele |
Age Related Macular Degeneration
|
February 2011 | Phase 3 |
| NCT03878524 | OHSU Knight Cancer Institute|Oregon Health and Science University |
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic+Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic+Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic+Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma
|
April 1, 2020 | Phase 1 |
| NCT01860144 | Peking University |
Metastatic Colorectal Cancer
|
June 2012 | |
| NCT00265850 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Southwest Oncology Group|Bristol-Myers Squibb|Aptuit Inc. |
Colorectal Cancer
|
November 2005 | Phase 3 |
| NCT00884741 | National Cancer Institute (NCI)|Radiation Therapy Oncology Group|NRG Oncology |
Glioblastoma|Gliosarcoma|Supratentorial Glioblastoma
|
April 15, 2009 | Phase 3 |
| NCT00662129 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Breast Cancer
|
November 2008 | Phase 2 |
| NCT04305106 | Qilu Hospital of Shandong University|Renmin Hospital of Wuhan University|Ialy Moriggia Pelascini Gravedona Hospital S.p.A|Wuhan University|Jiangbei Union Hospital of Huazhong University of science and technology|Shandong Provincial Chest Hospital |
COVID-19 Pneumonia
|
March 17, 2020 | Not Applicable |
| NCT00193622 | SCRI Development Innovations, LLC|Genentech, Inc. |
Neoplasms, Unknown Primary
|
April 2004 | Phase 2 |
| NCT04175470 | Vejle Hospital |
Ovarian Cancer Recurrent
|
October 29, 2019 | Phase 2 |
| NCT00473590 | Genentech, Inc. |
Multiple Myeloma
|
June 2007 | Phase 2 |
| NCT00989651 | National Cancer Institute (NCI)|NRG Oncology |
Fallopian Tube Carcinoma|Fallopian Tube Carcinosarcoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Neoplasm|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Ovarian Brenner Tumor|Ovarian Carcinoma|Ovarian Carcinosarcoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Tumor|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIA Fallopian Tube Cancer AJCC v6 and v7|Stage IIA Ovarian Cancer AJCC V6 and v7|Stage IIB Fallopian Tube Cancer AJCC v6 and v7|Stage IIB Ovarian Cancer AJCC v6 and v7|Stage IIC Fallopian Tube Cancer AJCC v6 and v7|Stage IIC Ovarian Cancer AJCC v6 and v7|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7
|
October 28, 2009 | Phase 1 |
| NCT05603039 | Qilu Pharmaceutical Co., Ltd. |
Advanced Liver Cancer
|
July 1, 2021 | Phase 1|Phase 2 |
| NCT02648711 | NewLink Genetics Corporation|Lumos Pharma |
Solid Tumors
|
October 2015 | Phase 1 |
| NCT05180006 | Gustave Roussy, Cancer Campus, Grand Paris|Hoffmann-La Roche |
Breast Cancer
|
February 24, 2022 | Phase 2 |
| NCT00383812 | Asan Medical Center |
Polypoidal Choroidal Vasculopathy
|
May 2006 | Not Applicable |
| NCT00369551 | National Cancer Institute (NCI) |
Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Stage II Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer
|
June 2006 | Phase 1 |
| NCT03925233 | Xijing Hospital |
Breast Cancer Organoids
|
January 2, 2019 | |
| NCT01490866 | SCRI Development Innovations, LLC|Pfizer |
Colorectal Cancer
|
January 2012 | Phase 2 |
| NCT03083990 | Innovent Biologics (Suzhou) Co. Ltd. |
Healthy
|
March 9, 2017 | Phase 1 |
| NCT05363722 | Shanghai Zhongshan Hospital |
Hepatocellular Carcinoma
|
May 2022 | Phase 1 |
| NCT04761614 | Ning Jin|Ohio State University Comprehensive Cancer Center |
Metastatic Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8
|
April 2, 2021 | Phase 1 |
| NCT00370721 | Shahid Beheshti University of Medical Sciences |
Diabetic Retinopathy
|
March 2006 | Phase 3 |
| NCT00613028 | Duke University|Genentech, Inc. |
Glioblastoma|Gliosarcoma
|
April 2008 | Phase 2 |
| NCT05068206 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Unresectable Metastatic Colorectal Cancer
|
October 8, 2021 | Phase 2 |
| NCT00992849 | Chang Gung Memorial Hospital |
Corneal Neovascularization
|
May 2009 | Phase 2 |
| NCT00492089 | National Cancer Institute (NCI) |
Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Meningioma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Central Nervous System Germ Cell Tumor|Adult Choroid Plexus Tumor|Adult Diffuse Astrocytoma|Adult Ependymoma|Adult Grade II Meningioma|Adult Grade III Meningioma|Adult Malignant Hemangiopericytoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Papillary Meningioma|Adult Pineocytoma|Malignant Neoplasm|Meningeal Melanocytoma|Radiation Toxicity|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Adult Brain Tumor|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage I Adenoid Cystic Carcinoma of the Oral Cavity|Stage I Basal Cell Carcinoma of the Lip|Stage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage I Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage I Lymphoepithelioma of the Nasopharynx|Stage I Lymphoepithelioma of the Oropharynx|Stage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage I Mucoepidermoid Carcinoma of the Oral Cavity|Stage I Salivary Gland Cancer|Stage I Squamous Cell Carcinoma of the Hypopharynx|Stage I Squamous Cell Carcinoma of the Larynx|Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage I Squamous Cell Carcinoma of the Nasopharynx|Stage I Squamous Cell Carcinoma of the Oropharynx|Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage I Verrucous Carcinoma of the Larynx|Stage I Verrucous Carcinoma of the Oral Cavity|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Basal Cell Carcinoma of the Lip|Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage III Mucoepidermoid Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Basal Cell Carcinoma of the Lip|Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Lymphoepithelioma of the Oropharynx|Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage IV Mucoepidermoid Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity
|
June 2007 | Phase 2 |
| NCT01295112 | Texas Retina Associates |
Non-Ischemic Central Retinal Vein Occlusion
|
May 2011 | Phase 2|Phase 3 |
| NCT05540275 | Henan Provincial People´s Hospital |
Recurrent Glioblastoma
|
November 1, 2022 | Phase 2 |
| NCT05112861 | Outlook Therapeutics, Inc. |
Age-Related Macular Degeneration|Neovascular Age-related Macular Degeneration|Wet Macular Degeneration|BRVO - Branch Retinal Vein Occlusion|Diabetic Macular Edema
|
November 15, 2021 | Phase 3 |
| NCT05488522 | Abramson Cancer Center of the University of Pennsylvania |
Hepatocellular Carcinoma
|
September 1, 2022 | Phase 1 |
| NCT01996306 | Epidemiological and Clinical Research Information Network |
Colorectal Neoplasms|Neoplasm Metastasis|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms
|
December 2, 2013 | Phase 3 |
| NCT01727089 | National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma
|
November 1, 2012 | Phase 2 |
| NCT00618657 | University of California, Irvine|National Institutes of Health (NIH)|National Cancer Institute (NCI) |
Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
|
February 2008 | Phase 2 |
| NCT00911170 | Amgen |
Cancer|Colon Cancer|Colorectal Cancer|Fever|Locally Advanced|Metastatic Colorectal Cancer|Neutropenia|Rectal Cancer
|
November 3, 2009 | Phase 3 |
| NCT00737971 | Rubens Belfort Jr.|Federal University of São Paulo |
Diabetic Macular Edema
|
August 2008 | Phase 4 |
| NCT01635790 | Prof. dr. R.O. Schlingemann|University Medical Center Groningen|Free University Medical Center|Erasmus Medical Center|Radboud University Medical Center|Leiden University Medical Center|UMC Utrecht|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
Diabetic Macular Edema
|
June 2012 | Phase 2|Phase 3 |
| NCT02139579 | Sun Yat-sen University|First Affiliated Hospital, Sun Yat-Sen University|Second Affiliated Hospital, Sun Yat-Sen University |
Lung, Carcinoma
|
May 2014 | Phase 2 |
| NCT00162669 | Gustave Roussy, Cancer Campus, Grand Paris|Hoffmann-La Roche |
Hepatocellular Carcinoma
|
May 2005 | Phase 2 |
| NCT00700570 | Hoffmann-La Roche |
Colorectal Cancer
|
August 2008 | Phase 2 |
| NCT01187199 | M.D. Anderson Cancer Center |
Advanced Cancer
|
August 2010 | Phase 1 |
| NCT03141684 | National Cancer Institute (NCI) |
Metastatic Alveolar Soft Part Sarcoma|Unresectable Alveolar Soft Part Sarcoma
|
March 3, 2017 | Phase 2 |
| NCT01588431 | The University of Texas Health Science Center at San Antonio |
Carcinoma, Squamous Cell of Head and Neck
|
December 2011 | Phase 2 |
| NCT01871571 | University of Southern California|National Cancer Institute (NCI) |
Mucinous Adenocarcinoma of the Rectum|Signet Ring Adenocarcinoma of the Rectum|Stage IIA Rectal Cancer|Stage IIB Rectal Cancer|Stage IIC Rectal Cancer|Stage IIIA Rectal Cancer|Stage IIIB Rectal Cancer|Stage IIIC Rectal Cancer
|
August 2, 2013 | Phase 2 |
| NCT00776698 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
April 2009 | Phase 1 |
| NCT02093000 | Hoffmann-La Roche |
Lung Adenocarcinoma
|
November 30, 2014 | |
| NCT04158258 | Hoffmann-La Roche|Latin American Cooperative Oncology Group |
Breast Cancer
|
February 21, 2020 | |
| NCT01695772 | Hoffmann-La Roche |
Colorectal Cancer
|
October 16, 2012 | Phase 4 |
| NCT02840409 | The Hospital for Sick Children|Hoffmann-La Roche |
Low Grade Glioma
|
August 2016 | Phase 2 |
| NCT00992121 | GlaxoSmithKline |
Carcinoma, Renal Cell
|
November 18, 2009 | Phase 1 |
| NCT01802749 | National Cancer Institute, Naples|Mario Negri Institute for Pharmacological Research |
Recurrent Ovarian Cancer
|
November 2013 | Phase 3 |
| NCT00976677 | National Cancer Institute (NCI) |
Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
|
January 2010 | Phase 2 |
| NCT00887536 | NSABP Foundation Inc|Genentech, Inc.|US Oncology Research |
Breast Cancer
|
May 2009 | Phase 3 |
| NCT01303497 | Centre Oscar Lambret|French Sarcoma Group|Study Group of Bone Tumors |
Angiosarcoma
|
September 10, 2010 | Phase 2 |
| NCT01767545 | Ludwig-Maximilians - University of Munich |
Macular Edema Caused by Retinal Vein Occlusion
|
September 2010 | Phase 4 |
| NCT00524069 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Pancreatic Cancer
|
January 2007 | Not Applicable |
| NCT03414983 | Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd |
Colorectal Cancer
|
February 20, 2018 | Phase 2|Phase 3 |
| NCT00499369 | National Cancer Institute (NCI)|North Central Cancer Treatment Group|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|NCIC Clinical Trials Group |
Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
|
June 2007 | Phase 3 |
| NCT03425292 | Saint John´s Cancer Institute |
Newly Diagnosed High Grade Glioma
|
March 1, 2018 | Phase 1 |
| NCT00276055 | New Mexico Cancer Care Alliance |
Sarcoma
|
November 2005 | Phase 1 |
| NCT00681876 | Hellenic Oncology Research Group|University Hospital of Crete |
Colorectal Cancer
|
April 2008 | Phase 2 |
| NCT04275414 | Qilu Hospital of Shandong University|Renmin Hospital of Wuhan University|Moriggia-Pelascini Gravedona Hospital |
Coronavirus Infections
|
February 15, 2020 | Phase 2 |
| NCT02226289 | Sixth Affiliated Hospital, Sun Yat-sen University |
Neoplasm|Colorectal Cancer|Metastatic Neoplasm
|
September 2020 | Phase 2 |
| NCT04721132 | M.D. Anderson Cancer Center |
Resectable Hepatocellular Carcinoma|Stage I Hepatocellular Carcinoma AJCC v8|Stage IA Hepatocellular Carcinoma AJCC v8|Stage IB Hepatocellular Carcinoma AJCC v8|Stage II Hepatocellular Carcinoma AJCC v8
|
February 10, 2021 | Phase 2 |
| NCT01399190 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2011 | |
| NCT01967810 | Angiochem Inc |
Glioma|Glioblastoma|Brain Tumor, Recurrent
|
October 2013 | Phase 2 |
| NCT00809133 | Boehringer Ingelheim |
Neoplasms
|
May 2007 | Phase 1 |
| NCT00720512 | Gruppo Oncologico del Nord-Ovest |
Colorectal Cancer
|
June 2008 | Phase 3 |
| NCT00417833 | Asociación para Evitar la Ceguera en México |
Diabetic Proliferative Retinopathy|Vascular Vein Oclussion|Choroidal Neovascularization
|
December 2005 | Phase 2|Phase 3 |
| NCT03462251 | iOMEDICO AG|Novartis Pharmaceuticals |
Breast Cancer|Hormone Receptor Positive Tumor|HER 2 Negative Breast Cancer
|
May 24, 2018 | Phase 3 |
| NCT02015351 | University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo |
Choroidal Neovascularization
|
September 2012 | Not Applicable |
| NCT01459380 | National Cancer Institute (NCI)|NRG Oncology |
Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Ovarian Carcinoma
|
October 11, 2011 | Phase 1 |
| NCT01996826 | Reza Dana, MD|United States Department of Defense|Bascom Palmer Eye Institute|New York Presbyterian Hospital|Massachusetts Eye and Ear Infirmary |
Corneal Neovascularization|Corneal Graft Failure
|
April 2014 | Phase 1|Phase 2 |
| NCT01072357 | Reza Dana, MD|Massachusetts Eye and Ear Infirmary |
Corneal Neovascularization|Corneal Graft Failure
|
December 2009 | Phase 1|Phase 2 |
| NCT00378573 | Sanofi |
Non-small Cell Lung Cancer
|
January 2007 | Phase 2 |
| NCT00559754 | Hoffmann-La Roche |
Breast Cancer
|
December 2007 | Phase 2 |
| NCT01648348 | National Cancer Institute (NCI) |
Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Neoplasm
|
November 2012 | Phase 1|Phase 2 |
| NCT00101686 | Pfizer |
Colorectal Neoplasms
|
February 2003 | Phase 3 |
| NCT05546879 | University Hospital, Grenoble|NETRIS Pharma |
Hepatocellular Carcinoma
|
November 2022 | Phase 1 |
| NCT03451370 | Istituto Oncologico Veneto IRCCS |
Elderly Metastatic Colorectal Cancer Patients
|
November 1, 2017 | |
| NCT00874744 | Universidade Federal de Goias |
Diabetic Macular Edema
|
March 2008 | Phase 2 |
| NCT00290810 | National Cancer Institute (NCI) |
B-cell Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia
|
December 2005 | Phase 2 |
| NCT01229943 | National Cancer Institute (NCI) |
Advanced Pancreatic Neuroendocrine Tumor|Locally Advanced Pancreatic Neuroendocrine Tumor|Pancreatic Gastrinoma|Pancreatic Neuroendocrine Tumor G1|Pancreatic Neuroendocrine Tumor G2|Pancreatic Vipoma
|
October 15, 2010 | Phase 2 |
| NCT00411593 | M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc.|Genentech, Inc. |
Lung Cancer
|
November 2006 | Phase 1|Phase 2 |
| NCT00892710 | SCRI Development Innovations, LLC|Genentech, Inc. |
Non Small Cell Lung Cancer
|
June 2009 | Phase 2 |
| NCT05263947 | Tianjin Medical University Cancer Institute and Hospital |
Carcinoma, Non-Small-Cell Lung|Bevacizumab|EGF-R Positive Non-Small Cell Lung Cancer|Tyrosine Kinase Inhibitor
|
August 30, 2021 | Phase 3 |
| NCT05035381 | Tianjin Medical University Cancer Institute and Hospital |
MSI-H Advanced Colorectal Cancer
|
January 1, 2019 | Phase 2 |
| NCT05582577 | Shahid Beheshti University of Medical Sciences |
Diabetic Macular Edema
|
October 15, 2022 | Phase 2|Phase 3 |
| NCT00121199 | National Cancer Institute (NCI) |
Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma
|
June 2005 | Phase 2 |
| NCT05314673 | University Hospital Fattouma Bourguiba |
Pterygium
|
January 1, 2019 | Phase 4 |
| NCT00819780 | Amgen |
Colon Cancer|Colorectal Cancer|Rectal Cancer|Metastatic Colorectal Cancer
|
April 24, 2009 | Phase 2 |
| NCT03698461 | Asan Medical Center|Hoffmann-La Roche |
Colorectal Neoplasms|Neoplasm Metastasis|Colonic Neoplasms|Rectal Neoplasms
|
May 15, 2019 | Phase 2 |
| NCT00600262 | Asociación para Evitar la Ceguera en México |
Severe Nonproliferative|Proliferative Diabetic Retinopathy|Active Photocoagulated Diabetic Retinopathy
|
December 2005 | Phase 2|Phase 3 |
| NCT00717990 | University Hospital of Crete |
Metastatic Colorectal Cancer
|
April 2008 | Phase 2 |
| NCT00369070 | Amgen |
Advanced Non-squamous NSCLC
|
January 31, 2007 | Phase 2 |
| NCT03834753 | Outlook Therapeutics, Inc. |
Age-related Macular Degeneration|Neovascular Age-related Macular Degeneration|Wet Macular Degeneration
|
June 25, 2019 | Phase 3 |
| NCT04730999 | Gruppo Oncologico Italiano di Ricerca Clinica|Roche Pharma, Italy|YGHEA, CRO Division of Ecol Studio spa|Dr. Luca Boni U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino - IST NORD CBA |
Small Cell Lung Cancer
|
July 1, 2020 | Phase 2 |
| NCT00729846 | California Retina Consultants|Novartis |
Age Related Macular Degeneration|Choroidal Neovascularization|Macular Edema
|
May 2006 | Phase 2 |
| NCT01236560 | National Cancer Institute (NCI) |
Brain Stem Glioma|Cerebral Astrocytoma|Childhood Cerebellar Anaplastic Astrocytoma|Childhood Cerebral Anaplastic Astrocytoma|Childhood Spinal Cord Neoplasm
|
November 15, 2010 | Phase 2|Phase 3 |
| NCT01837251 | AGO Research GmbH|Arbeitsgemeinschaft Gynaekologische Onkologie Austria|ARCAGY+ GINECO GROUP|Australia New Zealand Gynaecological Oncology Group|Scottish Gynaecological Cancer Study Group |
Recurrent Platinum-sensitive Ovarian Cancer
|
May 2013 | Phase 3 |
| NCT01293942 | Ottawa Hospital Research Institute|Hoffmann-La Roche|Sanofi |
Metastatic Colorectal Cancer
|
March 2011 | Phase 2 |
| NCT04245085 | ETOP IBCSG Partners Foundation|Roche Pharma AG |
EGFRmutant Stage IIIB+C or IV Non-squamous NSCLC
|
September 29, 2020 | Phase 2 |
| NCT03654833 | University of Leicester|British Lung Foundation|Clovis Oncology, Inc.|Eli Lilly and Company|Merck Sharp & Dohme LLC|BerGenBio ASA|Roche Pharma AG|University Hospitals, Leicester|The Christie NHS Foundation Trust|GlaxoSmithKline |
Mesothelioma, Malignant
|
January 28, 2019 | Phase 2 |
| NCT00296062 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) |
Colorectal Cancer|Unspecified Adult Solid Tumor, Protocol Specific
|
March 2006 | Phase 1 |
| NCT02857920 | Fuda Cancer Hospital, Guangzhou|Shenzhen Hank Bioengineering Institute |
Malignant Solid Tumour
|
August 1, 2016 | Phase 1|Phase 2 |
| NCT01836536 | Center Eugene Marquis |
Glioblastoma|Glioma
|
September 2012 | Not Applicable |
| NCT03161041 | Hospices Civils de Lyon |
Colorectal Carcinomatosis
|
September 21, 2018 | Phase 2 |
| NCT00114179 | National Cancer Institute (NCI)|NRG Oncology |
Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer
|
January 2005 | Phase 2 |
| NCT00548197 | Iran University of Medical Sciences |
Intravitreal Bevacizumab Injection|Pars Plana Vitrectomy|Tractional Retinal Detachment|Diabetic Retinopathy
|
February 2007 | Phase 1 |
| NCT01686529 | Instituto de Oftalmología Fundación Conde de Valenciana |
Pterygium
|
March 2010 | Phase 1 |
| NCT00625651 | Amgen |
Metastatic Colorectal Cancer|Colon Cancer|Colorectal Cancer|Rectal Cancer
|
October 2007 | Phase 1|Phase 2 |
| NCT04138420 | Federico II University |
Exudative Age-related Macular Degeneration
|
January 25, 2017 | |
| NCT00727753 | University of Zurich |
Macular Degeneration
|
July 2008 | |
| NCT00804921 | University of Sao Paulo |
Macular Edema|Diabetic Retinopathy|Macular Degeneration
|
Phase 2 | |
| NCT01724385 | Khon Kaen University |
Vitreous Hemorrhage|Proliferative Diabetic Retinopathy
|
August 2012 | Phase 4 |
| NCT04164069 | Anne Noonan|Ohio State University Comprehensive Cancer Center |
Advanced Colorectal Carcinoma|Metastatic Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8|Stage II Colon Cancer|Stage II Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Esophageal Cancer|Pancreatic Cancer|Bile Duct Cancer|Gastric Cancer|Gall Bladder Cancer|Small Bowel Adenocarcinoma
|
September 2, 2020 | Phase 1 |
| NCT01051934 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Non-Small Cell Lung Cancer|Adenocarcinoma
|
December 29, 2009 | Phase 1 |
| NCT02641873 | Sumitomo Pharma Co., Ltd. |
Metastatic Colorectal Cancer
|
December 2015 | Phase 1 |
| NCT00541099 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) |
Lung Cancer
|
January 2008 | Phase 2 |
| NCT03732235 | Giammaria Fiorentini|International Group of Endovascular Oncology |
Liver Metastasis Colon Cancer
|
October 1, 2018 | |
| NCT03616691 | Samsung Medical Center |
Non Small Cell Lung Cancer
|
August 1, 2018 | Phase 2 |
| NCT04194203 | Hoffmann-La Roche |
Carcinoma, Non-Small-Cell Lung
|
April 9, 2020 | Phase 3 |
| NCT00574769 | University of Southern California|Novartis|Genentech, Inc. |
Prostate Cancer
|
February 17, 2010 | Phase 1|Phase 2 |
| NCT00350753 | Rigshospitalet, Denmark|Aarhus University Hospital |
Cholangiocarcinoma|Gallbladder Cancer
|
June 2006 | Phase 2 |
| NCT00426998 | Retinal Consultants Medical Group |
Choroidal Neovascularization|Macular Degeneration
|
April 2006 | Phase 2 |
| NCT01290263 | Dana-Farber Cancer Institute|Amgen |
Glioblastoma Multiforme
|
December 2010 | Phase 1|Phase 2 |
| NCT00611793 | SCRI Development Innovations, LLC|Novartis |
Refractory Malignancy|Advanced Malignancies
|
October 2004 | Phase 1 |
| NCT04101877 | Vastra Gotaland Region |
Neovascular Age-related Macular Degeneration
|
September 3, 2020 | Phase 2 |
| NCT01507480 | Hospices Civils de Lyon |
Rendu Osler Disease|Telangiectasia, Hereditary Hemorrhagic
|
October 2011 | Phase 1 |
| NCT03115762 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
Healthy
|
June 2017 | Phase 1 |
| NCT01656304 | Barbara Ann Karmanos Cancer Institute|Genentech, Inc. |
Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer
|
May 2007 | Phase 2 |
| NCT02847559 | Northwestern University|NovoCure Ltd.|National Cancer Institute (NCI) |
Anaplastic (Malignant) Meningioma|Atypical Meningioma|Grade II Meningioma|Grade III Meningioma|Recurrent Meningioma|Supratentorial Meningioma
|
August 2016 | Phase 2 |
| NCT04181060 | National Cancer Institute (NCI) |
Advanced Lung Non-Squamous Non-Small Cell Carcinoma|Metastatic Lung Non-Squamous Non-Small Cell Carcinoma|Recurrent Lung Non-Squamous Non-Small Cell Carcinoma|Stage IIIB Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8
|
October 22, 2020 | Phase 3 |
| NCT00499694 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) |
Prostate Cancer
|
October 2007 | Not Applicable |
| NCT01069796 | ARCAGY+ GINECO GROUP |
Triple Negative Metastatic Breast Cancer
|
April 2010 | Phase 2 |
| NCT01200121 | AIO-Studien-gGmbH |
Malignant Ascites|Gastrointestinal Cancers
|
February 2010 | Phase 2 |
| NCT02339116 | Gruppo Oncologico del Nord-Ovest |
Metastatic Colorectal Cancer
|
February 26, 2015 | Phase 3 |
| NCT02416999 | Hebei Yanda Hospital|Beijing Tiantan Hospital |
Recurrent High-grade Glioma
|
May 2015 | Not Applicable |
| NCT04109924 | Roswell Park Cancer Institute|National Comprehensive Cancer Network |
Advanced Colorectal Carcinoma|Metastatic Colon Adenocarcinoma|Metastatic Rectal Adenocarcinoma|Recurrent Colon Adenocarcinoma|Recurrent Colorectal Adenocarcinoma|Recurrent Rectal Adenocarcinoma|Stage III Colon Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8|Stage III Rectal Cancer AJCC v8|Stage IIIA Colon Cancer AJCC v8|Stage IIIA Colorectal Cancer AJCC v8|Stage IIIB Colorectal Cancer AJCC v8|Stage IIIB Rectal Cancer AJCC v8|Stage IIIC Colon Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IV Colon Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Rectal Cancer AJCC v8|Stage IVB Colon Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Rectal Cancer AJCC v8|Stage IVC Colon Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8|Stage IVC Rectal Cancer AJCC v8|Unresectable Colon Adenocarcinoma|Unresectable Colorectal Carcinoma|Unresectable Rectal Adenocarcinoma
|
December 27, 2019 | Phase 2 |
| NCT01024504 | Hellenic Oncology Research Group|University Hospital of Crete |
Metastatic Colorectal Cancer
|
March 2006 | Phase 2 |
| NCT00753909 | Hellenic Oncology Research Group |
Non Small Cell Lung Cancer
|
November 2008 | Phase 2 |
| NCT00203411 | Translational Oncology Research International|Genentech, Inc. |
Colorectal Cancer
|
March 2006 | Phase 2 |
| NCT00392704 | SCRI Development Innovations, LLC|Genentech, Inc. |
Head and Neck Cancer
|
December 2006 | Phase 2 |
| NCT00442507 | Washington University School of Medicine |
Esophageal Neoplasms|Esophageal Diseases
|
March 2007 | Phase 2 |
| NCT00393861 | Indiana University|Genentech, Inc. |
Neoplasms, Germ Cell and Embryonal
|
October 2006 | Phase 2 |
| NCT04832776 | Fudan University |
Liver Metastasis Colon Cancer
|
April 17, 2021 | Phase 2 |
| NCT01214720 | Hoffmann-La Roche |
Pancreatic Cancer
|
July 2005 | Phase 3 |
| NCT03607643 | Leaf Vertical Inc. |
Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme
|
January 15, 2019 | Phase 1|Phase 2 |
| NCT00288015 | Northwestern University|Genentech, Inc. |
Sarcoma
|
October 2005 | Phase 2 |
| NCT00403130 | George Albert Fisher|Genentech, Inc.|Eli Lilly and Company|Stanford University |
Breast Cancer|Metastatic Breast Cancer
|
February 2006 | Phase 2 |
| NCT04067856 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Allergan|Doheny Image Reading Center |
Diabetic Macular Edema|Cataract
|
January 1, 2020 | Not Applicable |
| NCT00467012 | Chugai Pharmaceutical |
Metastatic Breast Cancer
|
April 2007 | Phase 2 |
| NCT00281528 | Celgene |
Breast Neoplasms|Neoplasm Metastasis
|
February 1, 2006 | Phase 2 |
| NCT01202032 | Centre Leon Berard |
Metastatic Renal Cell Carcinoma|Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed
|
July 2010 | Phase 1 |
| NCT01442649 | UNICANCER |
Colorectal Cancer
|
December 2010 | Phase 2 |
| NCT01243359 | National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage I Renal Cell Cancer|Stage II Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor, Protocol Specific
|
October 2010 | Phase 1 |
| NCT03961698 | Infinity Pharmaceuticals, Inc.|Roche Pharma AG |
Breast Cancer|Renal Cell Carcinoma
|
December 17, 2019 | Phase 2 |
| NCT00388700 | Galectin Therapeutics Inc. |
Colorectal Cancer
|
October 2006 | Phase 2 |
| NCT00588237 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. |
Ovarian Cancer|Primary PERITONEUM|Fallopian Tube Cancer
|
August 2006 | Phase 2 |
| NCT04725448 | Sichuan Cancer Hospital and Research Institute |
Pulmonary Sarcomatoid Carcinoma|Non-small Cell Lung Cancer|Lung Diseases|Thoracic Neoplasms
|
April 6, 2021 | Phase 2 |
| NCT01623102 | Sichuan Cancer Hospital and Research Institute |
Lung Cancer
|
February 2013 | Phase 2 |
| NCT01441388 | Pfizer |
Carcinoma, Renal Cell|Glioblastoma|Carcinoma, Hepatocellular
|
December 2011 | Phase 1 |
| NCT02394834 | Takeda |
Colorectal Cancer
|
May 29, 2015 | Phase 3 |
| NCT00403026 | Narayana Nethralaya |
Wet AMD|Macular Oedema|Proliferative Diabetic Retinopathy
|
August 2006 | Not Applicable |
| NCT00524875 | Shahid Beheshti University of Medical Sciences |
Diabetic Retinopathy
|
January 2007 | Not Applicable |
| NCT05480306 | Leap Therapeutics, Inc. |
Colorectal Cancer|Colorectal Adenocarcinoma|Colo-rectal Cancer|Colorectal Cancer Metastatic
|
August 30, 2022 | Phase 2 |
| NCT00052390 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Sarcoma
|
October 2002 | Phase 2 |
| NCT00352521 | Duke University|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
April 2006 | Phase 2 |
| NCT01048554 | Mt. Sinai Medical Center, Miami|Northern California Melanoma Center |
Melanoma
|
November 2009 | Phase 2 |
| NCT01256762 | Geron Corporation |
Locally Recurrent or Metastatic Breast Cancer
|
November 2010 | Phase 2 |
| NCT05530785 | Yongchang Zhang|Hunan Province Tumor Hospital |
Hepatocellular Carcinoma Non-resectable
|
August 1, 2022 | Not Applicable |
| NCT00755157 | University Hospital of Crete |
Small Cell Lung Cancer
|
April 2008 | Phase 2 |
| NCT00754650 | Hoffmann-La Roche |
Lymphocytic Leukemia, Chronic
|
September 2008 | Phase 2 |
| NCT03387085 | ImmunityBio, Inc. |
Triple Negative Breast Cancer
|
March 16, 2018 | Phase 1|Phase 2 |
| NCT00049088 | National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
August 2002 | Phase 1 |
| NCT05113511 | First Affiliated Hospital of Zhejiang University|Sinocelltech Ltd. |
Healthy
|
May 9, 2018 | Phase 1 |
| NCT00451906 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
August 2006 | Phase 4 |
| NCT00107315 | Roswell Park Cancer Institute |
Colorectal Cancer
|
July 2004 | Phase 2 |
| NCT00909987 | Grupo Espanol Multidisciplinario del Cancer Digestivo|Royal Marsden NHS Foundation Trust |
Rectum Cancer
|
March 2009 | Phase 2 |
| NCT00074308 | National Cancer Institute (NCI) |
Recurrent Melanoma|Stage III Melanoma|Stage IV Melanoma|Unspecified Adult Solid Tumor, Protocol Specific
|
October 2003 | Phase 1|Phase 2 |
| NCT04556071 | Xiaoxiang Chen|Jiangsu Cancer Institute & Hospital |
Ovarian Neoplasms|Fallopian Tube Neoplasms|Endocrine Gland Neoplasms|Neoplasms by Site|Neoplasms|Genital Neoplasms, Female|Urogenital Neoplasms|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|Carcinoma, Ovarian Epithelial|Ovarian Diseases|Adnexal Diseases|Genital Diseases, Female|Endocrine System Diseases|Gonadal Disorders|Carcinoma|Bevacizumab|Enzyme Inhibitors|Antineoplastic Agents|Molecular Mechanisms of Pharmacological Action|Angiogenesis|BRCA1 Mutation|BRCA2 Mutation|Homologous Recombination Deficiency
|
November 6, 2020 | Phase 2 |
| NCT00843440 | Hospices Civils de Lyon |
Hemorrhagic Hereditary Telangiectasia
|
March 2009 | Phase 2 |
| NCT04107168 | CCTU- Cancer Theme|Microbiotica Ltd|Cambridge University Hospitals NHS Foundation Trust |
Melanoma|Renal Cancer|Lung Cancer
|
July 8, 2020 | |
| NCT00781846 | Merck Sharp & Dohme LLC|Ariad Pharmaceuticals |
Solid Tumor
|
October 2008 | Phase 1 |
| NCT02521051 | Massachusetts General Hospital|Genentech, Inc. |
Non-Small Cell Lung Cancer (NSCLC)
|
October 2015 | Phase 1|Phase 2 |
| NCT00667277 | Ronald Hoffman|Myeloproliferative Disorders-Research Consortium|National Cancer Institute (NCI)|Icahn School of Medicine at Mount Sinai |
Myelofibrosis
|
March 2008 | Phase 2 |
| NCT03181100 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Metastatic Thyroid Gland Carcinoma|Poorly Differentiated Thyroid Gland Carcinoma|Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8|Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8|Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8|Thyroid Gland Anaplastic Carcinoma|Unresectable Thyroid Gland Carcinoma
|
July 27, 2017 | Phase 2 |
| NCT00804206 | Asociación para Evitar la Ceguera en México |
Macular Edema
|
July 2008 | Phase 4 |
| NCT01013285 | Jonsson Comprehensive Cancer Center |
Brain and Central Nervous System Tumors
|
June 2006 | Phase 2 |
| NCT02036424 | Raj K. Maturi, MD|Allergan|Maturi, Raj K., M.D., P.C. |
Diabetic Macular Edema
|
January 2014 | Phase 4 |
| NCT01288404 | Ramathibodi Hospital |
Pterygium of the Conjunctiva and Cornea
|
January 2008 | Not Applicable |
| NCT01012297 | National Cancer Institute (NCI)|NRG Oncology |
Recurrent Uterine Corpus Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Corpus Leiomyosarcoma
|
November 2009 | Phase 3 |
| NCT01113398 | Katy Peters|Amgen|Duke University |
Glioblastoma Multiforme|Gliosarcoma
|
August 2010 | Phase 2 |
| NCT00807573 | Memorial Sloan Kettering Cancer Center |
Lung Cancer
|
December 2008 | Phase 2 |
| NCT01878422 | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
Metastatic Colorectal Cancer
|
November 2007 | Phase 3 |
| NCT00116506 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc.|Sanofi-Synthelabo |
Colorectal Cancer|Neoplasm Metastasis
|
January 2005 | Phase 2 |
| NCT01635803 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Leiden University Medical Center|Free University Medical Center|Erasmus Medical Center|Radboud University Medical Center|UMC Utrecht|University Medical Center Groningen |
Retinal Vein Occlusion
|
June 2012 | Phase 2|Phase 3 |
| NCT01390948 | Hoffmann-La Roche |
High Grade Glioma
|
October 18, 2011 | Phase 2 |
| NCT01022541 | Royal Marsden NHS Foundation Trust|Roche Pharma AG |
Metastatic Colorectal Cancer
|
June 2006 | Phase 2 |
| NCT00755118 | University Hospital of Crete |
Colorectal Cancer
|
October 2008 | Phase 2 |
| NCT04619303 | Lions Eye Institute, Perth, Western Australia|Lions Outback Vision|Allergan |
Diabetic Macular Edema|Diabetic Retinopathy
|
February 7, 2017 | Phase 4 |
| NCT02555800 | Centro de Investigación en. Enfermedades Infecciosas, Mexico |
Recurrent Respiratory Papillomatosis
|
December 2014 | Phase 2 |
| NCT01834014 | EPS Corporation |
Liver Metastasis|Colorectal Cancer
|
May 2013 | Not Applicable |
| NCT00959647 | Genentech, Inc. |
Ovarian Cancer|Basal Cell Carcinoma|Metastatic Colorectal Cancer
|
September 2009 | Phase 2 |
| NCT02217956 | Gustave Roussy, Cancer Campus, Grand Paris |
Ovarian Adenocarcinoma|Fallopian Tube Adenocarcinoma|Primary Peritoneal Carcinoma
|
June 2011 | Phase 1 |
| NCT04605796 | Shanghai Junshi Bioscience Co., Ltd. |
Advanced Hepatocellular Carcinoma (HCC)
|
April 10, 2020 | Phase 2 |
| NCT00321685 | National Cancer Institute (NCI) |
Rectal Adenocarcinoma|Stage II Rectal Cancer AJCC v7|Stage III Rectal Cancer AJCC v7
|
July 25, 2006 | Phase 2 |
| NCT03912415 | Biocad |
Cervical Cancer
|
October 1, 2019 | Phase 3 |
| NCT02681549 | Yale University |
Melanoma|Non-small Cell Lung Cancer|Brain Metastasis
|
May 2016 | Phase 2 |
| NCT00462423 | Lynn E. Spitler, MD|Celgene Corporation|Genentech, Inc.|Northern California Melanoma Center |
Metastatic Malignant Melanoma
|
April 2007 | Phase 2 |
| NCT00533429 | Eli Lilly and Company|Genentech, Inc. |
Non-small Cell Lung Cancer
|
October 2007 | Phase 2 |
| NCT01478321 | Northwestern University |
Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma
|
December 14, 2011 | Phase 2 |
| NCT02005549 | Hoffmann-La Roche |
Breast Cancer
|
February 2006 | Phase 2 |
| NCT00354978 | M.D. Anderson Cancer Center|Genentech, Inc.|Pfizer |
Colorectal Cancer
|
January 2005 | Phase 2 |
| NCT00591734 | SCRI Development Innovations, LLC|Genentech, Inc.|Novartis |
Metastatic Melanoma
|
January 2008 | Phase 2 |
| NCT01349660 | SCRI Development Innovations, LLC|Novartis |
Glioblastoma Multiforme
|
December 2011 | Phase 1|Phase 2 |
| NCT00354679 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Esophageal Cancer
|
April 2006 | Phase 2 |
| NCT00436332 | Southwest Oncology Group|National Cancer Institute (NCI) |
Lung Cancer
|
July 2007 | Phase 2 |
| NCT01182350 | Karen D. Wright MD|Boston Children´s Hospital|University of California, San Francisco|Ann & Robert H Lurie Children´s Hospital of Chicago|Children´s Healthcare of Atlanta|Children´s Hospital Colorado|Children´s Hospital Los Angeles|Children´s Hospital of Michigan|Children´s Hospitals and Clinics of Minnesota|Cook Children´s Medical Center|OHSU Doernbecher Children´s Hospital|Duke University|Johns Hopkins University|Nicklaus Children´s Hospital f+k+a Miami Children´s Hospital|Nemours Children´s Clinic|New York University|Milton S. Hershey Medical Center|Seattle Children´s Hospital|Lucile Packard Children´s Hospital|University of Louisville|Children´s National Research Institute|Washington University School of Medicine|Phoenix Children´s Hospital|Medical University of South Carolina|Dana-Farber Cancer Institute |
Diffuse Intrinsic Pontine Glioma
|
September 2011 | Phase 2 |
| NCT04175158 | Genor Biopharma Co., Ltd. |
Non-small Cell Lung Cancer
|
April 24, 2017 | Phase 1 |
| NCT03169777 | ImmunityBio, Inc. |
Colorectal Cancer
|
August 2018 | Phase 1|Phase 2 |
| NCT00800202 | Hoffmann-La Roche |
Non-Small Cell Lung Cancer
|
April 2009 | Phase 2 |
| NCT00567554 | German Breast Group|AGO Study Group |
Breast Cancer
|
October 2007 | Phase 3 |
| NCT01359397 | The Netherlands Cancer Institute |
Metastatic Gastric Cancer|Adenocarcinoma of the Gastro-oesophageal Junction
|
March 2011 | Phase 2 |
| NCT01197170 | M.D. Anderson Cancer Center |
Solid Tumors|Advanced Cancer
|
September 7, 2010 | Phase 1 |
| NCT00974389 | Osaka Medical College|National Cancer Institute (NCI) |
Colorectal Cancer
|
July 2009 | Phase 2 |
| NCT00980239 | M.D. Anderson Cancer Center |
Liver Cancer|Advanced Cancer
|
September 2009 | Phase 1 |
| NCT01428388 | Barnes Retina Institute|Retina Associates of Florida, P.A.|Illinois Retina Associates|Kresge Eye Institute|Long Island Vitreoretinal Consultants|Mid Atlantic Retina|Retina Associates, Kansas City|Massachusetts Eye and Ear Infirmary |
Retinal Vein Occlusion|Macular Edema
|
September 2011 | Not Applicable |
| NCT00536640 | Aktion Bronchialkarzinom e.V.|Roche Pharma AG |
Carcinoma, Non-Small-Cell Lung
|
November 2007 | Phase 2 |
| NCT02060305 | National Taiwan University Hospital |
Hemophilia|Synovitis
|
February 1, 2014 | Phase 1 |
| NCT01501760 | University Hospital, Limoges |
Corneal Newvessels
|
May 13, 2012 | Phase 3 |
| NCT03635489 | Hoffmann-La Roche |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
|
August 15, 2018 | Phase 3 |
| NCT00361231 | Massachusetts General Hospital|Genentech, Inc.|Sanofi|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Dana-Farber Cancer Institute |
Biliary Tract Cancer|Gallbladder Adenocarcinoma
|
May 2006 | Phase 2 |
| NCT01213238 | M.D. Anderson Cancer Center |
Advanced Cancers
|
September 30, 2010 | Phase 1 |
| NCT05030493 | Takeda |
Colorectal Cancer
|
August 31, 2021 | |
| NCT01095809 | Hospital Clinic of Barcelona |
Uveitis
|
April 2010 | Phase 3 |
| NCT05355155 | The First Affiliated Hospital with Nanjing Medical University |
Post-orthotopic Liver Transplantation|Hepatocellular Carcinoma Recurrent
|
May 1, 2022 | Phase 2 |
| NCT00569790 | Taiho Pharmaceutical Co., Ltd. |
Colorectal Cancer
|
October 2007 | Phase 2 |
| NCT05609370 | BeiGene |
Unresectable or Metastatic Microsatellite Stable+Mismatch Repair Proficient Colorectal Cancer
|
November 2022 | Phase 1|Phase 2 |
| NCT00900172 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Lung Cancer
|
March 15, 2008 | |
| NCT01652560 | LiNanlin,Ph.D, Chief Physician,Clinical Professor|Roche Pharma AG|Xijing Hospital |
Breast Cancer|Bevacizumab|Neoadjuvant Chemotherapy|Molecular Targeted Therapy
|
June 2012 | |
| NCT01910610 | GERCOR - Multidisciplinary Oncology Cooperative Group|Hoffmann-La Roche |
Colorectal Cancer Metastatic
|
October 30, 2013 | Phase 3 |
| NCT04126044 | Pfizer |
Pharmacokinetics
|
January 22, 2021 | Phase 1 |
| NCT03661723 | Dana-Farber Cancer Institute|Merck Sharp & Dohme LLC |
Glioblastoma
|
September 28, 2018 | Phase 2 |
| NCT01159236 | M.D. Anderson Cancer Center |
Breast Cancer
|
September 2010 | Not Applicable |
| NCT03227263 | Hospices Civils de Lyon |
Rendu Osler Disease|Telangiectasia, Hereditary Hemorrhagic
|
September 28, 2017 | Phase 3 |
| NCT04224636 | Ludwig-Maximilians - University of Munich |
Hepatocellular Carcinoma Non-resectable
|
April 6, 2020 | Phase 2 |
| NCT03351296 | Gustave Roussy, Cancer Campus, Grand Paris|National Cancer Institute, France |
Pancreatic Cancer
|
February 9, 2018 | Phase 2 |
| NCT00886691 | GOG Foundation|National Cancer Institute (NCI) |
Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
|
December 27, 2010 | Phase 2 |
| NCT03743662 | Memorial Sloan Kettering Cancer Center |
Glioblastoma
|
November 12, 2018 | Phase 2 |
| NCT02768389 | Case Comprehensive Cancer Center|University of Cincinnati|OhioHealth Research Institute |
Glioblastoma|Brain Tumor
|
September 6, 2016 | Early Phase 1 |
| NCT05238831 | OHSU Knight Cancer Institute|Oregon Health and Science University|Genentech, Inc. |
Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Locally Advanced Breast Carcinoma|Locally Advanced Malignant Solid Neoplasm|Locally Advanced Ovarian Carcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Ovarian Carcinoma|Refractory Breast Carcinoma|Refractory Malignant Solid Neoplasm|Refractory Ovarian Carcinoma|Stage III Ovarian Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Unresectable Malignant Solid Neoplasm|Unresectable Ovarian Carcinoma
|
December 1, 2022 | Phase 2 |
| NCT01159171 | Hoffmann-La Roche |
Colorectal Cancer
|
January 2006 | Phase 2 |
| NCT01627249 | Jaeb Center for Health Research|National Eye Institute (NEI)|Genentech, Inc.|Regeneron Pharmaceuticals |
Diabetic Macular Edema
|
August 2012 | Phase 3 |
| NCT01621880 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
Nasopharyngeal Carcinoma|Adverse Effect of Radiation Therapy|Brain Necrosis
|
June 2012 | Phase 2 |
| NCT00891527 | Boston Children´s Hospital |
Pulmonary Veno Occlusive Disease
|
October 2008 | Phase 1|Phase 2 |
| NCT00600301 | Asociación para Evitar la Ceguera en México |
Diffuse Diabetic Macular Edema
|
Phase 3 | |
| NCT00262067 | Genentech, Inc. |
Metastatic Breast Cancer
|
December 2005 | Phase 3 |
| NCT00055913 | National Cancer Institute (NCI) |
Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Salivary Gland Squamous Cell Carcinoma|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
|
March 2003 | Phase 1|Phase 2 |
| NCT00915603 | SCRI Development Innovations, LLC|Novartis |
Metastatic Breast Cancer
|
July 2009 | Phase 2 |
| NCT00217503 | National Cancer Institute (NCI) |
Lymphoma
|
July 2005 | Phase 2 |
| NCT04008030 | Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd |
Metastatic Colorectal Cancer
|
August 5, 2019 | Phase 3 |
| NCT00924820 | M.D. Anderson Cancer Center|Genentech, Inc. |
Neoplastic Meningitis
|
June 2009 | Phase 1|Phase 2 |
| NCT00387751 | National Cancer Institute (NCI) |
Recurrent Melanoma|Stage III Skin Melanoma|Stage IV Skin Melanoma
|
August 2006 | Phase 2 |
| NCT00803062 | National Cancer Institute (NCI)|NRG Oncology |
Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVB Cervical Cancer
|
April 2009 | Phase 3 |
| NCT05239741 | Merck Sharp & Dohme LLC |
Colorectal Neoplasms
|
April 2, 2022 | Phase 3 |
| NCT01212822 | Fox Chase Cancer Center|National Cancer Institute (NCI) |
Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Squamous Cell Carcinoma of the Esophagus|Stage IA Esophageal Cancer|Stage IA Gastric Cancer|Stage IB Esophageal Cancer|Stage IB Gastric Cancer|Stage IIA Esophageal Cancer|Stage IIA Gastric Cancer|Stage IIB Esophageal Cancer|Stage IIB Gastric Cancer|Stage IIIA Esophageal Cancer|Stage IIIA Gastric Cancer|Stage IIIB Esophageal Cancer|Stage IIIB Gastric Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Gastric Cancer
|
April 27, 2011 | Phase 2 |
| NCT01417494 | Federation Francophone de Cancerologie Digestive|Roche Pharma AG |
Colorectal Cancer
|
July 2011 | Phase 2 |
| NCT01004172 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc. |
Metastatic Breast Cancer|Breast Cancer|Progressive Breast Cancer
|
November 2009 | Phase 2 |
| NCT02594423 | University of Nottingham |
Corneal Neovascularisation
|
December 2015 | Phase 4 |
| NCT00709657 | Medical University of Vienna |
Macular Degeneration|Regional Blood Flow|Vascular Endothelial Growth Factor
|
March 2008 | Not Applicable |
| NCT00278889 | AstraZeneca |
Colorectal Cancer
|
January 2006 | Phase 2 |
| NCT05438108 | Huazhong University of Science and Technology |
Metastatic Colorectal Cancer
|
July 1, 2022 | Phase 2 |
| NCT02314377 | University of California, San Francisco |
Brain Arteriovenous Malformation
|
June 2016 | Phase 1 |
| NCT02272413 | Boehringer Ingelheim |
Carcinoma, Non-Small-Cell Lung
|
July 8, 2015 | Phase 3 |
| NCT00335829 | Yale University|National Cancer Institute (NCI)|Northwestern University |
Liver Cancer
|
May 2006 | Phase 2 |
| NCT01831089 | PharmaMar |
Breast Cancer|Ovarian Cancer|Gynecological Cancer|Head and Neck Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Non-squamous Cell Lung Cancer
|
September 2013 | Phase 1 |
| NCT01860586 | Wills Eye |
Retinal Detachment|Vitreoretinopathy Proliferative
|
June 2013 | Not Applicable |
| NCT00368992 | National Cancer Institute (NCI) |
Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
|
August 2006 | Phase 2 |
| NCT02299999 | UNICANCER|Fondation ARC|AstraZeneca |
Metastatic Breast Cancer
|
April 7, 2014 | Phase 2 |
| NCT05462613 | Centre Hospitalier Universitaire de Besancon |
Metastatic Colorectal Cancer
|
November 2022 | Phase 2|Phase 3 |
| NCT03631836 | Assistance Publique Hopitaux De Marseille |
Glioblastoma
|
January 1, 2019 | Phase 1 |
| NCT02312245 | Mayo Clinic|National Cancer Institute (NCI) |
Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
|
July 21, 2015 | Phase 2 |
| NCT01089413 | Hoffmann-La Roche |
Colorectal Cancer
|
January 2010 | |
| NCT01164189 | European Organisation for Research and Treatment of Cancer - EORTC|Hoffmann-La Roche |
Central Nervous System Tumors
|
February 2011 | Phase 2 |
| NCT05303038 | Fudan University |
Metastatic Breast Cancer in the Liver
|
May 1, 2022 | Phase 2 |
| NCT04988191 | Peking University |
Colorectal Carcinoma
|
December 24, 2020 | Phase 1|Phase 2 |
| NCT00973609 | AIO-Studien-gGmbH|Roche Pharma AG |
Colorectal Neoplasms
|
August 2009 | Phase 3 |
| NCT00735241 | Sirtex Medical |
Colorectal Carcinoma|Liver Metastases
|
July 2008 | Phase 2|Phase 3 |
| NCT02292758 | Academic and Community Cancer Research United|National Cancer Institute (NCI) |
Colorectal Adenocarcinoma|RAS Wild Type|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7
|
December 12, 2014 | Phase 2 |
| NCT00883688 | M.D. Anderson Cancer Center|CERN Foundation - Collaborative Ependymoma Research Network |
Brain Cancer|Pediatric Cancers
|
July 2009 | Phase 2 |
| NCT00621686 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
September 2008 | Phase 2 |
| NCT04486352 | Alliance Foundation Trials, LLC.|Genentech, Inc.|Foundation Medicine|Pfizer |
Endometrial Cancer
|
October 20, 2021 | Phase 1|Phase 2 |
| NCT00234052 | Northwestern University|National Cancer Institute (NCI) |
Lung Cancer
|
July 28, 2005 | Phase 2 |
| NCT00126490 | National Cancer Institute (NCI) |
Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer
|
March 2005 | Phase 2 |
| NCT00327093 | Hospices Civils de Lyon |
Colorectal Cancer|Neoplasm Metastasis
|
May 2006 | Phase 4 |
| NCT01684397 | Roswell Park Cancer Institute|GlaxoSmithKline |
Clear Cell Renal Cell Carcinoma|Stage IV Renal Cell Cancer
|
November 21, 2012 | Phase 1|Phase 2 |
| NCT04487067 | Hoffmann-La Roche |
Carcinoma, Hepatocellular
|
August 25, 2020 | Phase 3 |
| NCT00658697 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc. |
Prostate Cancer
|
June 2008 | Phase 2 |
| NCT05160896 | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Advanced Metastatic Colorectal Cancer
|
November 12, 2021 | Phase 2 |
| NCT04541173 | Aiwu Ruth He, MD|Georgetown University|Genentech, Inc.|Hoosier Cancer Research Network |
Hepatocellular Carcinoma
|
November 30, 2020 | Phase 2 |
| NCT02655536 | National Taiwan University Hospital |
Carcinoma, Non-Small-Cell Lung|Brain Neoplasms
|
August 1, 2017 | Phase 2 |
| NCT00307723 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Genentech, Inc.|Sanofi |
Pancreatic Cancer|Pancreatic Ductal Adenocarcinoma
|
May 2006 | Phase 1|Phase 2 |
| NCT03698162 | University of Southern California|National Cancer Institute (NCI) |
Brain Metastases|Glioma of Brain|Brain Tumor|Metastatic Melanoma
|
April 13, 2021 | Not Applicable |
| NCT00406744 | Asociación para Evitar la Ceguera en México |
Age Related Macular Degeneration|Choroidal Neovascularization
|
May 2006 | Phase 3 |
| NCT03832179 | Bay Area Retina Associates|Allergan |
Diabetic Macular Edema|Cataract
|
November 15, 2018 | Phase 4 |
| NCT00609765 | H. Lee Moffitt Cancer Center and Research Institute|Genentech, Inc. |
Pancreatic Cancer
|
August 2007 | Phase 2 |
| NCT01183663 | M.D. Anderson Cancer Center|Celgene |
Advanced Cancers
|
August 2010 | Phase 1 |
| NCT03647956 | The University of Hong Kong |
NSCLC Stage IIIB|NSCLC Stage IV|EGFR Activating Mutation
|
October 1, 2018 | Phase 2 |
| NCT00416494 | Herbert Hurwitz, MD|National Cancer Institute (NCI)|Duke University |
Colorectal Cancer
|
September 2003 | Phase 2 |
| NCT03271255 | Shenzhen People´s Hospital |
Colorectal Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms
|
May 23, 2018 | Phase 2 |
| NCT05273814 | Tianjin Medical University Cancer Institute and Hospital |
Non-Small Cell Lung Cancer
|
August 1, 2022 | Phase 1 |
| NCT00118105 | Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Colorectal Cancer|Metastatic Cancer
|
November 2006 | Phase 2 |
| NCT03167164 | ImmunityBio, Inc. |
Merkel Cell Carcinoma
|
December 2017 | Phase 1|Phase 2 |
| NCT00774241 | Hoffmann-La Roche |
Breast Cancer
|
January 2010 | Phase 4 |
| NCT05173298 | CHA University|Boryung Pharmaceutical Co., Ltd |
Advanced Hepatocellular Carcinoma
|
August 2, 2021 | |
| NCT03511963 | Shanghai Henlius Biotech |
Metastatic Colorectal Cancer (mCRC)
|
April 9, 2018 | Phase 3 |
| NCT00467194 | National Cancer Centre, Singapore |
Liver Cancer
|
December 2006 | Phase 1 |
| NCT04796025 | Sun Yat-sen University |
Hepatocellular Carcinoma
|
September 23, 2021 | Phase 2 |
| NCT01399684 | Genentech, Inc. |
Metastatic Colorectal Cancer
|
November 2011 | Phase 2 |
| NCT01067469 | M.D. Anderson Cancer Center |
Brain Cancer|Glioblastoma
|
January 2010 | Phase 2 |
| NCT02794571 | Genentech, Inc. |
Advanced+Metastatic Tumors
|
May 23, 2016 | Phase 1 |
| NCT05070104 | Cornerstone Pharmaceuticals |
C04.588.274.476.411.307
|
March 30, 2023 | Phase 1 |
| NCT04952571 | Beijing Sanbo Brain Hospital |
Recurrent Glioblastoma
|
May 1, 2021 | Phase 2 |
| NCT01144988 | Medical University Innsbruck|Roche, Austria |
Recurrent Malignant Glioma
|
March 2010 | Phase 2 |
| NCT00656435 | National Taiwan University Hospital |
Proliferative Diabetic Retinopathy
|
December 2006 | Phase 3 |
| NCT02350530 | Sun Yat-sen University |
Metastatic Colorectal Cancer
|
January 2015 | Phase 2 |
| NCT05065021 | University Health Network, Toronto|GlaxoSmithKline |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|High Grade Serous Cancer|High Grade Endometrioid Cancer
|
June 6, 2022 | Phase 2 |
| NCT00407563 | Accelerated Community Oncology Research Network|Genentech, Inc.|Celgene Corporation |
Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma
|
January 2007 | Phase 2 |
| NCT01093235 | Cambridge University Hospitals NHS Foundation Trust|National Cancer Institute (NCI) |
Breast Cancer|Cardiac Toxicity|Perioperative+Postoperative Complications
|
April 2009 | Phase 3 |
| NCT05571267 | IVERIC bio, Inc. |
Macular Degeneration
|
October 20, 2016 | Phase 2 |
| NCT00445406 | Swiss Group for Clinical Cancer Research |
Breast Cancer
|
December 2006 | Phase 2 |
| NCT02414165 | Tocagen Inc. |
Glioblastoma Multiforme|Anaplastic Astrocytoma
|
November 30, 2015 | Phase 2|Phase 3 |
| NCT01209442 | University of Colorado, Denver|Genentech, Inc. |
Glioblastoma Multiforme
|
September 16, 2010 | Phase 2 |
| NCT00365365 | Sanofi |
Breast Cancer
|
August 2006 | Phase 2 |
| NCT00828672 | Universitaire Ziekenhuizen KU Leuven |
Locally Advanced Rectal Cancer
|
June 2009 | Phase 2 |
| NCT01640405 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Roche Pharma AG |
Metastatic Colorectal Cancer
|
July 2012 | Phase 3 |
| NCT01664182 | National Cancer Institute (NCI) |
Advanced Renal Cell Carcinoma|Advanced Sarcomatoid Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7
|
August 1, 2012 | Phase 2 |
| NCT04705519 | Peking University|Qilu Pharmaceutical Co., Ltd. |
Neuroendocrine Carcinoma
|
January 5, 2021 | Phase 2 |
| NCT00670982 | Harold J. Burstein, MD, PhD|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Genentech, Inc.|New Hampshire Oncology-Hematology PA|Lowell General Hospital|Hartford Hospital|Dana-Farber Cancer Institute |
Breast Cancer
|
May 2008 | Phase 2 |
| NCT04356729 | Elizabeth Buchbinder|Genentech, Inc.|Dana-Farber Cancer Institute |
Clinical Stage III Cutaneous Melanoma AJCC v8|Stage IV Melanoma|Unresectable Stage III Cutaneous Melanoma|Unresectable Stage IV Cutaneous Melanoma
|
August 6, 2020 | Phase 2 |
| NCT00434356 | Genentech, Inc. |
Metastatic Breast Cancer
|
March 2007 | Phase 2 |
| NCT00203372 | Translational Oncology Research International|Genentech, Inc. |
Breast Cancer
|
May 2005 | Phase 2 |
| NCT01164007 | Hoffmann-La Roche |
Malignant Melanoma
|
June 30, 2006 | Phase 2 |
| NCT00280007 | Medical University of Vienna |
Hepatocellular Carcinoma
|
January 2006 | Phase 2 |
| NCT00423696 | UNICANCER |
Colorectal Cancer
|
March 23, 2006 | Phase 2 |
| NCT01722162 | Washington University School of Medicine |
Colorectal Neoplasms
|
April 2013 | Phase 2 |
| NCT05537402 | University of Texas Southwestern Medical Center|Genentech, Inc. |
Hepatocellular Carcinoma
|
January 1, 2023 | Phase 2 |
| NCT05440708 | Tvardi Therapeutics, Incorporated |
Hepatocellular Carcinoma
|
November 2022 | Phase 1|Phase 2 |
| NCT00525525 | University of California, San Francisco |
Glioblastoma|Gliosarcoma
|
September 2007 | Phase 2 |
| NCT01392209 | Memorial Sloan Kettering Cancer Center|Genentech, Inc.|Columbia University|University of California, San Francisco |
Brain Cancer|MALIGNANT GLIOMA|Glioblastoma|Anaplastic Astrocytoma (AA)|Anaplastic Oligodendroglioma (AO)|Anaplastic Oligo-astrocytoma (AOA)|Anaplastic Mixed Gliomas|Malignant Glioma NOS
|
July 8, 2011 | Phase 1 |
| NCT01788280 | University of Utah |
Glioblastoma Multiforme (GBM)
|
January 2018 | Phase 2 |
| NCT03587311 | National Cancer Institute (NCI) |
Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube High Grade Serous Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian High Grade Serous Adenocarcinoma|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Primary Peritoneal High Grade Serous Adenocarcinoma
|
June 29, 2018 | Phase 2 |
| NCT00590681 | University of Chicago|Genentech, Inc. |
Glioblastoma Multiforme
|
February 2007 | Phase 2 |
| NCT00546156 | Ian E. Krop, MD, PhD|Genentech, Inc.|Massachusetts General Hospital|Brigham and Women´s Hospital|New Hampshire Oncology-Hematology PA|Dana-Farber Cancer Institute |
Breast Cancer
|
October 2007 | Phase 2 |
| NCT00854529 | Rabin Medical Center |
Bleb Vascularity|Bleb Fibrosis|Trabeculectomy Failure
|
April 2009 | Phase 2 |
| NCT00970957 | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
Macular Edema|Retinal Vein Occlusion
|
September 2009 | Phase 3 |
| NCT00773188 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
December 2008 | Phase 1 |
| NCT00418431 | Asociación para Evitar la Ceguera en México |
Central Serous Chorioretinopathy
|
April 2006 | Phase 2|Phase 3 |
| NCT01191697 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Genentech, Inc. |
Esophageal Cancer|Gastric Cancer
|
February 2011 | Phase 2 |
| NCT05386524 | Fudan University |
Breast Cancer
|
June 15, 2022 | Phase 2 |
| NCT03387098 | ImmunityBio, Inc. |
Pancreatic Cancer
|
January 2, 2018 | Phase 1|Phase 2 |
| NCT01738646 | Duke University|Genentech, Inc.|Merck Sharp & Dohme LLC |
Recurrent Glioblastoma Multiforme|Malignant Glioma|Adult Brain Tumor
|
January 2013 | Phase 2 |
| NCT02024607 | Sumitomo Pharma Oncology, Inc. |
Advanced Gastrointestinal Cancer
|
January 2014 | Phase 1|Phase 2 |
| NCT02623621 | Azienda Ospedaliero, Universitaria Pisana |
Metastatic Colorectal Cancer
|
November 2015 | |
| NCT03303495 | Sun Yat-sen University |
Colorectal Neoplasms|Neoplasm Metastasis|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms
|
November 14, 2011 | Phase 3 |
| NCT00623233 | Eli Lilly and Company|Genentech, Inc. |
Metastatic Breast Cancer|Locally Advanced Breast Cancer
|
March 2008 | Phase 2 |
| NCT01198158 | National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7
|
September 15, 2010 | Phase 3 |
| NCT01015222 | M.D. Anderson Cancer Center |
Advanced Cancer
|
November 2009 | Phase 1 |
| NCT00497497 | Genentech, Inc. |
Colorectal Cancer
|
October 2007 | Phase 1 |
| NCT02314182 | Hospices Civils de Lyon |
Rectal Adenocarcinoma
|
November 20, 2014 | Phase 3 |
| NCT04449874 | Genentech, Inc. |
Non-Small Cell Lung Cancer|Colorectal Cancer|Advanced Solid Tumors
|
July 29, 2020 | Phase 1 |
| NCT00345696 | Unidad Integral de Investigación en Oncología S.L.|Hoffmann-La Roche |
Metastatic Colorectal Cancer
|
June 2006 | Phase 2 |
| NCT00659022 | Radboud University Medical Center |
Colorectal Neoplasms|Liver Neoplasms
|
July 2008 | Phase 2 |
| NCT01206530 | Abramson Cancer Center of the University of Pennsylvania |
Rectal Cancer|Colon Cancer|Metastasis|Adenocarcinoma
|
September 2010 | Phase 1|Phase 2 |
| NCT03556839 | Grupo Español de Investigación en Cáncer de Ovario|Hoffmann-La Roche|ARCAGY+ GINECO GROUP|Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies|MaNGO|NSGO|Japanese Gynecologic Oncology Group|Gynecologic Oncology Group Foundation|AGO Study Group |
Carcinoma of the Cervix, Stage IVB
|
September 25, 2018 | Phase 3 |
| NCT02959749 | Qingdao Central Hospital |
Progression Free Survival
|
August 2015 | Phase 2|Phase 3 |
| NCT02488330 | Hoffmann-La Roche |
Solid Tumor
|
August 27, 2015 | Phase 3 |
| NCT02497157 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan|Hiroshima Prefectural Hospital|National Hospital Organization Shikoku Cancer Center |
Metastatic Colorectal Cancer
|
May 21, 2015 | Phase 2 |
| NCT00480831 | Genentech, Inc. |
Non-Small Cell Lung Cancer
|
June 2007 | Phase 2 |
| NCT00404404 | Premiere Oncology|National Cancer Institute (NCI) |
Breast Cancer
|
October 2006 | Phase 2 |
| NCT00348998 | Virginia Mason Hospital+Medical Center|National Cancer Institute (NCI) |
Prostate Cancer
|
April 2006 | Phase 2 |
| NCT03806049 | Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
Ovarian Cancer
|
December 2019 | Phase 3 |
| NCT00876993 | Johns Hopkins All Children´s Hospital|The V Foundation|Brain Tumor Alliance |
Central Nervous System Tumors
|
September 2008 | Phase 1 |
| NCT00318136 | Genentech, Inc. |
Non-small Cell Lung Cancer
|
September 2005 | Phase 2 |
| NCT02582970 | Hoffmann-La Roche |
Colorectal Cancer
|
May 2005 | Phase 4 |
| NCT00015951 | University of Maryland, Baltimore|National Cancer Institute (NCI)|University of Maryland Greenebaum Cancer Center |
Leukemia|Myelodysplastic Syndromes
|
April 2001 | Phase 2 |
| NCT04466917 | Amgen|Parexel |
Metastatic Non-small Cell Lung Cancer (NSCLC)|Non-squamous NSCLC
|
May 15, 2021 | Phase 3 |
| NCT04938583 | CanariaBio Inc.|Korean Cancer Study Group |
Ovarian Cancer by FIGO Stage|Ovarian Cancer Stage III|Ovarian Cancer Stage IV
|
March 17, 2021 | Phase 1|Phase 2 |
| NCT00409565 | National Cancer Institute (NCI) |
Head and Neck Cancer|Squamous Cell Carcinoma
|
September 2006 | Phase 2 |
| NCT00268450 | Medical University of South Carolina |
Bladder Cancer
|
September 21, 2005 | Phase 2 |
| NCT01306591 | Peking University People´s Hospital |
Exudative Age-related Macular Degeneration
|
January 2008 | Not Applicable |
| NCT01622543 | Canadian Cancer Trials Group|Oncolytics Biotech |
Colorectal Cancer
|
June 11, 2012 | Phase 2 |
| NCT02698254 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Recurrent Brain Neoplasm
|
July 20, 2016 | Not Applicable |
| NCT00853073 | Wills Eye |
Glaucoma
|
February 2009 | Phase 2|Phase 3 |
| NCT00643565 | Hoffmann-La Roche |
Sarcoma
|
July 29, 2008 | Phase 2 |
| NCT01858649 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Grand Hôpital de Charleroi |
Metastatic Colorectal Cancer
|
May 2013 | Phase 2 |
| NCT03240549 | Beijing Hospital |
Non-small Cell Lung Cancer Metastatic
|
August 2017 | Phase 2 |
| NCT00468429 | Grewal Eye Institute |
Glaucoma
|
May 2007 | Phase 4 |
| NCT03367182 | Yonsei University |
Ovarian Cancer
|
September 1, 2017 | |
| NCT00317200 | Hoosier Cancer Research Network|Genentech, Inc.|Walther Cancer Institute |
Small Cell Lung Cancer
|
April 2006 | Phase 2 |
| NCT00642577 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2007 | Phase 3 |
| NCT03321513 | Jaeb Center for Health Research |
Diabetic Macular Edema
|
December 7, 2017 | Phase 3 |
| NCT00376701 | Lawson Health Research Institute|QLT Inc.|Canadian Retinal Trials Group |
Age Related Macular Degeneration
|
September 2006 | Phase 2 |
| NCT03694262 | Medical College of Wisconsin|Genentech, Inc.|Clovis Oncology, Inc. |
Endometrial Cancer|Uterine Carcinosarcoma
|
July 19, 2019 | Phase 2 |
| NCT00550537 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) |
Lung Cancer
|
October 2007 | Phase 2 |
| NCT00126503 | National Cancer Institute (NCI) |
Chromophobe Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Sarcomatoid Renal Cell Carcinoma|Stage IV Renal Cell Cancer
|
May 2005 | Phase 1|Phase 2 |
| NCT00027599 | National Cancer Institute (NCI) |
Prostate Cancer
|
December 2001 | Phase 2 |
| NCT00661778 | Hoffmann-La Roche |
Non-small Cell Lung Cancer
|
July 2007 | Phase 2 |
| NCT00417976 | Tony Bekaii-Saab|Genentech, Inc.|Ohio State University Comprehensive Cancer Center |
Pancreatic Cancer
|
December 2006 | Phase 2 |
| NCT00879437 | Baylor College of Medicine|Cook Children´s Medical Center|University of Oklahoma|University of Texas, Southwestern Medical Center at Dallas|The University of Texas Health Science Center at San Antonio|M.D. Anderson Cancer Center |
Glial Cell Tumors|Malignant Gliomas|Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliomatosis Cerebri|Gliosarcoma|Brainstem Glioma|Diffuse Intrinsic Pontine Glioma
|
September 1, 2009 | Phase 2 |
| NCT01014468 | Instituto de Olhos de Goiania |
Age Related Macular Degeneration
|
March 2009 | Phase 3 |
| NCT02250599 | Sun Yat-sen University |
Nasopharyngeal Neoplasms
|
August 2014 | Phase 2 |
| NCT00631371 | Pfizer |
Renal Cell Carcinoma
|
April 2008 | Phase 3 |
| NCT00705874 | Progen Pharmaceuticals |
Cancer
|
May 2006 | Phase 1 |
| NCT04425187 | Fudan University |
PFS
|
June 8, 2020 | Phase 2 |
| NCT05191784 | Genexine, Inc. |
Recurrent Glioblastoma
|
January 26, 2022 | Phase 2 |
| NCT00805649 | Johann Wolfgang Goethe University Hospital |
Age-Related Macular Degeneration
|
January 2006 | Phase 4 |
| NCT02187302 | NewLink Genetics Corporation|Lumos Pharma |
Metastatic Renal Cell Carcinoma
|
July 2014 | Phase 2 |
| NCT01305213 | National Cancer Institute (NCI)|NRG Oncology |
Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
|
March 21, 2011 | Phase 2 |
| NCT02925234 | The Netherlands Cancer Institute|Amgen|AstraZeneca|Bayer|Bristol-Myers Squibb|Novartis|Roche Pharma AG|Merck Sharp & Dohme LLC|Boehringer Ingelheim|Ipsen|Eisai Inc.|Pfizer|Clovis Oncology, Inc.|Eli Lilly and Company|Janssen, LP |
Cancer|Tumors|Neoplasm|Neoplasia
|
August 2016 | Phase 2 |
| NCT00530907 | M.D. Anderson Cancer Center |
Advanced Cancer
|
June 2007 | Phase 1 |
| NCT01792934 | Radboud University Medical Center|Erasmus Medical Center |
Multi-organ Metastatic Colorectal Cancer
|
May 2013 | Not Applicable |
| NCT01314274 | Medical University of Vienna |
HHT|Morbus Osler|Epistaxis
|
March 2011 | Phase 2 |
| NCT01765582 | Hoffmann-La Roche |
Colorectal Neoplasms
|
January 23, 2013 | Phase 2 |
| NCT00381797 | National Cancer Institute (NCI) |
Childhood Cerebral Anaplastic Astrocytoma|Childhood Oligodendroglioma|Childhood Spinal Cord Neoplasm|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma
|
August 2006 | Phase 2 |
| NCT03452579 | Case Comprehensive Cancer Center |
Glioblastoma
|
May 21, 2018 | Phase 2 |
| NCT00252564 | US Oncology Research|Bristol-Myers Squibb|Memorial Sloan Kettering Cancer Center|Prologue Research International |
Metastatic Colorectal Cancer
|
September 2005 | Phase 3 |
| NCT03082209 | AbbVie |
Advanced Solid Tumors|Cancer|Hematologic Malignancies
|
March 20, 2017 | Phase 1 |
| NCT00620971 | Hellenic Oncology Research Group|University Hospital of Crete |
Non Small Cell Lung Cancer
|
January 2008 | Phase 2 |
| NCT05318443 | Shanghai Institute Of Biological Products|Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Non-squamous Non-small-cell Lung Cancer
|
April 17, 2020 | Phase 3 |
| NCT01232777 | Vision Research Foundation |
Retinopathy of Prematurity
|
June 2012 | Phase 2 |
| NCT05616390 | Tianjin Medical University Cancer Institute and Hospital |
Hepatocellular Carcinoma
|
November 2022 | Phase 2 |
| NCT00121134 | Harold J. Burstein, MD, PhD|Genentech, Inc.|Beth Israel Deaconess Medical Center|Indiana University School of Medicine|University of California, San Francisco|University of North Carolina|Dana-Farber Cancer Institute |
Breast Cancer
|
June 2005 | Not Applicable |
| NCT00745511 | Ora Bio Ltd. |
Macular Degeneration
|
March 2009 | Phase 1|Phase 2 |
| NCT00666692 | Abbott |
Non-small Cell Lung Cancer
|
April 2008 | Phase 1 |
| NCT04393220 | Fuda Cancer Hospital, Guangzhou |
Progress Free Survival (PFS) and Overall Survival (OS)
|
May 11, 2020 | Phase 2 |
| NCT01115491 | Hoffmann-La Roche |
Glioblastoma Multiforme
|
June 2010 | Phase 2 |
| NCT02698280 | Huashan Hospital |
Glioblastoma
|
July 2015 | Phase 2 |
| NCT00786669 | Children´s Hospital Medical Center, Cincinnati |
Solid Tumor
|
October 2008 | Phase 1 |
| NCT00365144 | University of California, San Francisco |
Pancreatic Cancer
|
February 2006 | Phase 2 |
| NCT04524871 | Hoffmann-La Roche|Sanofi|Tempest Therapeutics |
Advanced Liver Cancers
|
November 2, 2020 | Phase 1|Phase 2 |
| NCT01706120 | National Cancer Institute, Naples|Mario Negri Institute for Pharmacological Research |
Ovarian Cancer
|
October 2012 | Phase 4 |
| NCT02305758 | AbbVie |
Untreated Metastatic Colorectal Cancer
|
December 2, 2014 | Phase 2 |
| NCT01731158 | Central European Society for Anticancer Drug Research |
Metastatic Renal Cell Carcinoma
|
October 2012 | Phase 2 |
| NCT00815594 | Capital Medical University |
Bleb Vascularity|Conjunctival Scarring
|
December 2008 | Phase 4 |
| NCT03897192 | Changhua Christian Hospital |
Punctate Inner Choroidopathy
|
October 1, 2018 | |
| NCT01745757 | UNICANCER |
Metastatic|Breast Cancer
|
June 2012 | |
| NCT00766246 | Pharmatech|Genentech, Inc.|Sanofi |
Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV
|
October 2008 | Phase 2 |
| NCT01115517 | The University of Texas Health Science Center, Houston|Hermann Eye Center |
Pterygium
|
October 2010 | Phase 2 |
| NCT04601688 | He Eye Hospital |
Branch Retinal Vein Occlusion
|
October 31, 2020 | Not Applicable |
| NCT05044871 | Tongji Hospital|Qilu Hospital of Shandong University|Hubei Cancer Hospital|Hunan Cancer Hospital|Peking University Cancer Hospital & Institute|Obstetrics and Gynecology Hospital of Zhejiang University|Sun Yat-sen University|Anhui Provincial Cancer Hospital|Jilin Provincial Tumor Hospital|First Affiliated Hospital, Sun Yat-Sen University|Affiliated Hospital of Jiangnan University |
Ovarian Cancer
|
January 1, 2023 | Phase 2 |
| NCT00924209 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
NSCLC|Stage IIIA (N2)
|
March 2009 | Phase 2 |
| NCT00118755 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2005 | Phase 2 |
| NCT00025233 | National Cancer Institute (NCI)|Gynecologic Oncology Group |
Cervical Squamous Cell Carcinoma|Recurrent Cervical Cancer
|
April 2002 | Phase 2 |
| NCT01912443 | Sun Yat-sen University|Proswell Medical Corporation |
Metastatic Colorectal Cancer
|
August 2013 | |
| NCT01705002 | Lipomedix Pharmaceuticals Inc. |
Cancer|Solid Tumor|Metastatic Colorectal Cancer (mCRC)
|
October 2012 | Phase 1 |
| NCT00536939 | Eli Lilly and Company|Genentech, Inc. |
Breast Cancer
|
November 2007 | Phase 2 |
| NCT00378066 | Asan Medical Center |
Metastatic Colorectal Cancer
|
August 2006 | Phase 2 |
| NCT02354612 | Tracon Pharmaceuticals Inc. |
Solid Tumors
|
||
| NCT01920984 | National Taiwan University Hospital |
Proliferative Diabetic Retinopathy
|
January 2005 | Not Applicable |
| NCT01823081 | Shahid Beheshti University of Medical Sciences |
Diabetic Macular Edema
|
January 2013 | Phase 3 |
| NCT00898794 | Kantonsspital Graubuenden|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific
|
October 2007 | |
| NCT00690768 | University of Sao Paulo |
Diabetic Retinopathy|Retinal Detachment
|
March 2008 | Phase 2 |
| NCT00694200 | Hellenic Oncology Research Group|University Hospital of Crete |
Breast Cancer
|
April 2008 | Phase 2 |
| NCT05446870 | Merck Sharp & Dohme LLC |
High-grade Serous Ovarian Carcinoma|Ovarian Carcinoma
|
July 25, 2022 | Phase 2 |
| NCT01206049 | Vejle Hospital |
Cholangiocarcinoma
|
September 2010 | Phase 2 |
| NCT00879359 | The Cleveland Clinic|Genentech, Inc. |
Endometrial Carcinoma
|
December 2007 | Phase 2 |
| NCT00890786 | Children´s Hospital Medical Center, Cincinnati|Genentech, Inc. |
Newly Diagnosed High-Grade Gliomas|Diffuse Intrinsic Pontine Glioma
|
May 2009 | Early Phase 1 |
| NCT00098787 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) |
Colorectal Cancer
|
July 2005 | Phase 2 |
| NCT00140556 | David M. Brizel, MD|Genentech, Inc.|OSI Pharmaceuticals|Duke University |
Head and Neck Cancer|Pharynx Cancer
|
August 2005 | Early Phase 1 |
| NCT02669173 | Case Comprehensive Cancer Center |
Glioblastoma
|
October 11, 2016 | Phase 1 |
| NCT02715531 | Hoffmann-La Roche |
Solid Tumor
|
April 6, 2016 | Phase 1 |
| NCT00559715 | Klinikum Bremen-Mitte, gGmbH|Kompetenzzentrum für Klinische Studien, Bremen |
Age-Related Neovascular Macular Degeneration
|
August 2008 | Phase 3 |
| NCT00671372 | Genentech, Inc. |
Colorectal Cancer
|
July 2006 | Phase 1 |
| NCT00868634 | iOMEDICO AG|Arbeitsgemeinschaft fur Internistische Onkologie|Arbeitskreis Klinische Studien|Roche Pharma AG |
Metastatic Breast Cancer
|
February 2009 | Phase 3 |
| NCT00885326 | New Approaches to Neuroblastoma Therapy Consortium|National Cancer Institute (NCI) |
Neuroblastoma
|
December 2009 | Phase 1 |
| NCT00142467 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Genentech, Inc.|Sanofi-Synthelabo|Eli Lilly and Company |
Hepatocellular Carcinoma
|
April 2004 | Phase 2 |
| NCT00359164 | University of British Columbia |
Macular Degeneration
|
July 2006 | Phase 2 |
| NCT01107626 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Lung Cancer
|
August 12, 2010 | Phase 3 |
| NCT00749567 | Hellenic Oncology Research Group|University Hospital of Crete |
Non-small-cell Lung Cancer
|
July 2008 | Phase 2 |
| NCT00254592 | University of California, Irvine |
Breast Cancer
|
October 2005 | Phase 2 |
| NCT01311050 | King Faisal Specialist Hospital & Research Center |
Metastatic Colorectal Cancer
|
January 2009 | |
| NCT03434379 | Hoffmann-La Roche |
Carcinoma, Hepatocellular
|
March 15, 2018 | Phase 3 |
| NCT00096278 | National Cancer Institute (NCI)|NSABP Foundation Inc |
Colon Adenocarcinoma|Stage IIA Colon Cancer AJCC v7|Stage IIB Colon Cancer AJCC v7|Stage IIC Colon Cancer AJCC v7|Stage IIIA Colon Cancer AJCC v7|Stage IIIB Colon Cancer AJCC v7|Stage IIIC Colon Cancer AJCC v7
|
September 15, 2004 | Phase 3 |
| NCT01389505 | Instituto do Coracao|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. |
Proliferative Diabetic Retinopathy
|
February 2011 | Phase 2 |
| NCT02590094 | Panhandle Eye Group, LLP |
Diabetic Retinopathy
|
October 2015 | Not Applicable |
| NCT02158520 | Academic and Community Cancer Research United|National Cancer Institute (NCI) |
Metastatic Melanoma|Mucosal Melanoma|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Uveal Melanoma AJCC v7|Unresectable Melanoma
|
October 18, 2013 | Phase 2 |
| NCT01193595 | Sanofi |
Neoplasms, Malignant
|
September 2010 | Phase 1 |
| NCT00025389 | University of Chicago|National Cancer Institute (NCI) |
Lung Cancer
|
November 2001 | Phase 2 |
| NCT03693573 | Hoffmann-La Roche |
Renal Cell Carcinoma
|
January 11, 2019 | Phase 3 |
| NCT00354549 | Swiss Group for Clinical Cancer Research |
Lung Cancer
|
January 2006 | Phase 2 |
| NCT05118776 | Ascletis Pharmaceuticals Co., Ltd. |
Recurrent Glioblastoma
|
January 21, 2022 | Phase 3 |
| NCT01189240 | National Cancer Institute (NCI) |
Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
|
December 2010 | Phase 1|Phase 2 |
| NCT01203306 | University of Turin, Italy |
Neuroendocrine Carcinomas
|
January 2006 | Phase 2 |
| NCT00675259 | Ohio State University Comprehensive Cancer Center|Celgene Corporation|Genentech, Inc. |
Breast Cancer
|
July 2008 | Phase 2 |
| NCT00203424 | Translational Oncology Research International|Genentech, Inc. |
Prostate Cancer
|
January 2006 | Phase 2 |
| NCT00537901 | King Faisal Specialist Hospital & Research Center |
Colonic Neoplasms|Rectal Neoplasms
|
October 2007 | Not Applicable |
| NCT04553692 | IGM Biosciences, Inc. |
Solid Tumor|Colorectal Cancer|Non Hodgkin Lymphoma|Sarcoma|Chondrosarcoma|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia|Acute Myeloid Leukemia
|
September 23, 2020 | Phase 1 |
| NCT02195336 | Karl Kölbeck|Karolinska University Hospital |
Non-small Cell Lung Cancer
|
August 2014 | Not Applicable |
| NCT02988843 | Masonic Cancer Center, University of Minnesota |
Germ Cell Tumor
|
March 29, 2017 | Phase 2 |
| NCT05305131 | National University Hospital, Singapore |
Nasopharyngeal Cancer
|
March 28, 2022 | Phase 2 |
| NCT00604461 | H. Lee Moffitt Cancer Center and Research Institute|Genentech, Inc. |
Mesothelioma
|
October 2007 | Phase 1|Phase 2 |
| NCT02393898 | Hoffmann-La Roche |
Ovarian Cancer
|
April 23, 2015 | |
| NCT00797303 | Instituto de Olhos de Goiania |
Corneal Neovascularization
|
January 2006 | Phase 4 |
| NCT03390686 | Prestige Biopharma Limited |
Lung Cancer|Non-small Cell Lung Cancer
|
November 15, 2019 | Phase 3 |
| NCT00513266 | Centre Hospitalier Universitaire Vaudois|National Cancer Institute (NCI) |
Colorectal Cancer|Metastatic Cancer
|
June 2007 | Phase 2 |
| NCT01061515 | Washington University School of Medicine |
Carcinoma
|
May 10, 2011 | Phase 1 |
| NCT00088998 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Breast Cancer
|
December 2004 | Phase 2 |
| NCT03647592 | Hunan Province Tumor Hospital |
Non Small Cell Lung Cancer
|
June 1, 2018 | |
| NCT01832415 | ARCAGY+ GINECO GROUP|Roche Pharma AG |
Epithelial Ovarian Cancer
|
April 2013 | |
| NCT00337389 | Mast Therapeutics, Inc. |
Metastatic Colorectal Cancer|Colon Cancer|Rectal Cancer
|
May 2006 | Phase 3 |
| NCT01818973 | Sun Yat-sen University |
Rectal Cancer
|
March 2013 | Phase 2 |
| NCT01468844 | National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC) |
Retinal Vein Occlusion
|
December 21, 2011 | Phase 1|Phase 2 |
| NCT00438737 | European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) |
Colorectal Cancer|Metastatic Cancer
|
January 2007 | Phase 2 |
| NCT01580969 | University of Utah |
Recurrent Glioma
|
July 6, 2012 | Phase 1|Phase 2 |
| NCT00265824 | GERCOR - Multidisciplinary Oncology Cooperative Group |
Colorectal Cancer
|
May 2005 | Phase 3 |
| NCT02078648 | Stemline Therapeutics, Inc. |
Adult Brain Glioblastoma|Glioblastoma Multiforme
|
May 2014 | Phase 1|Phase 2 |
| NCT00370786 | Shahid Beheshti University of Medical Sciences |
Choroidal Neovascularization
|
November 2005 | Phase 3 |
| NCT01125943 | Radboud University Medical Center|Dutch Cancer Society |
Hypertension|Cancer|Endothelial Dysfunction
|
June 2010 | Not Applicable |
| NCT01151722 | University of Sao Paulo |
Recurrent|Hemorrhage
|
December 2009 | Phase 2 |
| NCT00541125 | Federation Francophone de Cancerologie Digestive |
Colorectal Cancer
|
November 2007 | Phase 2 |
| NCT02017717 | Bristol-Myers Squibb |
Recurrent Glioblastoma
|
February 7, 2014 | Phase 3 |
| NCT00217282 | Mt. Sinai Medical Center, Miami|Sanofi-Synthelabo|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
June 2004 | Phase 2 |
| NCT00531336 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
Macular Degeneration
|
July 2006 | Phase 2 |
| NCT03197584 | ImmunityBio, Inc. |
Ovarian Cancer
|
December 2017 | Phase 1|Phase 2 |
| NCT00782275 | Beth Israel Deaconess Medical Center|Genentech, Inc.|Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Vanderbilt University Medical Center |
Renal Cell Carcinoma|Kidney Cancer
|
April 2009 | Phase 2 |
| NCT02898012 | Assistance Publique - Hôpitaux de Paris|Roche Pharma AG |
Glioblastoma Multiforme|Primary Brain Tumor
|
October 2010 | Phase 2 |
| NCT00416637 | Herbert Hurwitz, MD|National Cancer Institute (NCI)|Duke University |
Unspecified Adult Solid Tumor, Protocol Specific
|
January 2004 | Phase 1 |
| NCT02390531 | Jaeb Center for Health Research|Pediatric Eye Disease Investigator Group|National Eye Institute (NEI) |
Retinopathy of Prematurity
|
April 28, 2015 | Phase 1 |
| NCT04525326 | Fudan University |
Colorectal Cancer|Liver Metastases
|
October 1, 2020 | Phase 3 |
| NCT05394233 | Sichuan Cancer Hospital and Research Institute |
Non-squamous Non-small Cell Lung Cancer|EGFR Gene Mutation
|
June 1, 2022 | Phase 2 |
| NCT00576901 | Hoffmann-La Roche |
Breast Cancer
|
November 2007 | Phase 2 |
| NCT02515734 | Japan Clinical Cancer Research Organization |
Colorectal Cancer
|
August 2015 | Phase 2 |
| NCT04929223 | Hoffmann-La Roche |
Metastatic Colorectal Cancer
|
October 22, 2021 | Phase 1 |
| NCT05523440 | University of Oklahoma|GlaxoSmithKline |
Recurrent Endometrial Carcinoma|Recurrent Ovarian Carcinoma|ARID1A Gene Mutation
|
January 2023 | Phase 2 |
| NCT00451763 | University of Sao Paulo|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. |
Retina|Telangiectasis
|
January 2006 | Phase 3 |
| NCT00570531 | University of Michigan Rogel Cancer Center|Genentech, Inc. |
Loco-regional Esophageal Cancer
|
June 2007 | Phase 2 |
| NCT04416035 | Zhejiang Teruisi Pharmaceutical Inc. |
Advanced Non-squamous Non-small-cell Lung Cancer
|
August 17, 2020 | Phase 3 |
| NCT00055692 | National Cancer Institute (NCI) |
Adult Primary Hepatocellular Carcinoma|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
|
February 2003 | Phase 2 |
| NCT00682539 | Medical University of Vienna |
Diabetic Macular Edema
|
October 2007 | Phase 4 |
| NCT01190345 | Institut Paoli-Calmettes |
Breast Cancer
|
May 2010 | Phase 2 |
| NCT05192798 | First Affiliated Hospital Bengbu Medical College |
Triple-negative Breast Cancer
|
January 14, 2022 | Phase 2 |
| NCT01041690 | Cairo University |
Proliferative Diabetic Retinopathy
|
June 2007 | Not Applicable |
| NCT00364611 | Sanofi |
Breast Cancer
|
August 2006 | Phase 2 |
| NCT01068977 | Genentech, Inc. |
Solid Cancers
|
August 2007 | Phase 1 |
| NCT00723255 | National Cancer Institute (NCI)|NRG Oncology |
Recurrent Endometrial Carcinoma
|
September 2008 | Phase 2 |
| NCT01976923 | J. Fernando Arevalo, MD FACS|Pan American Collaborative Retina Study Group|King Khaled Eye Specialist Hospital |
Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
|
November 2013 | Phase 3 |
| NCT00323869 | Stanford University|Eli Lilly and Company|Genentech, Inc. |
Lung Cancer|Non-small Cell Lung Cancer (NSCLC)
|
June 2006 | Phase 2 |
| NCT04940546 | Sun Yat-sen University |
Colorectal Cancer Metastatic
|
June 16, 2021 | Phase 1|Phase 2 |
| NCT01471054 | Arman Mashayekhi|Allergan|Wills Eye |
Macular Edema|Cystoid Macular Edema|Uveal Melanoma|Radiation Maculopathy|Radiation Retinopathy
|
April 2014 | Phase 2 |
| NCT01120158 | Hellenic Oncology Research Group|University Hospital of Crete |
Breast Cancer
|
September 2009 | Phase 2 |
| NCT02734004 | AstraZeneca|Iqvia Pty Ltd |
Ovarian|Breast|SCLC|Gastric Cancers
|
March 17, 2016 | Phase 1|Phase 2 |
| NCT03353324 | Shahid Beheshti University of Medical Sciences |
Retinal Vein Occlusion With Macular Edema
|
November 1, 2017 | Phase 2|Phase 3 |
| NCT02250118 | Institut Curie|Henri Mondor University Hospital |
Pleural Effusion, Malignant|Breast Cancer
|
December 9, 2014 | Phase 1 |
| NCT03175432 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
BRAF V600 Wild Type|Clinical Stage IV Cutaneous Melanoma AJCC v8|Intracranial Melanoma|Metastatic Malignant Neoplasm in the Brain|Metastatic Melanoma|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Refractory Melanoma
|
June 15, 2017 | Phase 2 |
| NCT00436215 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Ovarian Neoplasm|Fallopian Tube Cancer|Primary Peritoneal Cancer
|
December 12, 2006 | Phase 2 |
| NCT00801866 | Asociación para Evitar la Ceguera en México |
Macular Edema
|
Phase 4 | |
| NCT00077298 | National Cancer Institute (NCI) |
Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
|
December 2003 | Phase 2 |
| NCT01091259 | NYU Langone Health|Genentech, Inc. |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma
|
March 2010 | Phase 2 |
| NCT01743950 | University of Wisconsin, Madison|Genentech, Inc.|National Cancer Institute (NCI) |
Glioma
|
December 3, 2012 | Phase 2 |
| NCT00447330 | Duke University|Hoffmann-La Roche|Sanofi|Genentech, Inc. |
Esophageal Neoplasms|Stomach Neoplasms|Neoplasm Metastasis
|
February 2007 | Phase 2 |
| NCT00636610 | Genentech, Inc. |
Metastatic Colorectal Cancer
|
May 2008 | Phase 2 |
| NCT04072198 | Gruppo Oncologico Italiano di Ricerca Clinica |
Colorectal Cancer
|
September 26, 2019 | Phase 2 |
| NCT00845884 | Rabin Medical Center |
Advanced Gastric Cancer
|
February 2009 | Phase 1|Phase 2 |
| NCT01274273 | University of Aarhus|Danish Renal Cancer Study Group |
Metastatic Renal Cell Carcinoma
|
October 2009 | Phase 2 |
| NCT02627144 | Hoffmann-La Roche |
Renal Cell Cancer
|
January 2008 | |
| NCT04868708 | Akeso |
Recurrent or Metastatic Cervical Cancer
|
April 1, 2021 | Phase 2 |
| NCT00021060 | National Cancer Institute (NCI) |
Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
|
August 2002 | Phase 2|Phase 3 |
| NCT00667485 | University of Chicago|Genentech, Inc. |
Advanced Cancer|Metastatic Cancer
|
April 2008 | Phase 1 |
| NCT02942043 | Peking University Cancer Hospital & Institute|Peking University First Hospital|Peking University Third Hospital |
Malignant Pleural Effusion
|
October 2016 | Phase 2 |
| NCT02623673 | Retina Clinic, Sao Paulo, Brazil |
Macular Edema
|
September 2015 | |
| NCT00705315 | Hellenic Oncology Research Group |
Breast Cancer
|
May 2008 | Phase 1|Phase 2 |
| NCT03307785 | Tesaro, Inc. |
Neoplasms|Metastatic Cancer|Advanced Cancer|Solid Tumor|Non Small Cell Lung Cancer Metastatic|Non Small Cell Lung Cancer Stage IIIB|Non Small Cell Lung Cancer
|
October 12, 2017 | Phase 1 |
| NCT00741988 | SCRI Development Innovations, LLC|Bristol-Myers Squibb|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
September 2008 | Phase 2 |
| NCT02606305 | ImmunoGen, Inc. |
Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
|
December 2015 | Phase 1|Phase 2 |
| NCT01005329 | National Cancer Institute (NCI)|Radiation Therapy Oncology Group |
Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage IA Uterine Corpus Cancer AJCC v7|Stage IB Uterine Corpus Cancer AJCC v7|Stage II Uterine Corpus Cancer AJCC v7|Stage IIIA Uterine Corpus Cancer AJCC v7|Stage IIIB Uterine Corpus Cancer AJCC v7|Stage IIIC Uterine Corpus Cancer AJCC v7|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7
|
November 6, 2009 | Phase 2 |
| NCT02413853 | University of Southern California|National Cancer Institute (NCI)|Prism Pharma Co., Ltd. |
Colorectal Adenocarcinoma|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer
|
November 2015 | Phase 2 |
| NCT05197504 | CHA University |
Hepatocellular Carcinoma
|
December 20, 2021 | |
| NCT00257608 | Genentech, Inc. |
Non-Small Cell Lung Cancer
|
January 2006 | Phase 3 |
| NCT01069627 | Hoffmann-La Roche |
Malignant Melanoma
|
December 2006 | Phase 2 |
| NCT00328497 | CASI Pharmaceuticals, Inc. |
Carcinoid Tumor
|
May 2006 | Phase 2 |
| NCT00681603 | National Taiwan University Hospital |
Lipid Keratopathy|Penetrating Keratoplasty|Herpetic Keratopathy|Rosacea
|
August 2007 | Not Applicable |
| NCT01327612 | Amgen |
Advanced Solid Tumors|Carcinoid|Colorectal Cancer|Locally Advanced|Lymphoma|Metastatic Cancer|Non-Small Cell Lung Cancer|Sarcoma|Solid Tumors
|
March 3, 2011 | Phase 2 |
| NCT00423917 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Breast Cancer
|
August 2007 | Phase 2 |
| NCT00444041 | Austrian Society Of Surgical Oncology |
Metastatic Colorectal Cancer
|
January 2007 | Phase 1|Phase 2 |
| NCT00545792 | Dana-Farber Cancer Institute|Genentech, Inc.|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Lowell General Hospital|Saint Anne´s Hospital |
Cervical Cancer|Endometrial Cancer|Ovarian Cancer|Vaginal Cancer|Carcinoma of the Vulva
|
May 2007 | Phase 2 |
| NCT02839707 | National Cancer Institute (NCI)|NRG Oncology |
Fallopian Tube High Grade Serous Adenocarcinoma|Ovarian High Grade Serous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Primary Peritoneal High Grade Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Fallopian Tube Clear Cell Adenocarcinoma|Recurrent Fallopian Tube Endometrioid Adenocarcinoma|Recurrent Fallopian Tube Undifferentiated Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Ovarian Clear Cell Adenocarcinoma|Recurrent Ovarian Endometrioid Adenocarcinoma|Recurrent Ovarian Undifferentiated Carcinoma|Recurrent Platinum-Resistant Fallopian Tube Carcinoma|Recurrent Platinum-Resistant Ovarian Carcinoma|Recurrent Platinum-Resistant Primary Peritoneal Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Primary Peritoneal Clear Cell Adenocarcinoma|Recurrent Primary Peritoneal Endometrioid Adenocarcinoma|Recurrent Primary Peritoneal Undifferentiated Carcinoma
|
May 12, 2017 | Phase 2|Phase 3 |
| NCT01632228 | Hoffmann-La Roche |
Glioblastoma
|
June 29, 2012 | Phase 2 |
| NCT01767792 | University of Alabama at Birmingham|Genentech, Inc. |
Neurofibromatosis Type 2|Progressive Vestibular Schwannomas
|
May 15, 2013 | Phase 2 |
| NCT00268359 | Duke University|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
May 2005 | Phase 2 |
| NCT05009082 | AGO Study Group|European Network of Gynaecological Oncological Trial Groups (ENGOT) |
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
|
September 13, 2022 | Phase 3 |
| NCT04426825 | Hoffmann-La Roche |
Carcinoma, Non-Small-Cell Lung
|
September 9, 2020 | Phase 2 |
| NCT03093155 | Yale University|R-Pharm-US, LLC |
Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
|
April 3, 2017 | Phase 2 |
| NCT04633564 | Mylan Pharmaceuticals Inc|Viatris Inc. |
NSCLC Stage IV
|
January 21, 2017 | Phase 3 |
| NCT00614653 | M.D. Anderson Cancer Center|Genentech, Inc. |
Pancreatic Cancer
|
January 2008 | Phase 1 |
| NCT00734890 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) |
Lung Cancer|Lymphoma|Lymphoproliferative Disorder|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific
|
March 2008 | Phase 1 |
| NCT02343549 | Wake Forest University Health Sciences|NovoCure Ltd. |
Cancer of Brain and Nervous System
|
January 2015 | Phase 2 |
| NCT01146795 | Jason D. Wright|Genentech, Inc.|Columbia University |
Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
|
May 17, 2010 | Phase 2 |
| NCT00161291 | University of Alabama at Birmingham|Genentech, Inc. |
Breast Cancer
|
June 2005 | Phase 2 |
| NCT04456699 | Merck Sharp & Dohme LLC |
Metastatic Colorectal Cancer
|
August 19, 2020 | Phase 3 |
| NCT03196986 | Beijing Mabworks Biotech Co., Ltd.|Betta Pharmaceuticals Co., Ltd. |
Non-small Cell Lung Cancer
|
August 15, 2017 | Phase 3 |
| NCT00222729 | University of Pittsburgh|Eli Lilly and Company|Genentech, Inc. |
Cancer
|
November 2005 | Phase 2 |
| NCT01940887 | Ophthotech Corporation|IVERIC bio, Inc. |
Age-Related Macular Degeneration
|
May 2014 | Phase 3 |
| NCT02759588 | Genelux Corporation |
Ovarian Cancer|Peritoneal Carcinomatosis|Fallopian Tube Cancer
|
May 2016 | Phase 1|Phase 2 |
| NCT00710229 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|Krankenanstalt Rudolfstiftung|Medical University of Vienna|Medical University of Graz|Medical University Innsbruck|Krankenhaus der Barmherzigen Brüder Linz|Universitätsaugenklinik Salzburg|Hospital Hietzing|Hanuschkrankenhaus |
Age Related Macular Degeneration
|
July 2008 | Phase 3 |
| NCT00028834 | National Cancer Institute (NCI) |
Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
|
February 2002 | Phase 2 |
| NCT00016107 | National Cancer Institute (NCI) |
Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
|
June 2001 | Phase 2 |
| NCT01777412 | Johns Hopkins University|Genentech, Inc.|Guthy Jackson Charitable Foundation |
Neuromyelitis Optica|Neuromyelitis Optica Spectrum Disorder
|
June 2013 | Phase 1 |
| NCT00334763 | Northwestern University|National Cancer Institute (NCI) |
Lung Cancer
|
May 2006 | Phase 2 |
| NCT01462890 | AGO Study Group|ARCAGY+ GINECO GROUP|Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
Genital Diseases, Female|Ovarian Diseases|Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms
|
November 2011 | Phase 3 |
| NCT00615056 | Pfizer |
Colorectal Neoplasms
|
March 2008 | Phase 2 |
| NCT01046279 | University of Zurich |
Glioma Patients
|
January 2010 | |
| NCT00592176 | University of Alabama at Birmingham |
Pterygium
|
August 2007 | Phase 2 |
| NCT00403403 | Genentech, Inc. |
Small Cell Lung Cancer
|
March 2007 | Phase 2 |
| NCT00428922 | Bhuvaneswari Ramaswamy|Genentech, Inc.|Case Comprehensive Cancer Center|University of Pittsburgh|Ohio State University Comprehensive Cancer Center |
Breast Cancer
|
June 14, 2007 | Phase 2 |
| NCT05396937 | Fudan University|Roche Pharma AG |
Hepatocellular Carcinoma
|
January 12, 2022 | Phase 2 |
| NCT05075993 | M.D. Anderson Cancer Center|Lyvgen Biopharma Holdings Limited |
Metastatic Esophageal|Gastric Cancer|Metastatic Head and Neck Carcinoma|Metastatic Hepatocellular Carcinoma|Metastatic HPV Related Solid Tumors|Metastatic Ovarian Carcinoma|Metastatic Soft Tissue Sarcoma|Metastatic Uveal Melanoma
|
November 12, 2021 | Phase 1 |
| NCT01133990 | Eisai Inc.|PharmaBio Development Inc. |
Colorectal Cancer
|
April 2010 | Phase 1|Phase 2 |
| NCT05146687 | Novartis Pharmaceuticals|Novartis |
Age-related Macular Degeneration (AMD)
|
July 15, 2020 | |
| NCT00786643 | Accelerated Community Oncology Research Network|InterMune |
Colorectal Cancer
|
February 2006 | Phase 2 |
| NCT04215731 | Yanhong Deng|Sun Yat-sen University |
Rectal Cancer
|
March 27, 2020 | Phase 3 |
| NCT04217954 | Peking University |
Advanced Biliary Tract Cancer
|
July 28, 2020 | Phase 2 |
| NCT01332929 | Centre Francois Baclesse|National Cancer Institute, France|Roche Pharma AG|Institut Curie |
Metastatic Malignant Neoplasm to Brain
|
June 2010 | Phase 1 |
| NCT00517361 | University of Chicago|Genentech, Inc. |
Metastatic Breast Cancer
|
August 2007 | Phase 2 |
| NCT01338558 | Hoffmann-La Roche |
Colorectal Cancer
|
June 2011 | Phase 3 |
| NCT00846612 | NYU Langone Health|Genentech, Inc.|University of New Mexico Cancer Center |
Ovarian Cancer
|
January 2008 | Phase 1 |
| NCT00394433 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Genentech, Inc. |
Esophageal Cancer|Stomach Cancer
|
September 2006 | Phase 2 |
| NCT00960960 | Genentech, Inc. |
Breast Cancer
|
August 2009 | Phase 1 |
| NCT04952753 | Novartis Pharmaceuticals|Novartis |
Metastatic Colorectal Cancer
|
November 15, 2021 | Phase 2 |
| NCT00578149 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital |
Non-Small Cell Lung Cancer
|
May 2006 | Phase 2 |
| NCT05039801 | M.D. Anderson Cancer Center |
Advanced Endometrial Carcinoma|Advanced Head and Neck Squamous Cell Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Melanoma|Advanced Ovarian Clear Cell Adenocarcinoma|Chondrosarcoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Refractory Endometrial Carcinoma|Refractory Head and Neck Squamous Cell Carcinoma|Refractory High Grade Ovarian Serous Adenocarcinoma|Refractory Melanoma|Refractory Ovarian Clear Cell Adenocarcinoma|Stage III Ovarian Cancer AJCC v8|Stage III Uterine Corpus Cancer AJCC v8|Stage IIIA Ovarian Cancer AJCC v8|Stage IIIA Uterine Corpus Cancer AJCC v8|Stage IIIA1 Ovarian Cancer AJCC v8|Stage IIIA2 Ovarian Cancer AJCC v8|Stage IIIB Ovarian Cancer AJCC v8|Stage IIIB Uterine Corpus Cancer AJCC v8|Stage IIIC Ovarian Cancer AJCC v8|Stage IIIC Uterine Corpus Cancer AJCC v8|Stage IIIC1 Uterine Corpus Cancer AJCC v8|Stage IIIC2 Uterine Corpus Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Uterine Corpus Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Uterine Corpus Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Uterine Corpus Cancer AJCC v8
|
September 9, 2021 | Phase 1 |
| NCT00391144 | University of Trieste |
Choroidal Neovascularization Secondary to Pattern Dystrophy
|
July 2006 | Phase 2|Phase 3 |
| NCT01514123 | Circadian Technologies Ltd. |
Neoplasms|Cancer
|
December 29, 2011 | Phase 1 |
| NCT01582152 | M.D. Anderson Cancer Center|Cortice Biosciences, Inc. |
Brain Neoplasms|Central Nervous System Neoplasms
|
July 2012 | Phase 1|Phase 2 |
| NCT00312728 | Genentech, Inc. |
Non-Small Cell Lung Cancer|Brain Neoplasms
|
March 2006 | Phase 2 |
| NCT01759238 | Universitätsklinikum Hamburg-Eppendorf |
Colorectal Cancer|Metastases
|
May 2013 | Phase 2 |
| NCT00797485 | Southern Italy Cooperative Oncology Group|National Cancer Institute (NCI) |
Colorectal Cancer
|
July 2008 | Phase 3 |
| NCT04446793 | Cardiff Oncology |
Metastatic Colorectal Cancer|KRAS Gene Mutation
|
||
| NCT00851045 | Bristol-Myers Squibb |
Colorectal Cancer (CRC)
|
October 2009 | Phase 2 |
| NCT01403610 | The University of Texas Health Science Center at San Antonio |
HIGH GRADE GLIOMA
|
June 2011 | Phase 2 |
| NCT00130728 | Genentech, Inc. |
Non-Small Cell Lung Cancer
|
June 8, 2005 | Phase 3 |
| NCT02802098 | Centro Nacional de Investigaciones Oncologicas CARLOS III|Fundacion CRIS de Investigación para Vencer el Cáncer |
Metastatic Breast Cancer|Bevacizumab-alone Maintenance Treatment Progression
|
May 2016 | Early Phase 1 |
| NCT00881504 | Georgetown University|Sanofi |
Biliary Tract Cancer
|
June 2009 | Phase 2 |
| NCT01169558 | Hoffmann-La Roche |
Colorectal Cancer
|
May 2006 | Phase 3 |
| NCT00066846 | National Cancer Institute (NCI) |
Colorectal Cancer
|
August 2003 | Phase 2 |
| NCT00309998 | University of Rochester |
Lung Cancer
|
September 2005 | Phase 2 |
| NCT00607113 | M.D. Anderson Cancer Center|Novartis|Genentech, Inc. |
Neuroendocrine Carcinoma
|
January 2008 | Phase 2 |
| NCT00089609 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Prostatic Neoplasms
|
April 19, 2005 | Phase 2 |
| NCT02023710 | Peking University Cancer Hospital & Institute |
Melanoma
|
December 2013 | Phase 2 |
| NCT01735071 | Mario Negri Institute for Pharmacological Research|PharmaMar|Hoffmann-La Roche |
Ovarian Epithelial Cancer Recurrent
|
July 2013 | Phase 2 |
| NCT03424005 | Hoffmann-La Roche|Seagen Inc.|Gilead Sciences |
Triple Negative Breast Cancer
|
April 2, 2018 | Phase 1|Phase 2 |
| NCT00127920 | Gynecologic Oncology Associates|Genentech, Inc. |
Ovarian Neoplasms
|
August 2004 | Phase 2 |
| NCT01063010 | Beth Israel Deaconess Medical Center|The Cooper Health System|Carolinas Medical Center |
Septic Shock
|
February 2010 | Not Applicable |
| NCT01700400 | Cancer Research and Biostatistics Clinical Trials Consortium|University of Arizona|Providence Cancer Center, Earle A. Chiles Research Institute|Novartis Pharmaceuticals |
Non Small Cell Lung Cancer
|
September 2012 | Phase 1 |
| NCT00203905 | University of Chicago |
Head and Neck Cancer
|
January 2004 | Phase 2 |
| NCT02946359 | Chinese PLA General Hospital |
Lung Adenocarcinoma Metastatic
|
July 2016 | Phase 2 |
| NCT01290939 | European Organisation for Research and Treatment of Cancer - EORTC|Hoffmann-La Roche |
Glioblastoma Multiforme|Cognition Disorders|Disability Evaluation
|
October 2011 | Phase 3 |
| NCT00667342 | St. Jude Children´s Research Hospital|Genentech, Inc. |
Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone
|
June 3, 2008 | Phase 2 |
| NCT00055237 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Kaposi´s Sarcoma|HIV Infections|HIV Seronegativity
|
February 26, 2003 | Phase 2 |
| NCT00557713 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials|Hoffmann-La Roche |
Rectal Neoplasms|Locally Advanced Rectal Adenocarcinoma
|
February 2007 | Phase 2 |
| NCT00203502 | University of Arkansas|Genentech, Inc. |
Breast Cancer
|
September 2005 | Phase 2 |
| NCT00537173 | Hoosier Cancer Research Network|United States Department of Defense|Indiana University School of Medicine|University of Colorado, Denver|Baylor University|McGill University |
Breast Cancer
|
September 2007 | |
| NCT01113476 | M.D. Anderson Cancer Center |
Advanced Cancer
|
April 27, 2010 | Phase 1 |
| NCT01418222 | Genentech, Inc.|SCRI Development Innovations, LLC |
Colorectal Cancer
|
September 14, 2011 | Phase 2 |
| NCT01770171 | Catholic University of the Sacred Heart |
Stage III-IV or Recurrent Endometrial Cancer
|
April 2012 | Phase 2 |
| NCT00948675 | Eli Lilly and Company |
Advanced Non-Small Cell Lung Cancer
|
September 1, 2009 | Phase 3 |
| NCT00920868 | Herbert Hurwitz, MD|Bristol-Myers Squibb|Duke University |
Solid Tumor|Metastatic Colorectal Cancer
|
May 2009 | Phase 1 |
| NCT00945139 | New Mexico Cancer Care Alliance|Genentech, Inc.|NYU Langone Health |
Ovarian Cancer
|
March 2007 | Phase 2 |
| NCT05407155 | Fudan University |
Non-small Cell Lung Cancer Metastatic
|
June 2022 | Not Applicable |
| NCT02761070 | Kyorin University|Japan Clinical Oncology Group |
Glioblastoma|Recurrence|Progression
|
July 11, 2016 | Phase 3 |
| NCT04097444 | Chugai Pharmaceutical |
Metastatic Colorectal Cancer
|
October 11, 2019 | Phase 2 |
| NCT00365391 | National Cancer Institute (NCI) |
Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
|
August 2006 | Phase 2 |
| NCT02866903 | Hospices Civils de Lyon |
Peritoneal Carcinosis
|
May 18, 2017 | Phase 1|Phase 2 |
| NCT00351039 | H. Lee Moffitt Cancer Center and Research Institute|Genentech, Inc.|Eli Lilly and Company |
Non-Small Cell Lung Cancer
|
July 2006 | Phase 1|Phase 2 |
| NCT04405674 | Shanghai Chest Hospital |
Non Small Cell Lung Cancer
|
July 15, 2020 | Phase 2 |
| NCT00710268 | AstraZeneca |
Neoplasm Metastasis
|
June 2008 | Phase 1 |
| NCT01274624 | Oncolytics Biotech|Montefiore Medical Center |
KRAS Mutant Metastatic Colorectal Cancer
|
December 2010 | Phase 1 |
| NCT02705274 | Marashi Eye Clinic |
Proliferative Diabetic Retinopathy
|
February 2016 | Phase 2|Phase 3 |
| NCT00735306 | Duke University|Genentech, Inc. |
Pancreatic Cancer
|
July 2008 | Phase 1 |
| NCT00130780 | Memorial Sloan Kettering Cancer Center |
Carcinoma, Non-Small-Cell Lung
|
August 2005 | Phase 2 |
| NCT00345163 | Genentech, Inc. |
Glioblastoma
|
July 2006 | Phase 2 |
| NCT02022917 | Chang Gung Memorial Hospital|Hoffmann-La Roche|Asian Gynecologic Oncology Group|Taiwanese Gynecolgic Oncology Group |
Epithelial Ovarian Cancer
|
March 2014 | Phase 2 |
| NCT00861705 | National Cancer Institute (NCI) |
Male Breast Carcinoma|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage IIIA Breast Cancer AJCC v7|Triple-Negative Breast Carcinoma
|
May 15, 2009 | Phase 2 |
| NCT00027885 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) |
Breast Cancer
|
November 2001 | Phase 2 |
| NCT00977574 | National Cancer Institute (NCI)|NRG Oncology |
Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Uterine Corpus Cancer|Stage IIIA Uterine Corpus Cancer AJCC v7|Stage IIIB Uterine Corpus Cancer AJCC v7|Stage IIIC Uterine Corpus Cancer AJCC v7|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7
|
September 14, 2009 | Phase 2 |
| NCT01443676 | University of Zurich |
Glioblastoma
|
October 2011 | Phase 2 |
| NCT00597506 | Herbert Hurwitz|Novartis Pharmaceuticals|Genentech, Inc.|Duke University |
Colorectal Adenocarcinoma
|
October 2007 | Phase 2 |
| NCT05448677 | University Hospital, Grenoble|Genoscience Pharma |
Hepatocellular Carcinoma
|
October 2022 | Phase 2 |
| NCT00826800 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. |
Colon Cancer
|
February 2009 | Not Applicable |
| NCT01661790 | Chinese PLA General Hospital|Roche Pharma AG |
Malignant Pleural Effusion
|
August 2009 | Phase 3 |
| NCT04944069 | Second Affiliated Hospital of Nanchang University|Jiangsu Hansoh Pharmaceutical Co., Ltd. |
NSCLC|Leptomeningeal Metastasis|EGFR Activating Mutation
|
July 2021 | Not Applicable |
| NCT00406380 | Asociación para Evitar la Ceguera en México |
Telangiectasis
|
September 2006 | Phase 3 |
| NCT01523314 | King Saud University |
Diabetic Macular Edema
|
March 2012 | Phase 2|Phase 3 |
| NCT01298076 | University of Sydney|National Health and Medical Research Council, Australia |
Diabetic Retinopathy|Macular Edema
|
October 2010 | Phase 2 |
| NCT00811135 | Hoffmann-La Roche |
Breast Cancer
|
December 2008 | Phase 2 |
| NCT00640640 | Sheba Medical Center|Universitaire Ziekenhuizen KU Leuven |
Neovascular Age Related Macular Degeneration
|
August 2007 | Not Applicable |
| NCT00072046 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|NCIC Clinical Trials Group |
Kidney Cancer
|
October 2003 | Phase 3 |
| NCT00874107 | HiberCell, Inc. |
Non-Small Cell Lung Cancer
|
June 2009 | Phase 2 |
| NCT00761644 | M.D. Anderson Cancer Center |
Advanced Cancer
|
August 21, 2008 | Phase 1 |
| NCT05310344 | Lei Li|Peking Union Medical College Hospital |
Ovarian Carcinoma|Platinum-resistant Ovarian Cancer|Recurrent Ovarian Carcinoma|Albumin-bound Paclitaxel|Bevacizumab|Survival Outcomes|Adverse Events
|
March 27, 2022 | Phase 2 |
| NCT01217931 | M.D. Anderson Cancer Center|Novartis |
Kidney Cancer
|
January 19, 2011 | Phase 2 |
| NCT02313272 | H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme LLC |
Malignant Glioma
|
July 28, 2015 | Phase 1 |
| NCT00433381 | National Cancer Institute (NCI)|American College of Radiology Imaging Network|Radiation Therapy Oncology Group |
Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm
|
March 1, 2007 | Phase 2 |
| NCT00421512 | Memorial Sloan Kettering Cancer Center |
Metastatic Renal Cell Carcinoma|Kidney Cancer
|
March 2006 | Phase 1 |
| NCT00626561 | M.D. Anderson Cancer Center|Genentech, Inc. |
Cervical Cancer|Uterine Cancer
|
February 2008 | Phase 2 |
| NCT00780494 | Pamela L. Kunz|Genentech, Inc.|Stanford University |
Stomach Cancer|Gastric (Stomach) Cancer|Neoplasm of Cardioesophageal Junction|Gastrointestinal Stromal Tumor (GIST)
|
February 2009 | Phase 2 |
| NCT00390156 | University of California, San Francisco|Novartis |
Unspecified Adult Solid Tumor
|
August 2006 | Phase 1 |
| NCT00079430 | National Cancer Institute (NCI)|Gynecologic Oncology Group |
Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
|
June 2004 | Phase 1 |
| NCT03250832 | Tesaro, Inc.|GlaxoSmithKline |
Neoplasms
|
August 8, 2017 | Phase 1 |
| NCT04634578 | Jaeb Center for Health Research|Pediatric Eye Disease Investigator Group|National Eye Institute (NEI) |
Retinopathy of Prematurity
|
May 18, 2022 | Phase 2 |
| NCT00501891 | Duke University|Genentech, Inc.|Schering-Plough |
Glioblastoma Multiforme
|
July 2007 | Phase 2 |
| NCT01047293 | University of Utah|Novartis |
Colorectal Cancer
|
May 2010 | Phase 1|Phase 2 |
| NCT01736449 | Arrowhead Regional Medical Center |
Pterygium
|
April 2011 | Phase 4 |
| NCT02308644 | University of Sao Paulo |
Diabetic Macular Edema
|
February 2009 | Phase 3 |
| NCT01746238 | Massachusetts General Hospital |
Sarcoma
|
March 2013 | Phase 1 |
| NCT01445509 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Solid Tumors
|
December 29, 2008 | Phase 1 |
| NCT00084604 | National Cancer Institute (NCI) |
Adenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Gastric Cancer|Stage IIIA Gastric Cancer|Stage IIIB Gastric Cancer|Stage IIIC Gastric Cancer|Stage IV Gastric Cancer
|
April 2004 | Phase 2 |
| NCT03744806 | Medical University of Lublin |
Exudative Age-related Macular Degeneration
|
January 2015 | |
| NCT01025934 | University of Campania Luigi Vanvitelli|Napoli CTO Hospital |
Proliferative Diabetic Retinopathy
|
Phase 4 | |
| NCT03821168 | Shahid Beheshti University of Medical Sciences |
Refractory Diabetic Macular Edema
|
March 1, 2019 | Phase 2|Phase 3 |
| NCT02387957 | Ophthotech Corporation|Ophthotech |
Age-Related Macular Degeneration
|
April 26, 2016 | Phase 2 |
| NCT05525767 | Hebei Medical University Fourth Hospital |
Solid Tumor
|
March 31, 2022 | Phase 4 |
| NCT00097019 | Genentech, Inc. |
Ovarian Cancer
|
February 2005 | Phase 2 |
| NCT00343044 | Benaroya Research Institute|GlaxoSmithKline|Genentech, Inc. |
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
|
June 2006 | Phase 2 |
| NCT02934529 | Ludwig-Maximilians - University of Munich |
Metastatic Colorectal Cancer
|
March 2015 | Phase 3 |
| NCT01838538 | Chinese PLA General Hospital |
Ovarian Cancer With Malignant Ascites
|
June 2011 | Phase 2 |
| NCT00308529 | SCRI Development Innovations, LLC|Genentech, Inc. |
Carcinoma, Small Cell Lung|Lung Cancer
|
March 2006 | Phase 2 |
| NCT01811498 | Northwell Health|Feinstein Institute for Medical Research |
Glioblastoma Multiforme|Brain Tumor
|
February 2013 | Phase 1|Phase 2 |
| NCT04227028 | City of Hope Medical Center|National Cancer Institute (NCI) |
Locally Advanced Lung Non-Small Cell Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Recurrent Lung Non-Small Cell Carcinoma|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8
|
March 9, 2020 | Phase 1 |
| NCT00447031 | Yonsei University |
Macular Degeneration
|
March 2007 | Not Applicable |
| NCT00908219 | Baylor College of Medicine|Genentech, Inc. |
Malignant Ascites
|
July 2009 | Phase 2 |
| NCT00109239 | Genentech, Inc. |
Breast Cancer
|
November 2000 | Phase 3 |
| NCT04245865 | Vejle Hospital |
Colorectal Cancer Metastatic
|
June 26, 2020 | Phase 2 |
| NCT02661815 | Dana-Farber Cancer Institute|Celgene Corporation |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma
|
June 15, 2016 | Phase 1 |
| NCT00571142 | Asociación para Evitar la Ceguera en México |
* Diffuse Diabetic Macular Edema
|
November 2007 | Phase 3 |
| NCT00227019 | Heather Wakelee|Eli Lilly and Company|Genentech, Inc.|Stanford University |
Non-small Cell Lung Cancer (NSCLC)|Lung Cancer|Neoplasm Metastasis
|
March 2006 | Phase 2 |
| NCT00953121 | Annick Desjardins|Duke University |
Malignant Glioma
|
September 2009 | Phase 2 |
| NCT00865189 | Hoffmann-La Roche |
Rectal Cancer
|
October 23, 2007 | Phase 2 |
| NCT01712347 | Hoffmann-La Roche |
Colorectal Cancer
|
October 11, 2012 | |
| NCT01217398 | Institut Curie|National Cancer Institute (NCI) |
Intraocular Melanoma
|
October 2009 | Phase 2 |
| NCT00997191 | University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo |
Diabetic Macular Edema
|
October 2009 | Phase 3 |
| NCT05083689 | Shahid Beheshti University of Medical Sciences |
Diabetic Macular Edema
|
October 6, 2021 | Phase 2|Phase 3 |
| NCT02923739 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Fallopian Tube Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Malignant Ovarian Brenner Tumor|Ovarian Adenocarcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
|
May 5, 2017 | Phase 2 |
| NCT00356122 | Sanofi|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
July 2006 | Phase 2 |
| NCT04147351 | National Taiwan University Hospital |
NSCLC Stage IIIB~IV
|
April 10, 2020 | Phase 2 |
| NCT00806169 | Johann Wolfgang Goethe University Hospital |
Macular Edema|Diabetic Retinopathy
|
April 2006 | Phase 3 |
| NCT00531960 | Hoffmann-La Roche |
Non-Small Cell Lung Cancer
|
January 2008 | Phase 2 |
| NCT00887809 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. |
Sarcoma|Leiomyosarcoma|Malignant Fibrous|Histiocytoma|Angiosarcoma
|
April 2009 | Phase 2 |
| NCT00619268 | Centre Leon Berard |
Metastatic Renal Cell Carcinoma
|
February 2008 | Phase 2 |
| NCT00370370 | Shahid Beheshti University of Medical Sciences |
Neovascular Age-Related Macular Degeneration
|
November 2005 | Phase 3 |
| NCT00017394 | National Cancer Institute (NCI) |
Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
|
March 2001 | Phase 2 |
| NCT05588388 | Kamya Sankar|Genentech, Inc.|University of Michigan|VA Ann Arbor Healthcare System|Cedars-Sinai Medical Center |
Extensive-stage Small-cell Lung Cancer|Liver Metastases
|
February 1, 2023 | Phase 2 |
| NCT01205022 | City of Hope Medical Center|National Cancer Institute (NCI) |
Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
|
April 2011 | Phase 1 |
| NCT00043823 | M.D. Anderson Cancer Center|Genentech, Inc.|Vanderbilt-Ingram Cancer Center |
Lung Cancer
|
August 1, 2002 | Phase 1|Phase 2 |
| NCT02348255 | University of California, Davis|National Cancer Institute (NCI)|NovoCure Ltd. |
Adult Brain Glioblastoma|Recurrent Adult Brain Neoplasm
|
January 2016 | Phase 2 |
| NCT01189643 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. |
Sarcoma|Desmoplastic Small Round Cell Tumor (DSRCT)
|
August 2010 | Early Phase 1 |
| NCT02162563 | Dutch Colorectal Cancer Group |
Colorectal Cancer|Liver Metastases
|
July 2014 | Phase 3 |
| NCT03872661 | Sun Yat-sen University |
Lung Cancer Stage III
|
March 1, 2019 | Phase 2 |
| NCT02759614 | Guangdong Association of Clinical Trials |
NSCLC
|
April 1, 2016 | Phase 3 |
| NCT01270438 | National Cancer Institute (NCI) |
Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
|
December 2010 | Phase 2 |
| NCT03280563 | Hoffmann-La Roche |
Breast Neoplasms
|
December 26, 2017 | Phase 1|Phase 2 |
| NCT04973293 | Ruijin Hospital |
Lung Neoplasm Malignant
|
July 20, 2021 | Not Applicable |
| NCT00744718 | Vejle Hospital |
Ovarian Cancer
|
August 2008 | Phase 2 |
| NCT01405430 | Centre Leon Berard|UMR-S Inserm 1036 |
Colorectal Cancer|Metastasis
|
May 2010 | Not Applicable |
| NCT01331616 | West Penn Allegheny Health System |
Glioblastoma|Optic Neuropathy
|
March 2011 | Early Phase 1 |
| NCT00393497 | Indiana University School of Medicine|Indiana University |
Breast Cancer|Lymphedema
|
April 2007 | Phase 1 |
| NCT02337491 | Dana-Farber Cancer Institute |
Glioblastoma
|
February 9, 2015 | Phase 2 |
| NCT00101348 | National Cancer Institute (NCI) |
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Colon Cancer|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Non-small Cell Lung Cancer|Recurrent Pancreatic Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Basal Cell Carcinoma of the Lip|Stage III Colon Cancer|Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Lymphoepithelioma of the Oropharynx|Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage III Mucoepidermoid Carcinoma of the Oral Cavity|Stage III Pancreatic Cancer|Stage III Rectal Cancer|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IIIB Non-small Cell Lung Cancer|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Basal Cell Carcinoma of the Lip|Stage IV Colon Cancer|Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Lymphoepithelioma of the Oropharynx|Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage IV Mucoepidermoid Carcinoma of the Oral Cavity|Stage IV Non-small Cell Lung Cancer|Stage IV Pancreatic Cancer|Stage IV Rectal Cancer|Stage IV Renal Cell Cancer|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
January 2005 | Phase 1|Phase 2 |
| NCT00571740 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Colorectal Cancer
|
Phase 2 | |
| NCT02399592 | Vejle Hospital |
Ovarian Cancer
|
March 2015 | Phase 2 |
| NCT04138992 | Air Force Military Medical University, China |
Disease Free Survival
|
August 1, 2020 | Phase 2|Phase 3 |
| NCT04984980 | Fudan University |
Biliary Tract Carcinoma|Initially Unresectable
|
August 1, 2020 | Phase 2 |
| NCT02530801 | University of Nottingham |
Recurrent Pterygium
|
January 2017 | Phase 4 |
| NCT04074785 | University of Texas Southwestern Medical Center |
GBM|Glioblastoma|Brain Tumor|Brain Tumor, Recurrent
|
December 13, 2019 | Early Phase 1 |
| NCT04238169 | Xinqiao Hospital of Chongqing |
Non-Small-Cell Lung Cancer Stage IV
|
September 1, 2020 | Phase 2 |
| NCT05299476 | Chinese PLA General Hospital |
Advanced Gastroesophageal Adenocarcinoma|First-line Therapy|PDL1 CPS < 5
|
April 16, 2022 | Phase 2 |
| NCT05200364 | Sutro Biopharma, Inc. |
Ovarian Cancer|Ovarian Carcinoma|Ovary Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma
|
March 22, 2022 | Phase 1 |
| NCT00873756 | Genentech, Inc. |
Metastatic Colorectal Cancer
|
May 2009 | Phase 1 |
| NCT05440578 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
Ovarian Neoplasms
|
June 2022 | |
| NCT01860638 | Hoffmann-La Roche |
Glioblastoma
|
August 19, 2013 | Phase 2 |
| NCT00365417 | NSABP Foundation Inc|Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute |
Breast Cancer
|
August 2006 | Phase 2 |
| NCT00596362 | Memorial Sloan Kettering Cancer Center |
Uveal Melanoma
|
April 2007 | Not Applicable |
| NCT05231122 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Ovarian Clear Cell Adenocarcinoma|Platinum-Sensitive Ovarian Carcinoma|Recurrent Endometrial Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Fallopian Tube Endometrioid Adenocarcinoma|Recurrent Fallopian Tube Serous Adenocarcinoma|Recurrent Ovarian Carcinoma|Recurrent Ovarian Clear Cell Adenocarcinoma|Recurrent Ovarian Endometrioid Adenocarcinoma|Recurrent Ovarian Serous Adenocarcinoma|Recurrent Platinum-Resistant Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Primary Peritoneal Clear Cell Adenocarcinoma|Recurrent Primary Peritoneal Endometrioid Adenocarcinoma|Recurrent Primary Peritoneal Serous Adenocarcinoma
|
November 30, 2022 | Phase 2 |
| NCT01663727 | Hoffmann-La Roche |
Metastatic Breast Cancer
|
August 27, 2012 | Phase 3 |
| NCT03904563 | Sun Yat-sen University |
Lung Adenocarcinoma
|
January 1, 2019 | Phase 2 |
| NCT00776594 | Dana-Farber Cancer Institute|Genentech, Inc.|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Rutgers Cancer Institute of New Jersey |
Prostate Cancer
|
October 2008 | Phase 2 |
| NCT01730950 | Radiation Therapy Oncology Group|National Cancer Institute (NCI) |
Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
|
December 20, 2012 | Phase 2 |
| NCT00586508 | Eli Lilly and Company|Genentech, Inc. |
Recurrent Glioblastoma
|
November 2007 | Phase 2 |
| NCT00476827 | Duke University|Genentech, Inc. |
Breast Cancer
|
May 2007 | Phase 2 |
| NCT00468351 | University of Sao Paulo |
Diabetic Macular Edema
|
April 2006 | Phase 1 |
| NCT05468359 | St. Jude Children´s Research Hospital |
Refractory Solid Tumor|Hepatocellular Carcinoma|Malignant Solid Tumor|Pediatric Cancer|Pediatric Solid Tumor
|
November 2022 | Phase 1|Phase 2 |
| NCT00940303 | Hoffmann-La Roche |
Colorectal Cancer
|
June 2009 | Phase 2 |
| NCT04973904 | Peking Union Medical College Hospital |
Cervical Cancer
|
August 1, 2021 | Phase 2 |
| NCT00720356 | Northwestern University|M.D. Anderson Cancer Center |
Brain and Central Nervous System Tumors
|
July 7, 2009 | Phase 2 |
| NCT00193492 | SCRI Development Innovations, LLC|Genentech, Inc. |
Lymphoma, Follicular
|
September 2005 | Phase 2 |
| NCT00367601 | Nasser Hanna, M.D.|Genentech, Inc.|Walther Cancer Institute|Hoosier Cancer Research Network |
Lung Cancer
|
August 2006 | Phase 2 |
| NCT00267696 | Ohio State University Comprehensive Cancer Center|Genentech, Inc.|Eli Lilly and Company |
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
|
November 2005 | Phase 2 |
| NCT00295503 | University of Texas Southwestern Medical Center|University of Chicago|Columbia University|Duke University |
Mesothelioma
|
February 2006 | Phase 2 |
| NCT01201265 | Hoffmann-La Roche |
Breast Cancer
|
February 2011 | Phase 2 |
| NCT00287222 | University of Arkansas|Genentech, Inc. |
Hepatocellular Carcinoma
|
February 2006 | Phase 2 |
| NCT00407121 | Asociación para Evitar la Ceguera en México |
Vogt Koyanagi Harada Disease|Serpiginous Choroiditis|Multifocal Choroiditis
|
August 2006 | Phase 3 |
| NCT00449163 | University of Miami |
Colorectal Cancer
|
March 1, 2006 | Phase 2 |
| NCT00095706 | Translational Oncology Research International|Genentech, Inc. |
Breast Cancer
|
June 2003 | Phase 1|Phase 2 |
| NCT00828009 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Lung Cancer
|
December 22, 2010 | Phase 2 |
| NCT00845104 | Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium|Fred Hutchinson Cancer Center |
B-cell Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia
|
January 2009 | Phase 2 |
| NCT04659382 | Federation Francophone de Cancerologie Digestive |
Metastatic Colorectal Cancer|pMMR|MSS|Immune Checkpoint Inhibitor|Internal Radiotherapy
|
October 7, 2020 | Phase 2 |
| NCT00193154 | SCRI Development Innovations, LLC|AstraZeneca|Genentech, Inc. |
Kidney Cancer
|
February 2003 | Phase 2 |
| NCT00112840 | National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage IV Renal Cell Cancer
|
May 2005 | Phase 1|Phase 2 |
| NCT00569699 | Taiho Pharmaceutical Co., Ltd. |
Colorectal Cancer
|
October 2007 | Phase 2 |
| NCT00506155 | M.D. Anderson Cancer Center|Genentech, Inc. |
Bladder Cancer
|
June 2007 | Phase 2 |
| NCT00423059 | Yonsei University |
Diabetic Retinopathy
|
December 2006 | Not Applicable |
| NCT03843853 | The First Affiliated Hospital with Nanjing Medical University|Jiangsu HanSoh Tharmaceutical Group Co., Ltd |
Colorectal Neoplasms
|
May 1, 2019 | Phase 2 |
| NCT00504257 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Genentech, Inc.|Sanofi |
Fallopian Tube Cancer|Ovarian Cancer|Malignant Tumor of Peritoneum
|
March 2007 | Phase 2 |
| NCT00294931 | SCRI Development Innovations, LLC|Genentech, Inc. |
Carcinoma, Small Cell Lung
|
February 2006 | Phase 2 |
| NCT00336648 | M.D. Anderson Cancer Center|Genentech, Inc. |
Pancreatic Neoplasms
|
June 2006 | Phase 2 |
| NCT01131078 | Hoffmann-La Roche |
Colorectal Cancer
|
June 2005 | Phase 2 |
| NCT00318513 | Premiere Oncology of Arizona|Genentech, Inc. |
Lymphedema
|
Phase 1 | |
| NCT01995188 | Genentech, Inc. |
Non-Squamous Non-Small Cell Lung Cancer
|
December 16, 2013 | Phase 1 |
| NCT04954339 | Tae Won Kim|Asan Medical Center |
Hepatocellular Carcinoma
|
October 29, 2021 | Phase 2 |
| NCT00798603 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Lung Cancer
|
December 2008 | Phase 2 |
| NCT00394082 | Celgene |
Metastatic Breast Cancer
|
June 1, 2006 | Phase 2 |
| NCT01984242 | Hoffmann-La Roche |
Renal Cell Carcinoma
|
January 8, 2014 | Phase 2 |
| NCT03063762 | Hoffmann-La Roche |
Renal Cell Carcinoma
|
March 27, 2017 | Phase 1 |
| NCT01426074 | Abramson Cancer Center of the University of Pennsylvania |
Rectal Cancer Patients
|
August 2011 | Phase 2 |
| NCT01366131 | Genentech, Inc. |
Non-Squamous Non-Small Cell Lung Cancer
|
June 2011 | Phase 2 |
| NCT01439178 | Seoul St. Mary´s Hospital |
Complications of Diabetes Mellitus
|
August 2011 | Not Applicable |
| NCT00424840 | University of Massachusetts, Worcester|Millennium Pharmaceuticals, Inc.|Genentech, Inc. |
Lung Cancer
|
June 2006 | Phase 1 |
| NCT00227617 | University of California, San Francisco|Genentech, Inc.|Sanofi |
Gastrointestinal Carcinoid Tumor|Islet Cell Tumor|Lung Cancer|Neoplastic Syndrome|Neuroendocrine Tumor
|
June 8, 2005 | Phase 2|Phase 3 |
| NCT05445778 | ImmunoGen, Inc.|GOG Foundation |
Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
|
November 2022 | Phase 3 |
| NCT01474239 | Hoffmann-La Roche |
Glioblastoma Multiforme
|
November 2011 | Phase 2 |
| NCT02119026 | Prof. Dr. Werner Scheithauer|Medical University of Vienna |
Metastatic Colorectal Cancer
|
February 2011 | Phase 2 |
| NCT04857684 | Massachusetts General Hospital|Genentech, Inc. |
Hepatocellular Carcinoma|Resectable Hepatocellular Carcinoma
|
June 18, 2021 | Early Phase 1 |
| NCT03847428 | AstraZeneca |
Hepatocellular Carcinoma
|
April 29, 2019 | Phase 3 |
| NCT05551208 | Chongqing University Cancer Hospital |
Ovarian Cancer
|
August 15, 2022 | Phase 2 |
| NCT02885753 | Federation Francophone de Cancerologie Digestive |
Colorectal Neoplasms
|
December 2016 | Phase 3 |
| NCT00486759 | Hoffmann-La Roche|Genentech, Inc. |
B-cell Lymphoma
|
July 26, 2007 | Phase 3 |
| NCT00934440 | University of Kansas Medical Center|Celgene |
Renal Cell Carcinoma
|
June 2009 | Phase 1|Phase 2 |
| NCT04404881 | Hanny Al-Samkari, MD|Massachusetts General Hospital |
Hereditary Hemorrhagic Telangiectasia
|
November 23, 2020 | Phase 2 |
| NCT00785291 | National Cancer Institute (NCI) |
Estrogen Receptor Negative|Estrogen Receptor Positive|HER2+Neu Negative|HER2+Neu Positive|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IIIC Breast Cancer AJCC v6|Stage IV Breast Cancer AJCC v6 and v7
|
October 13, 2008 | Phase 3 |
| NCT05096715 | Massachusetts General Hospital|Genentech, Inc. |
Unresectable Hepatocellular Carcinoma
|
January 2022 | Phase 1 |
| NCT00653939 | Mateon Therapeutics |
Tumors
|
March 2008 | Phase 2 |
| NCT05337137 | Bristol-Myers Squibb |
Carcinoma, Hepatocellular
|
May 5, 2022 | Phase 1|Phase 2 |
| NCT01248949 | MedImmune LLC |
Advanced Solid Tumors|Advanced Recurrent Ovarian Tumors
|
October 2010 | Phase 1 |
| NCT00567372 | Asociación para Evitar la Ceguera en México |
Diffuse Diabetic Macular Edema
|
June 2008 | Phase 4 |
| NCT00280150 | UNC Lineberger Comprehensive Cancer Center|Genentech, Inc.|Eli Lilly and Company |
Lung Cancer
|
January 2006 | Phase 1|Phase 2 |
| NCT05468242 | Sun Yat-sen University |
Stage III Non-small Cell Lung Cancer
|
February 1, 2022 | Phase 2 |
| NCT05476341 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Rectal Cancer|Lung Cancer|Ovarian Cancer|Cervical Cancer|Glioblastoma
|
April 6, 2017 | Phase 1 |
| NCT04303988 | Fudan University |
Breast Cancer
|
March 30, 2020 | Phase 2 |
| NCT00308516 | SCRI Development Innovations, LLC|Genentech, Inc. |
Rectal Cancer|Cancer of the Rectum|Colorectal Cancer
|
March 2006 | Phase 2 |
| NCT00193258 | SCRI Development Innovations, LLC|Genentech, Inc.|Novartis |
Clear Cell Renal Cell Carcinoma
|
June 2004 | Phase 1|Phase 2 |
| NCT00756340 | St. Jude Children´s Research Hospital|Novartis Pharmaceuticals |
Recurrent or Refractory Solid Tumors|CNS Malignancies
|
July 2008 | Phase 1 |
| NCT02285959 | Global Neurosciences Institute |
Glioblastoma Multiforme
|
June 2014 | Phase 1 |
| NCT00851136 | Genentech, Inc. |
Metastatic Colorectal Cancer
|
May 2009 | Phase 1 |
| NCT00856492 | Southwest Oncology Group|National Cancer Institute (NCI) |
Breast Cancer
|
April 2010 | Phase 2 |
| NCT00321100 | Fox Chase Cancer Center |
Colorectal Neoplasms
|
April 12, 2006 | Phase 2 |
| NCT00881751 | Medical University of South Carolina |
Liver Cancer
|
March 2009 | Phase 2 |
| NCT03368859 | AbbVie |
Cancer
|
March 20, 2018 | Phase 2 |
| NCT04862949 | CHA University|Hoffmann-La Roche |
Advanced Hepatocellular Carcinoma
|
May 1, 2021 | |
| NCT00545870 | Ursula Schmidt-Erfurth, M.D.|Medical University of Vienna |
Diabetic Retinopathy|Diabetic Macular Edema|Proliferative Diabetic Retinopathy
|
June 2008 | Phase 3 |
| NCT01814813 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Agenus Inc. |
Recurrent Glioblastoma|Recurrent Adult Brain Tumor|Gliosarcoma
|
May 2013 | Phase 2 |
| NCT02229175 | University of California, San Francisco |
Diabetic Macular Edema
|
January 1, 2021 | Phase 2|Phase 3 |
| NCT02743923 | The Netherlands Cancer Institute|Dutch Society of Physicians for Pulmonology and Tuberculosis |
Carcinoma, Non-Small Cell Lung
|
April 2016 | Phase 3 |
| NCT03074513 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Appendix Adenocarcinoma|Human Papillomavirus-Related Anal Squamous Cell Carcinoma|Human Papillomavirus-Related Cervical Squamous Cell Carcinoma|Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis|Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma|Neuroendocrine Carcinoma|Pancreatic Neuroendocrine Tumor|Recurrent Merkel Cell Carcinoma|Recurrent Nasopharynx Carcinoma|Recurrent Peritoneal Malignant Mesothelioma|Recurrent Pleural Malignant Mesothelioma|Stage III Merkel Cell Carcinoma AJCC v7|Stage III Nasopharyngeal Carcinoma AJCC v7|Stage III Pleural Malignant Mesothelioma AJCC v7|Stage IV Merkel Cell Carcinoma AJCC v7|Stage IV Nasopharyngeal Carcinoma AJCC v7|Stage IV Pleural Malignant Mesothelioma AJCC v7|Stage IVA Nasopharyngeal Carcinoma AJCC v7|Stage IVB Nasopharyngeal Carcinoma AJCC v7|Stage IVC Nasopharyngeal Carcinoma AJCC v7|Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
|
March 3, 2017 | Phase 2 |
| NCT01933815 | Cortice Biosciences, Inc. |
Glioblastoma Multiforme
|
August 2013 | Phase 1|Phase 2 |
| NCT04737187 | Taiho Oncology, Inc.|Institut de Recherches Internationales Servier |
Refractory Metastatic Colorectal Cancer
|
November 25, 2020 | Phase 3 |
| NCT00976456 | PD Dr. med. Wolfgang Schuette|Roche Pharma AG|Eli Lilly and Company|Martha-Maria Krankenhaus Halle-Dölau gGmbH |
Non-squamous Non-small Cell Lung Cancer
|
September 2009 | Phase 3 |
| NCT00960297 | SCRI Development Innovations, LLC|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
August 2009 | Phase 2 |
| NCT01167712 | National Cancer Institute (NCI)|NRG Oncology |
Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIA Fallopian Tube Cancer AJCC v6 and v7|Stage IIA Ovarian Cancer AJCC V6 and v7|Stage IIB Fallopian Tube Cancer AJCC v6 and v7|Stage IIB Ovarian Cancer AJCC v6 and v7|Stage IIC Fallopian Tube Cancer AJCC v6 and v7|Stage IIC Ovarian Cancer AJCC v6 and v7|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7
|
September 27, 2010 | Phase 3 |
| NCT04803994 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
Hepatocellular Carcinoma
|
July 6, 2021 | Phase 3 |
| NCT00049322 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Genentech, Inc. |
Liver Cancer
|
June 2003 | Phase 2 |
| NCT00110214 | National Cancer Institute (NCI) |
Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
|
April 2005 | Phase 3 |
| NCT00612586 | Eli Lilly and Company|Roche Pharma AG |
Colorectal Cancer
|
February 2008 | Phase 2 |
| NCT02162537 | Centre Hospitalier Intercommunal Creteil|Groupe Francais De Pneumo-Cancerologie |
Non-small Cell Lung Cancer Metastatic|Non-small Cell Lung Cancer|Adenocarcinoma of Lung Metastatic to Brain|Cerebral Metastases
|
December 2013 | Phase 3 |
| NCT00054132 | National Cancer Institute (NCI) |
Recurrent Breast Carcinoma|Stage IV Breast Cancer
|
December 2002 | Phase 2 |
| NCT03511183 | Harbin Medical University|Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Fudan University|Sun Yat-sen University|First Affiliated Hospital of Harbin Medical University|The Second Affiliated Hospital of Harbin Medical University|Liaoning Tumor Hospital & Institute|Shengjing Hospital|The First Hospital of Jilin University|The First Affiliated Hospital of Dalian Medical University|Jilin Provincial Tumor Hospital|The First People´s Hospital of Jingzhou |
Colorectal Neoplasms|Chemotherapy
|
March 1, 2018 | Phase 2 |
| NCT03211741 | University Hospital, Ghent |
Retinal Neovascularization|Macular Edema
|
November 22, 2013 | Phase 4 |
| NCT00450827 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Neuroblastoma
|
August 2006 | Phase 1 |
| NCT05620771 | Northwestern University|National Cancer Institute (NCI) |
Hepatocellular Carcinoma
|
November 25, 2022 | Phase 2 |
| NCT04102098 | Hoffmann-La Roche |
Carcinoma, Hepatocellular
|
December 31, 2019 | Phase 3 |
| NCT03401294 | University of Saskatchewan |
Metastatic Colorectal Cancer
|
January 1, 2023 | Phase 2 |
| NCT01572350 | Hospital Universitario de Canarias |
Diabetic Macular Edema
|
October 2010 | Phase 3 |
| NCT03334513 | San Ni Chen|Changhua Christian Hospital |
Retinopathy of Prematurity
|
April 1, 2011 | |
| NCT05093608 | H. Lee Moffitt Cancer Center and Research Institute|Karyopharm Therapeutics Inc |
Hepatocellular Carcinoma
|
November 3, 2021 | Phase 1 |
| NCT00462501 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Genentech, Inc. |
Colorectal Cancer
|
March 2007 | Not Applicable |
| NCT05001880 | National Cancer Institute (NCI) |
Peritoneal Malignant Mesothelioma
|
October 15, 2021 | Phase 2 |
| NCT00425646 | University of Washington|National Cancer Institute (NCI) |
Lung Cancer
|
November 2006 | Phase 2 |
| NCT02096874 | King Khaled Eye Specialist Hospital |
Non-proliferative Diabetic Retinopathy|Proliferative Diabetic Retinopathy|Diabetic Macular Edema
|
June 2013 | Phase 4 |
| NCT05507606 | Tianjin Medical University Cancer Institute and Hospital |
Non Small Cell Lung Cancer
|
August 1, 2021 | Phase 2 |
| NCT05431582 | M.D. Anderson Cancer Center|Zentalis Pharmaceuticals |
Tumors|Ovarian Cancer|Breast Cancer|Lung Cancer|Pancreatic Cancer
|
December 30, 2022 | Phase 1 |
| NCT03532295 | Washington University School of Medicine|Incyte Corporation |
Glioma|Glioblastoma
|
April 20, 2020 | Phase 2 |
| NCT00819754 | Ottawa Hospital Research Institute|Hoffmann-La Roche|Pfizer|Sanofi|Ottawa Regional Cancer Foundation |
Metastatic Colorectal Cancer
|
November 2003 | Phase 1|Phase 2 |
| NCT02819479 | Norton Healthcare|University of Kentucky |
Radiation Necrosis
|
November 23, 2016 | Phase 2 |
| NCT01332604 | Genentech, Inc. |
Solid Cancers
|
July 2011 | Phase 1 |
| NCT03363867 | Peter MacCallum Cancer Centre, Australia |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma
|
July 10, 2018 | Phase 2 |
| NCT02843230 | Massachusetts General Hospital |
Glioblastoma
|
August 1, 2016 | |
| NCT01219777 | Ritu Salani|Genentech, Inc.|Ohio State University Comprehensive Cancer Center |
Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
|
September 2010 | Phase 1 |
| NCT01339039 | Patrick Y. Wen, MD|Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Genzyme, a Sanofi Company |
High Grade Glioma: Glioblastoma (GBM)|High Grade Glioma: Gliosarcoma|Anaplastic Astrocytoma (AA)|Anaplastic Oligodendroglioma (AO)|Mixed Anaplastic Oligoastrocytoma (AOA)
|
December 2011 | Phase 1 |
| NCT02246049 | EPS Corporation |
Colorectal Neoplasms
|
May 2014 | Phase 2 |
| NCT01571232 | Retina Macula Institute|Allergan |
Diabetic Macular Edema|Non-proliferative Diabetic Retinopathy|Proliferative Diabetic Retinopathy
|
April 2012 | Phase 2 |
| NCT04389073 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Beijing Huanxing Cancer Hospital |
Metastatic Breast Cancer
|
April 1, 2020 | Phase 2 |
| NCT04723004 | Shanghai Junshi Bioscience Co., Ltd. |
Advanced Hepatocellular Carcinoma (HCC)
|
October 15, 2020 | Phase 3 |
| NCT00405938 | SCRI Development Innovations, LLC|Genentech, Inc.|AstraZeneca |
Breast Cancer|Breast Neoplasms
|
November 2006 | Phase 2 |
| NCT05378867 | Zhejiang Teruisi Pharmaceutical Inc. |
Metastatic Colorectal Cancer (CRC)
|
August 1, 2022 | Phase 3 |
| NCT02596958 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
September 2007 | |
| NCT01270542 | University of Southern California |
Retinal Detachment|Diabetic Retinopathy
|
June 2009 | Not Applicable |
| NCT01239732 | Hoffmann-La Roche |
Ovarian Cancer
|
December 2010 | Phase 3 |
| NCT03937830 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Hepatocellular Cancer|Hepatocellular Carcinoma|Metastatic Hepatocellular Carcinoma
|
March 10, 2021 | Phase 2 |
| NCT02210117 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Metastatic Kidney Carcinoma|Stage IV Renal Cell Cancer AJCC v7
|
November 25, 2014 | Early Phase 1 |
| NCT02036723 | Biocad |
Wet Age-related Macular Degeneration
|
Phase 3 | |
| NCT01063283 | University of Chicago|Genentech, Inc. |
Advanced Non-squamous Non-Small Cell Lung Cancer
|
March 2010 | Not Applicable |
| NCT00762255 | H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme LLC |
Glioblastoma
|
September 2008 | Phase 1 |
| NCT00450203 | Professor David Cunningham|Cancer Research UK|Roche Pharma AG|GlaxoSmithKline|Medical Research Council |
Oesophagogastric Cancer
|
October 2007 | Phase 2|Phase 3 |
| NCT01481545 | National Cancer Institute, Naples |
Rectal Cancer
|
December 2006 | Phase 2 |
| NCT03247673 | Celltrion |
Healthy
|
August 7, 2017 | Phase 1 |
| NCT00305877 | National Cancer Institute (NCI) |
Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer
|
February 2006 | Phase 2 |
| NCT00463203 | Rigshospitalet, Denmark |
Brain Neoplasms|Glioma
|
March 2007 | Phase 2 |
| NCT02052648 | NewLink Genetics Corporation|Lumos Pharma |
Glioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain Tumor
|
March 2014 | Phase 1|Phase 2 |
| NCT00324987 | National Cancer Institute (NCI) |
Gastrointestinal Stromal Tumor
|
April 2008 | Phase 3 |
| NCT00305825 | University of California, San Francisco|National Cancer Institute (NCI)|Memorial Sloan Kettering Cancer Center |
Breast Cancer
|
August 2004 | Phase 2 |
| NCT01774474 | Maastricht University Medical Center|European Society of Cataract and Refractive Surgeons |
Cystoid Macular Edema|Cataract|Diabetes Mellitus
|
July 10, 2013 | Phase 3 |
| NCT00398320 | Pamela L. Kunz|Stanford University |
Neuroendocrine Tumors
|
November 2006 | Phase 2 |
| NCT00428545 | M.D. Anderson Cancer Center |
Advanced Malignancy|Lymphoma|Myeloma|Solid Tumors
|
January 2007 | Phase 1 |
| NCT00469469 | Dartmouth-Hitchcock Medical Center|Genentech, Inc. |
Adrenocortical Carcinoma
|
May 2007 | Phase 2 |
| NCT00345761 | Chugai Pharmaceutical|Yakult Honsha Co., LTD |
Colorectal Cancer
|
February 2006 | Phase 1|Phase 2 |
| NCT00652119 | Massachusetts General Hospital|Genentech, Inc.|National Cancer Institute (NCI) |
Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
|
February 2008 | Phase 1 |
| NCT01770301 | ARCAGY+ GINECO GROUP|Roche Pharma AG |
Ovarian Sex-cord Stromal Tumor
|
February 2013 | Phase 2 |
| NCT00387699 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) |
Lung Cancer
|
October 2006 | Phase 2 |
| NCT01031381 | University of Pittsburgh|Novartis Pharmaceuticals|Genentech, Inc. |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma
|
September 2010 | Phase 2 |
| NCT02244632 | Isofol Medical AB |
Colorectal Neoplasm
|
September 2014 | Phase 1|Phase 2 |
| NCT00846027 | Hoffmann-La Roche |
Breast Cancer
|
January 2009 | Phase 2 |
| NCT00661154 | Stanford University|Genentech, Inc. |
Colorectal Neoplasms|Colon Cancer|Rectal Cancer|Anal Cancer
|
February 2008 | |
| NCT00755261 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Sarcoma|Soft Tissue Sarcoma
|
September 2008 | Phase 2 |
| NCT00925769 | Hoffmann-La Roche |
Pancreatic Cancer
|
January 2009 | Phase 1 |
| NCT01083966 | Northwell Health|Feinstein Institute for Medical Research|Hofstra North Shore |
Vestibular Schwannoma
|
August 2011 | Phase 1 |
| NCT00545077 | Spanish Breast Cancer Research Group|Hoffmann-La Roche|German Breast Group |
Breast Cancer
|
November 6, 2007 | Phase 3 |
| NCT02394795 | Takeda |
Colorectal Cancer
|
May 29, 2015 | Phase 3 |
| NCT03912402 | Biocad |
Cervical Cancer|Cervical Cancer Metastatic|Cervical Cancer Recurrent
|
December 25, 2018 | Phase 2 |
| NCT01836653 | EPS Corporation |
Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer
|
May 2013 | Phase 2 |
| NCT01871766 | St. Jude Children´s Research Hospital |
Rhabdomyosarcoma
|
December 4, 2013 | Phase 2 |
| NCT02930954 | Caicun Zhou|Tongji University |
Non-small-cell Lung Cancer
|
November 2016 | Phase 2 |
| NCT04733963 | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Colorectal Cancer
|
March 1, 2021 | Phase 2 |
| NCT04042558 | Centre Francois Baclesse|GFPC |
NSCLC Stage IIIB|NSCLC Stage IV|EGFR Gene Mutation|ALK Gene Rearrangement Positive|ROS1 Gene Mutation
|
September 26, 2019 | Phase 2 |
| NCT01202890 | New Mexico Cancer Care Alliance|Celgene Corporation |
Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma
|
September 2010 | Phase 1 |
| NCT00667394 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma
|
April 2008 | Phase 2 |
| NCT00568048 | Swiss Group for Clinical Cancer Research |
Melanoma (Skin)
|
December 2007 | Phase 2 |
| NCT00565851 | National Cancer Institute (NCI)|NRG Oncology |
Clear Cell Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Mucinous Adenocarcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Clear Cell Adenocarcinoma|Primary Peritoneal Endometrioid Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Primary Peritoneal Transitional Cell Carcinoma|Primary Peritoneal Undifferentiated Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Carcinoma
|
December 6, 2007 | Phase 3 |
| NCT02090322 | Universidad Autonoma de San Luis Potosí |
Retinopathy of Prematurity
|
September 2013 | Not Applicable |
| NCT00626405 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Melanoma (Skin)
|
August 2008 | Phase 2 |
| NCT00576199 | Hoffmann-La Roche |
Liver Cancer
|
February 2008 | Phase 2 |
| NCT02833701 | University of Nebraska|National Cancer Institute (NCI) |
Glioblastoma|Glioma
|
March 2016 | Phase 1 |
| NCT01880385 | Association Tunisienne de lutte Contre le Cancer|Hoffmann-La Roche|Sanofi |
Inflammatory Breast Cancer
|
March 2011 | Phase 1 |
| NCT03597581 | Inspirna, Inc. |
Gastrointestinal Cancer|Gastrointestinal Neoplasms|Colorectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma|Gastric Cancer|Gastric Neoplasm|KRAS Mutation-Related Tumors|CRC|Colorectal Cancer Metastatic
|
June 5, 2018 | Phase 1 |
| NCT00795665 | University of California, Davis|National Cancer Institute (NCI)|Genentech, Inc. |
Glioma
|
June 2008 | Phase 2 |
| NCT02296567 | East Florida Eye Institute|Genentech, Inc. |
Age Related Macular Degeneration
|
December 2014 | Phase 2|Phase 3 |
| NCT03659305 | R-Pharm|Almedis |
Healthy
|
July 10, 2018 | Phase 1 |
| NCT00368875 | National Cancer Institute (NCI) |
Male Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
|
July 2006 | Phase 1|Phase 2 |
| NCT00496587 | M.D. Anderson Cancer Center|Eli Lilly and Company |
Renal Cell Carcinoma|Kidney Cancer
|
July 2007 | Phase 2 |
| NCT05281471 | Genelux Corporation|GOG Foundation |
Platinum-resistant Ovarian Cancer|Platinum-refractory Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|High-grade Serous Ovarian Cancer|Endometrioid Ovarian Cancer|Ovarian Clear Cell Carcinoma
|
August 31, 2022 | Phase 3 |
| NCT00308607 | University of Turku |
Metastatic Melanoma
|
August 2005 | Phase 2 |
| NCT00528567 | Hoffmann-La Roche |
Breast Cancer
|
December 2007 | Phase 3 |
| NCT05284643 | University of Miami |
Recurrent Glioblastoma
|
September 30, 2022 | Not Applicable |
| NCT01279681 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Cancer and Leukemia Group B |
Cognitive+Functional Effects|Colorectal Cancer|Neurotoxicity
|
January 2011 | Phase 3 |
| NCT01057212 | Providence Health & Services|Genentech, Inc.|Bristol-Myers Squibb |
Non-squamous Non-small Cell Lung Cancer
|
February 2010 | Phase 2 |
| NCT00618826 | Barbara Ann Karmanos Cancer Institute|Eli Lilly and Company|Genentech, Inc. |
Metastatic Breast Cancer
|
November 2006 | Phase 2 |
| NCT00114946 | Genentech, Inc. |
Colorectal Cancer
|
May 2005 | Phase 4 |
| NCT02354131 | Nordic Society of Gynaecological Oncology - Clinical Trials Unit|European Network of Gynaecological Oncological Trial Groups (ENGOT)|Gynecologic Cancer Intergroup (GCIG)|University of Utah|Massachusetts General Hospital|Myriad Genetics, Inc. |
Ovarian Cancer
|
February 15, 2015 | Phase 1|Phase 2 |
| NCT03746041 | University of Rochester |
Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia
|
February 14, 2019 | Phase 1 |
| NCT00408694 | National Cancer Institute (NCI)|Radiation Therapy Oncology Group |
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7|Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7|Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7|Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7|Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
|
December 13, 2006 | Phase 2 |
| NCT01149850 | Jonsson Comprehensive Cancer Center|Genentech, Inc. |
Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma
|
April 28, 2010 | Phase 2 |
| NCT02291289 | Hoffmann-La Roche |
Colorectal Cancer
|
April 17, 2015 | Phase 2 |
| NCT01222715 | National Cancer Institute (NCI) |
Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Pleomorphic Rhabdomyosarcoma|Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Childhood Rhabdomyosarcoma
|
October 2010 | Phase 2 |
| NCT03203525 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Advanced Malignant Neoplasm|Colorectal Carcinoma Metastatic in the Liver|Metastatic Malignant Neoplasm in the Liver|Refractory Malignant Neoplasm
|
June 23, 2020 | Phase 1 |
| NCT04180072 | National Health Research Institutes, Taiwan|National Taiwan University Hospital|Taipei Veterans General Hospital, Taiwan|Mackay Memorial Hospital|Changhua Christian Hospital|China Medical University Hospital|National Cheng-Kung University Hospital|Kaohsiung Medical University Chung-Ho Memorial Hospital|Taichung Veterans General Hospital |
Carcinoma, Hepatocellular
|
March 12, 2020 | Not Applicable |
| NCT00410605 | National Cancer Institute (NCI) |
Multiple Myeloma in Relapse|Stage II Multiple Myeloma|Stage III Multiple Myeloma
|
November 2006 | Phase 2 |
| NCT00696592 | University of Padova|Department of Ophthalmology, Conegliano Hospital, Treviso, Italy |
Neovascular Age-Related Macular Degeneration
|
January 2007 | Phase 2 |
| NCT01540435 | University of Regensburg|University of Halle Medical Faculty |
Colon Cancer Liver Metastasis
|
September 2012 | Phase 2 |
| NCT02364713 | Mayo Clinic|National Cancer Institute (NCI) |
Fallopian Tube Carcinosarcoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Ovarian Carcinosarcoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Primary Peritoneal Carcinosarcoma|Primary Peritoneal Clear Cell Adenocarcinoma|Primary Peritoneal Endometrioid Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Primary Peritoneal Transitional Cell Carcinoma|Primary Peritoneal Undifferentiated Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
|
March 13, 2015 | Phase 2 |
| NCT00738530 | Hoffmann-La Roche |
Renal Cell Cancer
|
June 2004 | Phase 3 |
| NCT00719264 | Novartis Pharmaceuticals|Roche Pharma AG|Novartis |
Carcinoma|Adenocarcinoma|Renal Cell|Nephroid Carcinoma|Hypernephroid
|
November 12, 2008 | Phase 2 |
| NCT01578551 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Carcinoma, Non-Small-Cell Lung|Lung Adenocarcinoma
|
May 2012 | Phase 2 |
| NCT02450981 | Biocad |
Neovascular Age-related Macular Degeneration
|
Phase 1 | |
| NCT04687631 | Fudan University |
Colorectal Cancer|Liver Metastases
|
January 14, 2021 | Phase 3 |
| NCT02803203 | Memorial Sloan Kettering Cancer Center|AstraZeneca|Genentech, Inc. |
Non-small Cell Lung Cancer|EGFR-mutant Lung Cancers
|
June 29, 2016 | Phase 1|Phase 2 |
| NCT00544700 | Swiss Group for Clinical Cancer Research |
Colorectal Cancer
|
November 26, 2007 | Phase 3 |
| NCT00888043 | Herbert Hurwitz, MD|Centocor, Inc.|Genentech, Inc.|Duke University |
Solid Tumors
|
March 2009 | Phase 1 |
| NCT03892434 | Yeungnam University College of Medicine |
Branch Retinal Vein Occlusion With Macular Edema
|
March 18, 2019 | Phase 4 |
| NCT00016549 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Breast Cancer
|
May 13, 2001 | Phase 2 |
| NCT01309633 | National University Hospital, Singapore |
Nasopharyngeal Carcinoma
|
September 2, 2011 | Phase 2 |
| NCT01200212 | German Breast Group |
Breast Cancer
|
July 2009 | Phase 3 |
| NCT04446416 | NaviFUS Corporation|Chang Gung Memorial Hospital |
Glioblastoma Multiforme|Glioblastoma|Glioma|Brain Tumor|Neoplasms|Neoplasms, Nerve Tissue
|
July 21, 2020 | Not Applicable |
| NCT00184015 | University of Southern California |
Renal Cell Cancer
|
August 18, 2005 | Phase 1|Phase 2 |
| NCT03326193 | Tesaro, Inc. |
Ovarian Neoplasms
|
December 12, 2017 | Phase 2 |
| NCT03126071 | Jiangsu Cancer Institute & Hospital |
Advanced Colorectal Cancer
|
February 15, 2017 | Phase 2 |
| NCT03288987 | AryoGen Pharmed Co. |
Metastatic Colorectal Cancer
|
October 4, 2016 | Phase 3 |
| NCT04250064 | Tata Memorial Centre |
DIPG
|
February 4, 2020 | Phase 2 |
| NCT01493843 | Genentech, Inc. |
Non-Small Cell Lung Cancer
|
January 20, 2012 | Phase 2 |
| NCT00911820 | Dana-Farber Cancer Institute|Massachusetts General Hospital|SCRI Development Innovations, LLC|Texas Oncology Cancer Center|Genentech, Inc. |
Esophageal Cancer|Gastric Cancer|Stomach Cancer
|
July 2009 | Phase 2 |
| NCT03798626 | Novartis Pharmaceuticals|Novartis |
Colorectal Cancer|Gastroesophageal Cancer|Renal Cell Carcinoma
|
May 22, 2019 | Phase 1 |
| NCT00356681 | Amgen |
Breast Neoplasms|Breast Tumors|Breast Cancer|Locally Recurrent and Metastatic Breast Cancer
|
December 2006 | Phase 2 |
| NCT03950154 | Tianjin Medical University Cancer Institute and Hospital |
Colorectal Cancer
|
June 1, 2019 | Phase 3 |
| NCT03175666 | ImmunityBio, Inc. |
Triple Negative Breast Cancer
|
December 2017 | Phase 1|Phase 2 |
| NCT00605722 | Hoffmann-La Roche |
Liver Cancer
|
March 2008 | Phase 2 |
| NCT05266846 | Hunan Province Tumor Hospital |
ALK Gene Mutation|Lung Adenocarcinoma|Immunotherapy
|
September 20, 2022 | Phase 2 |
| NCT01127360 | Oslo University Hospital |
Exudative Age-related Macular Degeneration
|
March 2009 | Phase 4 |
| NCT01969708 | The Emmes Company, LLC|National Eye Institute (NEI)|Milton S. Hershey Medical Center|University of Wisconsin, Madison |
Central Retinal Vein Occlusion
|
September 2014 | Phase 3 |
| NCT01718873 | National Cancer Institute, Naples |
Colorectal Cancer
|
May 2012 | Phase 3 |
| NCT02120287 | Ajay Niranjan|Genentech, Inc.|University of Pittsburgh |
Glioblastoma Multiforme|Glioblastoma - Category
|
May 2014 | Phase 2 |
| NCT01609790 | National Cancer Institute (NCI)|NRG Oncology |
Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Oligodendroglioma|Recurrent Brain Neoplasm|Recurrent Glioblastoma
|
June 4, 2012 | Phase 2 |
| NCT01368848 | Arbeitsgemeinschaft medikamentoese Tumortherapie|Sanofi|Roche Pharma AG |
NSCLC
|
April 2010 | Phase 2 |
| NCT00100841 | National Cancer Institute (NCI) |
Adenocarcinoma of the Rectum|Mucinous Adenocarcinoma of the Colon|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Stage IV Colon Cancer|Stage IV Rectal Cancer
|
November 2004 | Phase 2 |
| NCT00365547 | Masonic Cancer Center, University of Minnesota |
Lung Cancer
|
September 2006 | Phase 2 |
| NCT01283048 | Toni Choueiri, MD|Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute |
Renal Cell Carcinoma
|
September 2011 | Phase 1 |
| NCT01332721 | Tracon Pharmaceuticals Inc. |
Adult Solid Tumor
|
April 2011 | Phase 1 |
| NCT01250379 | Hoffmann-La Roche |
Breast Cancer
|
February 2011 | Phase 3 |
| NCT01531595 | Pia Osterlund|Helsinki University Central Hospital |
Metastatic Colorectal Cancer
|
February 2012 | Phase 2 |
| NCT01086345 | Case Comprehensive Cancer Center |
Glioblastoma|Gliosarcoma|Brain Tumor
|
February 2010 | Early Phase 1 |
| NCT00193375 | SCRI Development Innovations, LLC|Genentech, Inc.|Pharmacia and Upjohn |
Lung Cancer
|
August 2003 | Phase 2 |
| NCT02065466 | University of Arizona |
Metastatic Melanoma|Brain Metastases
|
July 2014 | Phase 1|Phase 2 |
| NCT00998166 | Columbia University |
Non-Small Cell Lung Cancer
|
June 2007 | Phase 2 |
| NCT00434226 | Genentech, Inc. |
Non-Small Cell Lung Cancer
|
March 2007 | Phase 2 |
| NCT01989780 | Japan Breast Cancer Research Group|Chugai Pharmaceutical |
Metastatic Breast Cancer
|
January 2014 | Phase 2 |
| NCT03169790 | ImmunityBio, Inc. |
Non Hodgkin Lymphoma
|
December 2017 | Phase 1|Phase 2 |
| NCT00106054 | Pfizer |
Colorectal Neoplasms|Liver Neoplasms
|
January 2006 | Phase 2 |
| NCT02884648 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Malignant Neoplasms of Female Genital Organs|Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
|
November 2016 | Phase 2 |
| NCT00600340 | Central European Cooperative Oncology Group |
Metastatic Breast Cancer
|
April 2008 | Phase 3 |
| NCT03463265 | Aadi Bioscience, Inc. |
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
|
August 1, 2018 | Phase 2 |
| NCT02672995 | National Taiwan University Hospital |
Brain Neoplasm
|
January 2018 | Phase 1 |
| NCT05005455 | Innovent Biologics (Suzhou) Co. Ltd. |
Healthy Male Subjects
|
July 30, 2021 | Phase 1 |
| NCT01802645 | Technische Universität Dresden |
Colorectal Cancer
|
March 2013 | Phase 2 |
| NCT02121990 | Memorial Sloan Kettering Cancer Center|AstraZeneca|Genentech, Inc. |
Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
|
April 21, 2014 | Phase 1 |
| NCT00268489 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Lung Cancer
|
May 2006 | Phase 2 |
| NCT00303628 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Adenocarcinoma of the Rectum|Stage II Rectal Cancer|Stage III Rectal Cancer
|
February 17, 2006 | Phase 3 |
| NCT00559845 | Hoffmann-La Roche |
Breast Cancer
|
February 2008 | Phase 2 |
| NCT01208103 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Ampulla of Vater Adenocarcinoma|Small Intestinal Adenocarcinoma|Stage III Ampulla of Vater Cancer AJCC v8|Stage III Small Intestinal Adenocarcinoma AJCC v8|Stage IIIA Ampulla of Vater Cancer AJCC v8|Stage IIIA Small Intestinal Adenocarcinoma AJCC v8|Stage IIIB Ampulla of Vater Cancer AJCC v8|Stage IIIB Small Intestinal Adenocarcinoma AJCC v8|Stage IV Ampulla of Vater Cancer AJCC v8|Stage IV Small Intestinal Adenocarcinoma AJCC v8
|
May 6, 2011 | Phase 2 |
| NCT01125046 | Northwestern University |
Acoustic Schwannoma|Adult Anaplastic Meningioma|Adult Ependymoma|Adult Grade I Meningioma|Adult Grade II Meningioma|Adult Meningeal Hemangiopericytoma|Adult Papillary Meningioma|Neurofibromatosis Type 1|Neurofibromatosis Type 2|Recurrent Adult Brain Tumor
|
June 17, 2010 | Phase 2 |
| NCT03085992 | Azienda Ospedaliero, Universitaria Pisana |
Rectal Cancer
|
March 2012 | Phase 2 |
| NCT01020747 | Massachusetts General Hospital |
Recurrent Respiratory Papillomatosis
|
November 2009 | Phase 1 |
| NCT04813913 | University Hospital, Rouen |
Oncology
|
May 5, 2019 | Phase 4 |
| NCT00081861 | M.D. Anderson Cancer Center|Genentech, Inc. |
Lymphoma
|
March 2004 | Phase 2 |
| NCT00593450 | University of Pennsylvania|National Eye Institute (NEI) |
Age Related Macular Degeneration
|
February 2008 | Phase 3 |
| NCT02767219 | Moorfields Eye Hospital NHS Foundation Trust |
Glaucoma
|
May 2016 | Phase 3 |
| NCT02519348 | MedImmune LLC |
Hepatocellular Carcinoma
|
October 19, 2015 | Phase 2 |
| NCT01015300 | Dartmouth-Hitchcock Medical Center|Genentech, Inc. |
Hemangioblastomas|Von Hippel Lindau Disease
|
December 2009 | Early Phase 1 |
| NCT00942578 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Metastatic Prostate Cancer
|
July 16, 2009 | Phase 2 |
| NCT05010434 | Sun Yat-sen University|Innovent Biologics (Suzhou) Co. Ltd. |
Recurrent Hepatocellular Carcinoma
|
August 16, 2021 | Phase 2 |
| NCT03197571 | ImmunityBio, Inc. |
Urothelial Carcinoma
|
December 2017 | Phase 1|Phase 2 |
| NCT02179567 | Hellenic Oncology Research Group |
NSCLC
|
March 2010 | Phase 2 |
| NCT03382886 | University of Utah|Bristol-Myers Squibb |
Hepatocellular Carcinoma
|
April 11, 2018 | Phase 1 |
| NCT04601701 | He Eye Hospital |
Central Retinal Vein Occlusion
|
October 17, 2020 | Not Applicable |
| NCT00610493 | M.D. Anderson Cancer Center |
Advanced Cancer
|
January 25, 2008 | Phase 1 |
| NCT00805961 | SCRI Development Innovations, LLC|Genentech, Inc.|Novartis |
Glioblastoma Multiforme
|
January 2009 | Phase 2 |
| NCT00491738 | Genentech, Inc. |
Renal Cell Carcinoma
|
August 2007 | Phase 2 |
| NCT03563144 | ImmunityBio, Inc. |
Metastatic Pancreatic Cancer
|
August 2018 | Phase 2 |
| NCT00673673 | Yale University|Genentech, Inc. |
Gastroesophageal Cancer|Gastric Cancer
|
May 2008 | Phase 2 |
| NCT01215123 | Hoffmann-La Roche |
Breast Cancer
|
January 2010 | |
| NCT00538005 | San Diego Pacific Oncology & Hematology Associates|National Cancer Institute (NCI) |
Melanoma (Skin)
|
May 2007 | Phase 1|Phase 2 |
| NCT03952403 | Shanghai Henlius Biotech |
Carcinoma|Non-Small-Cell Lung
|
December 2, 2019 | Phase 3 |
| NCT00873236 | Mount Vernon Cancer Centre at Mount Vernon Hospital|National Cancer Institute (NCI) |
Kidney Cancer
|
April 2008 | Phase 2 |
| NCT04003792 | Rabin Medical Center |
Liver Metastasis Colon Cancer
|
January 1, 2020 | Phase 2 |
| NCT00217737 | National Cancer Institute (NCI) |
Colon Mucinous Adenocarcinoma|Colon Signet Ring Cell Adenocarcinoma|Lynch Syndrome|Stage IIA Colon Cancer AJCC v7|Stage IIB Colon Cancer AJCC v7|Stage IIC Colon Cancer AJCC v7
|
August 4, 2005 | Phase 3 |
| NCT02456857 | M.D. Anderson Cancer Center |
Invasive Breast Carcinoma|Triple-Negative Breast Carcinoma
|
January 12, 2016 | Phase 2 |
| NCT03136406 | ImmunityBio, Inc. |
Pancreatic Cancer
|
August 14, 2017 | Phase 1|Phase 2 |
| NCT01156961 | Hoffmann-La Roche |
Breast Cancer
|
October 2010 | Phase 4 |
| NCT00177307 | University of Pittsburgh|Genentech, Inc. |
Cancer
|
January 2005 | Phase 2 |
| NCT01263782 | M.D. Anderson Cancer Center|Eli Lilly and Company|Genentech, Inc. |
Lung Cancer
|
May 17, 2011 | Phase 2 |
| NCT04121455 | TME Pharma AG |
Glioblastoma
|
September 12, 2019 | Phase 1|Phase 2 |
| NCT04739202 | Hospices Civils de Lyon |
Gastric Adenocarcinoma|Metastatic Gastric Cancer|Metastatic Adenocarcinoma|Advanced Gastric Carcinoma
|
March 19, 2021 | Phase 2 |
| NCT00458731 | National Cancer Institute (NCI) |
Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Progressive Hairy Cell Leukemia, Initial Treatment|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Hairy Cell Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Hodgkin Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IVA Mycosis Fungoides+Sezary Syndrome|Stage IVB Mycosis Fungoides+Sezary Syndrome|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific|Waldenström Macroglobulinemia
|
May 2007 | Phase 1 |
| NCT00137774 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Genentech, Inc.|Schering-Plough |
Neuroendocrine Tumors
|
November 2004 | Phase 2 |
| NCT00112528 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Pancreatic Cancer
|
June 2005 | Phase 2 |
| NCT01171170 | Dutch Society of Physicians for Pulmonology and Tuberculosis |
Non Small Cell Lung Cancer
|
January 2011 | Phase 2 |
| NCT00456261 | SCRI Development Innovations, LLC|Genentech, Inc.|Eli Lilly and Company |
Lung Cancer
|
March 2007 | Phase 2 |
| NCT00455975 | SCRI Development Innovations, LLC|Genentech, Inc. |
Renal Cancer|Kidney Cancer
|
February 2007 | Phase 2 |
| NCT01916447 | Taiho Oncology, Inc. |
Advanced Gastrointestinal Tumors
|
September 2013 | Phase 1 |
| NCT02396511 | Tracon Pharmaceuticals Inc. |
Choriocarcinoma
|
January 2015 | Phase 2 |
| NCT00119262 | National Cancer Institute (NCI) |
Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer
|
October 2005 | Phase 2 |
| NCT03940690 | Fondation Ophtalmologique Adolphe de Rothschild |
Retinal Telangiectasis|Coats Disease
|
October 24, 2019 | Phase 3 |
| NCT00436709 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Breast Cancer
|
July 2006 | Not Applicable |
| NCT00055809 | National Cancer Institute (NCI) |
Metastatic Gastrointestinal Carcinoid Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Regional Gastrointestinal Carcinoid Tumor
|
January 2003 | Phase 2 |
| NCT00129727 | Massachusetts General Hospital|Women and Infants Hospital of Rhode Island |
Ovarian Cancer
|
June 2005 | Phase 2 |
| NCT00142480 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Genentech, Inc.|Sanofi-Synthelabo|Hoffmann-La Roche |
Biliary Tract Cancer|Gallbladder Adenocarcinoma
|
December 2004 | Phase 2 |
| NCT05585814 | Shanghai Changzheng Hospital |
Locally Advanced Colorectal Cancer
|
October 2022 | Phase 2 |
| NCT03117049 | Ono Pharmaceutical Co. Ltd|Bristol-Myers Squibb |
Non-Small Cell Lung Cancer
|
June 13, 2017 | Phase 3 |
| NCT01085734 | Maturi, Raj K., M.D., P.C. |
Retinal Vein Occlusions
|
March 2010 | Phase 4 |
| NCT04727307 | University Hospital, Montpellier |
Hepatocellular Carcinoma
|
January 26, 2021 | Phase 2 |
| NCT00408408 | NSABP Foundation Inc|National Cancer Institute (NCI) |
Breast Cancer
|
November 2006 | Phase 3 |
| NCT01135498 | Hoffmann-La Roche |
Colorectal Cancer
|
November 2006 | Phase 2 |
| NCT00025337 | National Cancer Institute (NCI) |
Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
|
September 2001 | Phase 3 |
| NCT03533127 | Luye Pharma Group Ltd. |
Non Small Cell Lung Cancer|Non Small Cell Lung Cancer Metastatic|Non Small Cell Lung Cancer Recurrent
|
November 27, 2017 | Phase 3 |
| NCT00717405 | Hoffmann-La Roche |
Breast Cancer
|
October 2008 | Phase 2 |
| NCT00932152 | University of Pittsburgh |
Non-small Cell Lung Cancer|Postmenopausal Women
|
September 2010 | Phase 2 |
| NCT00022607 | California Cancer Consortium|National Cancer Institute (NCI) |
Multiple Myeloma and Plasma Cell Neoplasm
|
January 2002 | Phase 2 |
| NCT02654639 | Georgetown University |
Metastatic Colorectal Cancer
|
February 2016 | Phase 2 |
| NCT02467907 | Hoffmann-La Roche |
Cervical Cancer
|
July 28, 2015 | Phase 2 |
| NCT01562028 | ETOP IBCSG Partners Foundation|Spanish Lung Cancer Group |
Lung Cancer
|
June 2012 | Phase 2 |
| NCT00556205 | Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Pfizer |
Renal Cell Carcinoma
|
September 2009 | Phase 2 |
| NCT02971501 | National Cancer Institute (NCI) |
Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Brain|Stage IV Lung Non-Small Cell Cancer AJCC v7
|
June 23, 2017 | Phase 2 |
| NCT00964704 | Hoffmann-La Roche |
Breast Cancer
|
March 2011 | Phase 2 |
| NCT00460174 | Northwestern University|National Cancer Institute (NCI) |
Pancreatic Cancer
|
October 10, 2005 | Phase 2 |
| NCT00336323 | Jaeb Center for Health Research|National Eye Institute (NEI) |
Diabetic Retinopathy
|
June 2006 | Phase 2 |
| NCT04017455 | The Netherlands Cancer Institute|Hoffmann-La Roche |
Rectal Cancer
|
October 22, 2019 | Phase 2 |
| NCT03818061 | Centre Leon Berard |
Head and Neck Neoplasms
|
March 26, 2019 | Phase 2 |
| NCT01763645 | Biocad |
Non-small Cell Lung Cancer
|
October 2012 | Phase 3 |
| NCT00109226 | Genentech, Inc. |
Colorectal Cancer
|
August 2000 | Phase 2 |
| NCT01044329 | Shahid Beheshti University of Medical Sciences|Labbafinejad Medical Center |
Branch Retinal Vein Occlusion
|
January 2010 | Phase 2 |
| NCT01170767 | Hospices Civils de Lyon |
Age Related Macular Degeneration
|
June 2009 | Phase 3 |
| NCT00511459 | Amgen |
Locally Recurrent and Metastatic Breast Cancer
|
July 2007 | Phase 2 |
| NCT04682210 | Sun Yat-sen University |
HCC|Adjuvant Therapy|Immunotherapy
|
December 2020 | Phase 3 |
| NCT05540951 | Fudan University |
Colorectal Cancer
|
June 1, 2018 | Phase 3 |
| NCT00392665 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Emory University|University of North Carolina, Chapel Hill|Genentech, Inc.|OSI Pharmaceuticals |
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
|
October 2006 | Phase 2 |
| NCT05444374 | Sichuan Cancer Hospital and Research Institute |
Cervical Cancer
|
October 1, 2022 | Phase 2 |
| NCT00806923 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
February 2005 | Phase 3 |
| NCT01166594 | Sunnybrook Health Sciences Centre|Glaucoma Research Society of Canada |
Glaucoma|Optic Neuropathy|Fibrosis
|
June 2010 | Phase 4 |
| NCT02620800 | Celgene |
Metastatic Pancreas Adenocarcinoma
|
January 18, 2016 | Phase 1 |
| NCT00027703 | National Cancer Institute (NCI) |
Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Localized Malignant Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
|
October 2001 | Phase 2 |
| NCT03635021 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Amgen |
Colorectal Cancer
|
October 15, 2018 | Phase 3 |
| NCT03203447 | Clearside Biomedical, Inc. |
Macular Edema|Retinal Vein Occlusion
|
March 5, 2018 | Phase 3 |
| NCT01946529 | St. Jude Children´s Research Hospital|University of Tennessee Health Science Center|University of Florida|Nemours Children´s Clinic |
Desmoplastic Small Round Cell Tumor|Ewing Sarcoma of Bone or Soft Tissue|Localized Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Metastatic Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor
|
December 27, 2013 | Phase 2 |
| NCT00925652 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Translational Breast Cancer Research Consortium|Genentech, Inc. |
Breast Cancer
|
September 2010 | Phase 2 |
| NCT01102595 | Grupo Español de Investigación en Neurooncología |
Glioblastomas
|
December 2009 | Phase 2 |
| NCT02174172 | Hoffmann-La Roche |
Solid Cancers
|
August 18, 2014 | Phase 1 |
| NCT05087992 | Boehringer Ingelheim |
Gastrointestinal Cancer, Metastatic
|
November 24, 2021 | Phase 1 |
| NCT02175446 | Consorzio Oncotech|Clinical Research Technology S.r.l. |
Metastatic Breast Cancer|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
|
September 2014 | Phase 2 |
| NCT02496286 | Eastern Regional Medical Center |
Malignant Ascites
|
June 2015 | Phase 1 |
| NCT01588184 | Hoffmann-La Roche |
Neoplasms
|
July 13, 2012 | Phase 4 |
| NCT02873962 | Dana-Farber Cancer Institute|Bristol-Myers Squibb |
Peritoneal Cancer|Ovarian Cancer|Fallopian Tube Cancer
|
November 10, 2016 | Phase 2 |
| NCT00062426 | Prologue Research International|National Cancer Institute (NCI) |
Colorectal Cancer
|
May 2003 | Phase 3 |
| NCT00775073 | Gerhard Treiber|Crolll Gmbh|Estimate, GmbH|Janssen Diagnostics, LLC|Treiber, Gerhard |
Hepatocellular Carcinoma
|
October 2008 | Phase 2 |
| NCT00222469 | University of Oklahoma|Genentech, Inc.|Sanofi|M.D. Anderson Cancer Center |
Metastatic Pancreatic Cancer
|
August 2005 | Phase 2 |
| NCT04527068 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Qilu Pharmaceutical Co., Ltd.|Shanghai Junshi Bioscience Co., Ltd. |
Refractory Metastatic Colorectal Cancer|pMMR|MSS
|
September 20, 2020 | Phase 2 |
| NCT01303926 | Gruppo Oncologico Italia Meridionale |
Non-squamous Nonsmall Cell Neoplasm of Lung
|
January 2010 | Phase 3 |
| NCT00081614 | Genentech, Inc. |
Renal Cell Carcinoma|Metastases
|
March 2004 | Phase 2 |
| NCT03337698 | Hoffmann-La Roche |
Carcinoma, Non-Small-Cell Lung
|
January 2, 2018 | Phase 1|Phase 2 |
| NCT02663141 | Tehran University of Medical Sciences|Farabi Eye Hospital |
Diabetic Macular Edema
|
June 2015 | Phase 2 |
| NCT01057264 | M.D. Anderson Cancer Center |
Advanced Cancers
|
January 2010 | Phase 1 |
| NCT04421378 | Karyopharm Therapeutics Inc |
Glioblastoma Multiforme
|
June 8, 2020 | Phase 1|Phase 2 |
| NCT02821559 | Centre Hospitalier Universitaire de Besancon|Hospira, now a wholly owned subsidiary of Pfizer |
Metastatic Colorectal Cancer
|
July 2012 | Phase 2 |
| NCT01454102 | Bristol-Myers Squibb |
Non-small Cell Lung Cancer
|
December 16, 2011 | Phase 1 |
| NCT01763671 | Intergroupe Francophone de Cancerologie Thoracique |
Non-squamous Non-small Cell Lung Cancer
|
May 2013 | Phase 3 |
| NCT03690739 | AGO Research GmbH |
Recurrent Ovarian Carcinoma
|
August 9, 2019 | Phase 3 |
| NCT02192970 | University of Wisconsin, Madison |
Retinal Detachment|Proliferative Vitreoretinopathy
|
January 21, 2015 | Phase 2 |
| NCT00401817 | Weill Medical College of Cornell University |
Untreated Mantle Cell Lymphoma
|
November 2007 | Phase 2 |
| NCT01408953 | Tirgan, Michael H., M.D. |
Keloid
|
February 2012 | Phase 2 |
| NCT00234494 | Christopher Sweeney, MBBS|Genentech, Inc.|Eli Lilly and Company|Walther Cancer Institute|Hoosier Cancer Research Network |
Bladder Cancer
|
November 2005 | Phase 2 |
| NCT01383707 | Hoffmann-La Roche |
Colorectal Cancer
|
August 12, 2011 | Phase 2 |
| NCT01950390 | National Cancer Institute (NCI) |
Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Unresectable Melanoma
|
December 13, 2013 | Phase 2 |
| NCT00937560 | Hoffmann-La Roche |
Ovarian Cancer
|
June 25, 2009 | Phase 2 |
| NCT04861948 | Innovent Biologics (Suzhou) Co. Ltd. |
Solid Tumors|Lung Adenocarcinoma|Osteosarcoma
|
May 25, 2021 | Phase 1 |
| NCT00564148 | Ophthalmological Association Edelweiss |
Retinal Neovascularization
|
July 2007 | Phase 2 |
| NCT01374425 | Genentech, Inc. |
Colorectal Cancer
|
August 2011 | Phase 2 |
| NCT02754882 | Samsung Bioepis Co., Ltd. |
Lung Cancer|Non-small Cell Lung Cancer
|
July 5, 2016 | Phase 3 |
| NCT02891824 | ARCAGY+ GINECO GROUP|Hoffmann-La Roche |
Ovarian Cancer
|
September 22, 2016 | Phase 3 |
| NCT03387111 | ImmunityBio, Inc. |
Squamous Cell Carcinoma
|
January 13, 2018 | Phase 1|Phase 2 |
| NCT02919371 | King Faisal Specialist Hospital & Research Center |
Renal Cell Carcinoma
|
December 2014 | Phase 1|Phase 2 |
| NCT01422018 | Seoul St. Mary´s Hospital |
Diabetes Complications
|
August 2011 | Not Applicable |
| NCT01435395 | Emory University|Schering-Plough|Genentech, Inc.|Millennium Pharmaceuticals, Inc. |
Glioblastoma Multiforme
|
December 2011 | Phase 1 |
| NCT00404703 | Hoffmann-La Roche |
Non-Small Cell Lung Cancer
|
August 2006 | Phase 2 |
| NCT00531024 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
Macular Degeneration
|
August 2005 | Phase 2|Phase 3 |
| NCT00904839 | Boehringer Ingelheim |
Colorectal Neoplasms
|
May 2009 | Phase 2 |
| NCT05052099 | University Hospital, Essen |
Biliary Tract Cancer
|
October 2021 | Phase 1|Phase 2 |
| NCT02436993 | University of California, Irvine |
Breast Carcinoma
|
April 2015 | Phase 2 |
| NCT01972490 | Xu jianmin|Fudan University |
Colorectal Neoplasms
|
October 2013 | Phase 4 |
| NCT02363751 | UNICANCER |
Collecting Duct Carcinoma (Kidney)
|
December 2014 | Phase 2 |
| NCT00378638 | Chap, Linnea I., M.D.|Genentech, Inc. |
Breast Cancer
|
June 2006 | Phase 2 |
| NCT00113217 | M.D. Anderson Cancer Center|Genentech, Inc. |
Renal Cell Carcinoma|Kidney Cancer
|
February 2005 | Phase 2 |
| NCT01032109 | Kumamoto University |
Age-related Macular Degeneration
|
October 2006 | Not Applicable |
| NCT03329248 | ImmunityBio, Inc. |
Pancreatic Cancer
|
November 6, 2017 | Phase 1|Phase 2 |
| NCT00577109 | Hoffmann-La Roche|Merck KGaA, Darmstadt, Germany |
Colorectal Cancer
|
December 2007 | Phase 2 |
| NCT02835833 | University of Alabama at Birmingham|Boehringer Ingelheim |
Renal Cell Carcinoma|Colorectal Adenocarcinoma|Non-squamous Non-small Cell Lung Cancer|Platinum-refractory Ovarian Carcinoma|Cervical Carcinoma
|
June 9, 2016 | Phase 1 |
| NCT04262687 | Federation Francophone de Cancerologie Digestive |
Colorectal Cancer Metastatic|High Immune Infiltrate|Microsatellite Stable
|
April 6, 2021 | Phase 2 |
| NCT03272217 | Arjun Balar, MD|Roche-Genentech|Hoosier Cancer Research Network |
Urothelial Carcinoma
|
September 13, 2017 | Phase 2 |
| NCT01380678 | Khon Kaen University |
Pterygium|Inflammation
|
January 2009 | Phase 3 |
| NCT00326911 | Eli Lilly and Company |
Metastatic Pancreatic Cancer
|
May 2006 | Phase 2 |
| NCT05330065 | The First Affiliated Hospital of Zhengzhou University |
Malignant Pleural Effusion
|
August 1, 2022 | Phase 1|Phase 2 |
| NCT04660812 | Arcus Biosciences, Inc.|Gilead Sciences |
Metastatic Colorectal Cancer
|
May 10, 2021 | Phase 1|Phase 2 |
| NCT01608087 | Boehringer Ingelheim |
Healthy
|
May 1, 2012 | Phase 1 |
| NCT05593328 | Cardiff Oncology |
Colorectal Cancer|Metastatic Colorectal Cancer
|
November 2022 | Phase 2 |
| NCT01229202 | Nova Scotia Health Authority |
Glaucoma
|
July 2008 | Phase 4 |
| NCT01487629 | University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo |
Diabetic Retinopathy|Macular Edema
|
April 2010 | Phase 2 |
| NCT00023959 | National Cancer Institute (NCI) |
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Basal Cell Carcinoma of the Lip|Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Lymphoepithelioma of the Oropharynx|Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage III Mucoepidermoid Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Basal Cell Carcinoma of the Lip|Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Lymphoepithelioma of the Oropharynx|Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage IV Mucoepidermoid Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
July 2001 | Phase 1 |
| NCT01917877 | Qingdao Central Hospital |
Pulmonary Fibrosis
|
August 2013 | Phase 2 |
| NCT00976911 | Hoffmann-La Roche |
Ovarian Cancer
|
October 29, 2009 | Phase 3 |
| NCT04872582 | XIANG YANQUN|Sun Yat-sen University |
Recurrent Nasopharyngeal Carcinoma|Metastatic Nasopharyngeal Carcinoma|Chemotherapy Effect
|
July 29, 2021 | Phase 2 |
| NCT00600210 | Leo W. Jenkins Cancer Center|Genentech, Inc. |
Cervical Cancer
|
January 2008 | Phase 2 |
| NCT01128699 | Vanak Eye Surgery Center |
Refractory Glaucoma
|
May 2010 | Phase 3 |
| NCT00402883 | SCRI Development Innovations, LLC|Genentech, Inc.|Eli Lilly and Company |
Lung Cancer
|
November 2006 | Phase 2 |
| NCT00281697 | Genentech, Inc. |
Metastatic Breast Cancer
|
February 2006 | Phase 3 |
| NCT00434252 | Genentech, Inc. |
Melanoma
|
February 2007 | Phase 2 |
| NCT00019539 | National Cancer Institute (NCI) |
Stage IV Renal Cell Cancer|Recurrent Renal Cell Cancer
|
November 1998 | Phase 2 |
| NCT00434642 | Genentech, Inc. |
Ovarian Cancer
|
April 2007 | Phase 3 |
| NCT03169738 | ImmunityBio, Inc. |
Non-small Cell Lung Cancer
|
February 2018 | Phase 1|Phase 2 |
| NCT00520013 | Dana-Farber Cancer Institute|Genentech, Inc.|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Massachusetts General Hospital |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|Papillary Serous Mullerian Tumor|Clear Cell Mullerian Tumor
|
August 2007 | Phase 2 |
| NCT03554707 | SynerGene Therapeutics, Inc. |
Childhood CNS Tumor
|
June 2022 | Early Phase 1 |
| NCT00566761 | Asociación para Evitar la Ceguera en México |
Macular Edema|Central Retinal Vein Occlusion
|
June 2007 | Phase 4 |
| NCT00126542 | National Cancer Institute (NCI) |
Fallopian Tube Cancer|Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
|
April 2005 | Phase 2 |
| NCT04510584 | University Health Network, Toronto |
Ovarian Endometrioid Tumor|Fallopian Tube Cancer|Primary Peritoneal Cancer|TP53 Mutation
|
July 16, 2021 | Phase 2 |
| NCT01507740 | Medical University Innsbruck |
Hepatocellular Cancer|Non-small Cell Lung Cancer|Renal Cell Cancer|Colorectal Cancer
|
July 2009 | |
| NCT01091792 | Dartmouth-Hitchcock Medical Center|Genentech, Inc. |
Glioblastoma Multiforme
|
March 2010 | Early Phase 1 |
| NCT01043484 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Hoffmann-La Roche |
Rectal Cancer
|
December 2009 | Phase 2 |
| NCT05132413 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer
|
December 30, 2021 | Phase 3 |
| NCT02901236 | Athens Vision Eye Institute |
Glaucoma
|
January 2014 | Phase 2|Phase 3 |
| NCT00595322 | Memorial Sloan Kettering Cancer Center|Weill Medical College of Cornell University|Genentech, Inc. |
Brain Cancer|Recurrent Malignant Gliomas|Primary Brain Tumor
|
December 2005 | Not Applicable |
| NCT03220932 | Hospices Civils de Lyon |
Ovarian Epithelial Cancer
|
November 30, 2019 | Phase 3 |
| NCT00913913 | Dartmouth-Hitchcock Medical Center|National Cancer Institute (NCI) |
Metastatic Renal Cell Carcinoma
|
February 2009 | Phase 2 |
| NCT00347165 | Asociación para Evitar la Ceguera en México |
Age Related Macular Degeneration
|
September 2005 | Phase 2 |
| NCT00410956 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Liver Cancer
|
May 2007 | Phase 2 |
| NCT00137826 | Dana-Farber Cancer Institute|Massachusetts General Hospital|University of Chicago |
Mesothelioma
|
February 2004 | Phase 2 |
| NCT03246152 | Cairo University |
Diabetic Macular Edema|Ischemic Maculopathy
|
October 23, 2017 | Phase 4 |
| NCT01722968 | Theodoros Foukakis|Karolinska University Hospital |
Breast Cancer
|
November 2012 | Phase 2 |
| NCT01152203 | M.D. Anderson Cancer Center|Cephalon|National Comprehensive Cancer Network |
Advanced Cancer
|
June 2010 | Phase 1 |
| NCT03737643 | AstraZeneca|European Network of Gynaecological Oncological Trial Groups (ENGOT)|GOG Foundation, Inc. (GOG Foundation)|Myriad Genetic Laboratories, Inc. |
Advanced Ovarian Cancer
|
January 4, 2019 | Phase 3 |
| NCT03713944 | Nasser Hanna|Genentech, Inc.|Big Ten Cancer Research Consortium |
NSCLC Stage IV|NSCLC, Recurrent
|
November 15, 2018 | Phase 2 |
| NCT00651456 | Intergroupe Francophone de Cancerologie Thoracique|University Hospital, Caen|Groupe Francais De Pneumo-Cancerologie |
Mesothelioma
|
February 2008 | Phase 2|Phase 3 |
| NCT00773695 | Hoffmann-La Roche|Norwegian Radium Hospital |
Breast Cancer
|
November 7, 2008 | Phase 2 |
| NCT05214339 | Sun Yat-sen University|Third Affiliated Hospital, Sun Yat-Sen University|Nanfang Hospital of Southern Medical University|Xiangya Hospital of Central South University |
Unresectable Hepatocellular Carcinoma|Hepatocellular Carcinoma by BCLC Stage
|
March 16, 2022 | Phase 2 |
| NCT04299880 | Sumitomo Pharma Oncology, Inc. |
Oncology
|
February 24, 2020 | Phase 1 |
| NCT00118261 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) |
Colorectal Cancer
|
March 2005 | Phase 1 |
| NCT00537823 | Washington University School of Medicine |
Colorectal Cancer|Metastases
|
June 2007 | Phase 2 |
| NCT01004874 | Duke University|Genentech, Inc.|GlaxoSmithKline |
Malignant Glioma|Glioblastoma|Gliosarcoma
|
December 30, 2009 | Phase 2 |
| NCT00370630 | Shahid Beheshti University of Medical Sciences |
Retinovascular Disease
|
August 2006 | Phase 2 |
| NCT02031991 | Pfizer |
Healthy
|
January 2014 | Phase 1 |
| NCT00047710 | M.D. Anderson Cancer Center|Genentech, Inc. |
Pancreatic Cancer
|
September 2002 | Phase 1 |
| NCT02640365 | GERCOR - Multidisciplinary Oncology Cooperative Group|Merrimack Pharmaceuticals |
Unresectable Advanced Cancer
|
November 18, 2015 | Phase 1 |
| NCT01498328 | Celldex Therapeutics |
Glioblastoma|Small Cell Glioblastoma|Giant Cell Glioblastoma|Gliosarcoma|Glioblastoma With Oligodendroglial Component|Recurrent Glioblastoma|Relapsed Glioblastoma
|
December 2011 | Phase 2 |
| NCT00553800 | Fox Chase Cancer Center|Genentech, Inc.|OSI Pharmaceuticals |
Carcinoma, Non-Small-Cell Lung
|
July 5, 2007 | Phase 2 |
| NCT02574078 | Bristol-Myers Squibb |
Non-Small Cell Lung Cancer
|
November 23, 2015 | Phase 1|Phase 2 |
| NCT04310176 | National Cancer Institute, Naples |
Ras-mutated Metastatic Colorectal Cancer
|
May 24, 2019 | Phase 2 |
| NCT00957125 | Thomas Hatschek|Karolinska University Hospital |
Breast Cancer
|
September 2008 | Phase 2 |
| NCT00357318 | National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
June 2006 | Phase 1 |
| NCT04991350 | Cairo University |
Diabetic Macular Edema|Macular Ischemia|Diabetic Retinopathy|Vascular Endothelial Growth Factor Overexpression
|
November 26, 2021 | Phase 4 |
| NCT00262847 | National Cancer Institute (NCI)|NRG Oncology |
Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carcinoma
|
September 2005 | Phase 3 |
| NCT00384631 | Shahid Beheshti University of Medical Sciences |
Neovascular|Glaucoma
|
April 2006 | Not Applicable |
| NCT02420821 | Hoffmann-La Roche |
Renal Cell Carcinoma
|
May 20, 2015 | Phase 3 |
| NCT02810457 | Centus Biotherapeutics Limited |
Carcinoma, Non-Small-Cell Lung
|
September 7, 2016 | Phase 3 |
| NCT00324805 | National Cancer Institute (NCI)|Cancer and Leukemia Group B|NCIC Clinical Trials Group|North Central Cancer Treatment Group|Southwest Oncology Group |
Stage IB Lung Non-Small Cell Carcinoma AJCC v7|Stage IIA Lung Non-Small Cell Carcinoma AJCC v7|Stage IIB Lung Non-Small Cell Carcinoma AJCC v7|Stage IIIA Lung Non-Small Cell Cancer AJCC v7
|
June 1, 2007 | Phase 3 |
| NCT03555149 | Hoffmann-La Roche |
Colorectal Cancer
|
September 27, 2018 | Phase 1|Phase 2 |
| NCT03050814 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Colorectal Tumors|Colorectal Neoplasms|Colorectal Carcinoma|Colorectal Adenocarcinoma|Colorectal Cancer
|
April 5, 2017 | Phase 2 |
| NCT00130520 | University of Arizona|Genentech, Inc. |
Ovarian Neoplasms
|
June 2005 | Phase 2 |
| NCT00417716 | Asociación para Evitar la Ceguera en México |
Diabetes Mellitus Type 2|Diabetic Macular Edema
|
September 2005 | Phase 3 |
| NCT01552434 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Advanced Malignant Neoplasm|Castleman Disease|Digestive System Carcinoma|Erdheim-Chester Disease|Lip and Oral Cavity Carcinoma|Lymphangioleiomyomatosis|Malignant Endocrine Neoplasm|Malignant Female Reproductive System Neoplasm|Malignant Male Reproductive System Neoplasm|Malignant Neoplasm|Malignant Respiratory Tract Neoplasm|Malignant Thoracic Neoplasm|Malignant Urinary System Neoplasm|Mesothelial Neoplasm|Metastatic Malignant Neoplasm|Metastatic Urothelial Carcinoma|Neurofibromatosis Type 2|Recurrent Adult Soft Tissue Sarcoma|Recurrent Breast Carcinoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Digestive System Carcinoma|Recurrent Female Reproductive System Carcinoma|Recurrent Male Reproductive System Carcinoma|Recurrent Malignant Neoplasm|Recurrent Pharyngeal Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Malignant Neoplasm|Soft Tissue Neoplasm|Stage III Breast Cancer AJCC v7|Stage III Pharyngeal Cancer|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Pharyngeal Cancer|Stage IVA Pharyngeal Cancer|Stage IVB Pharyngeal Cancer|Stage IVC Pharyngeal Cancer|Thyroid Gland Neoplasm
|
March 16, 2012 | Phase 1 |
| NCT02033031 | Medical University of Vienna |
Branch Retinal Vein Occlusion
|
August 2012 | Phase 3 |
| NCT01588990 | Hoffmann-La Roche |
Colorectal Neoplasms
|
June 26, 2012 | Phase 4 |
| NCT01201850 | University of Colorado, Denver|Genentech, Inc. |
Radiation Necrosis
|
June 28, 2010 | Not Applicable |
| NCT01937715 | Pfizer |
Metastatic Colorectal Carcinoma
|
February 2014 | Phase 1|Phase 2 |
| NCT00323011 | University of Southern California|Pfizer |
Colorectal Cancer
|
May 2006 | Phase 2 |
| NCT02389959 | Stanford University |
HHT|Hereditary Hemorrhagic Telangiectasia|Epistaxis|Nose Bleeds|Nasal Bleeding
|
August 4, 2014 | Phase 4 |
| NCT00533585 | M.D. Anderson Cancer Center|Bayer |
Lung Cancer
|
May 2006 | Phase 1 |
| NCT00952029 | Federation Francophone de Cancerologie Digestive |
Colorectal Cancer
|
March 2010 | Phase 2|Phase 3 |
| NCT01249521 | Austin Health |
Metastatic Colorectal Cancer
|
November 2010 | Phase 2 |
| NCT04974944 | Sun Yat-sen University |
Stage IVB Cervical Cancer|Recurrent Cervical Cancer|Persistent Cervical Cancer
|
July 30, 2021 | Phase 2 |
| NCT00399750 | Sanofi |
Colorectal Cancer
|
November 2002 | Phase 2 |
| NCT00095459 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Neoplasms
|
November 2, 2004 | Phase 1 |
| NCT01083368 | Case Comprehensive Cancer Center |
Prostate Cancer
|
January 2009 | Phase 1|Phase 2 |
| NCT00974584 | Genentech, Inc. |
Non-Squamous Non-Small Cell Lung Cancer
|
October 2009 | Phase 1 |
| NCT01525082 | Shaheen Shagufta|National Cancer Institute (NCI)|Stanford University |
Gastrinoma|Glucagonoma|Insulinoma|Pancreatic Polypeptide Tumor|Recurrent Islet Cell Carcinoma|Recurrent Pancreatic Cancer|Somatostatinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
|
December 2012 | Phase 2 |
| NCT00967330 | Hoffmann-La Roche |
Glioblastoma Multiforme
|
June 2010 | Phase 2 |
| NCT00088894 | National Cancer Institute (NCI) |
Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
|
June 2004 | Phase 3 |
| NCT02743078 | RTOG Foundation, Inc.|NovoCure Ltd. |
Glioblastoma|Glioma|Gliosarcoma
|
May 9, 2017 | Phase 2 |
| NCT05525858 | Seoul National University Bundang Hospital|Korean Cancer Study Group|Roche Pharma AG |
Solid Tumor|Advanced Solid Tumor|Metastatic Cancer
|
September 28, 2022 | |
| NCT01900717 | Centre Hospitalier Universitaire Dijon |
Metastatic Colorectal Adenocarcinoma
|
July 2011 | Phase 2 |
| NCT03376659 | Georgetown University|Mayo Clinic|Indiana University|Emory University|National Cancer Institute (NCI)|George Mason University|Thomas Jefferson University|MedImmune LLC|Bavarian Nordic |
Metastatic Colorectal Cancer|Colorectal Adenocarcinoma|Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer
|
August 8, 2018 | Phase 1|Phase 2 |
| NCT03038100 | Hoffmann-La Roche|GOG Foundation|European Network of Gynaecological Oncological Trial Groups (ENGOT) |
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms
|
March 8, 2017 | Phase 3 |
| NCT00625898 | NSABP Foundation Inc|Cancer International Research Group (CIRG)|Hoffmann-La Roche|Genentech, Inc. |
Breast Cancer
|
April 2008 | Phase 3 |
| NCT03037736 | University of California, San Francisco |
Pterygium of Conjunctiva and Cornea
|
March 1, 2020 | Phase 4 |
| NCT00323739 | SCRI Development Innovations, LLC|Genentech, Inc.|Novartis |
Kidney Cancer
|
May 2006 | Phase 2 |
| NCT00515684 | Yonsei University |
Corneal Neovascularization
|
May 2007 | Not Applicable |
| NCT05303259 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
Brain Injuries
|
November 1, 2021 | Phase 2 |
| NCT01658033 | Fudan University |
Metastatic Breast Cancer
|
May 2012 | Phase 2 |
| NCT00026221 | National Cancer Institute (NCI) |
Recurrent Melanoma|Stage IV Skin Melanoma
|
November 2001 | Phase 2 |
| NCT01320683 | City of Hope Medical Center|National Cancer Institute (NCI) |
Liver Metastases|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
|
March 2011 | Phase 2 |
| NCT00867321 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Liver Cancer
|
April 2009 | Phase 1|Phase 2 |
| NCT01047059 | University of Cologne |
Non-Small-Cell Lung Carcinoma
|
January 2010 | Phase 2 |
| NCT00378703 | National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer AJCC v7
|
September 14, 2007 | Phase 2 |
| NCT00321828 | NSABP Foundation Inc|National Cancer Institute (NCI) |
Colorectal Cancer
|
March 2006 | Phase 2 |
| NCT00370422 | Shahid Beheshti University of Medical Sciences |
Diabetic Macular Edema
|
November 2005 | Phase 3 |
| NCT01105702 | NYU Langone Health|Genentech, Inc.|Atlantic Health System |
Brain Cancer
|
May 2010 | Phase 2 |
| NCT02342379 | The University of Texas Health Science Center at San Antonio |
Glioblastoma
|
May 2015 | Phase 2 |
| NCT00816595 | Mayo Clinic|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
February 2009 | Phase 2 |
| NCT01898130 | Northwestern University|Genentech, Inc. |
Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific
|
November 27, 2013 | Phase 2 |
| NCT00741195 | Hellenic Oncology Research Group |
Non-small-cell Lung Cancer
|
April 2008 | Phase 2 |
| NCT05109052 | University of Rochester |
Hepatocellular Carcinoma|Cancer of Liver
|
September 20, 2022 | Phase 1|Phase 2 |
| NCT00320541 | Eli Lilly and Company|Genentech, Inc. |
Breast Cancer
|
May 2006 | Phase 2 |
| NCT04732286 | Hoffmann-La Roche |
Carcinoma, Hepatocellular
|
May 4, 2021 | Phase 3 |
| NCT01763450 | Liaoning Tumor Hospital & Institute |
Liver Metastases|Colorectal Cancer
|
September 2012 | Phase 2 |
| NCT03990103 | China Medical University, China |
Metastatic Gastric Adenocarcinoma
|
November 1, 2017 | Phase 2 |
| NCT01229813 | Lund University Hospital|Hoffmann-La Roche |
Colorectal Cancer
|
October 2010 | Phase 3 |
| NCT01551745 | Gradalis, Inc. |
Stage III Ovarian Cancer|Stage IV Ovarian Cancer
|
March 2012 | Phase 2 |
| NCT00460603 | Pfizer |
Colorectal Neoplasms
|
January 2006 | Phase 1|Phase 2 |
| NCT00397982 | National Cancer Institute (NCI)|Fox Chase Cancer Center |
Recurrent Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin Melanoma
|
January 2008 | Phase 2 |
| NCT00407719 | Johns Hopkins University |
Choroidal Neovascularization|Degenerative Myopia|Pathological Myopia
|
June 2005 | Phase 1 |
| NCT03169764 | ImmunityBio, Inc. |
Head and Neck Squamous Cell Carcinoma
|
December 2017 | Phase 1|Phase 2 |
| NCT01414153 | Lpath, Inc. |
Exudative Age-related Macular Degeneration
|
August 2012 | Phase 2 |
| NCT02072720 | Amsterdam UMC, location VUmc|Noordwest Ziekenhuisgroep|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
Primary Esophageal Carcinoma
|
February 2014 | Early Phase 1 |
| NCT00588770 | National Cancer Institute (NCI) |
Neck Squamous Cell Carcinoma of Unknown Primary|Recurrent Hypopharyngeal Squamous Cell Carcinoma|Recurrent Laryngeal Squamous Cell Carcinoma|Recurrent Laryngeal Verrucous Carcinoma|Recurrent Lip and Oral Cavity Squamous Cell Carcinoma|Recurrent Neck Squamous Cell Carcinoma of Unknown Primary|Recurrent Oral Cavity Verrucous Carcinoma|Recurrent Oropharyngeal Squamous Cell Carcinoma|Recurrent Salivary Gland Carcinoma|Recurrent Sinonasal Squamous Cell Carcinoma|Salivary Gland Squamous Cell Carcinoma|Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7|Stage IV Major Salivary Gland Cancer AJCC v7|Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7|Stage IVA Laryngeal Verrucous Carcinoma AJCC v7|Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7|Stage IVA Major Salivary Gland Cancer AJCC v7|Stage IVA Oral Cavity Cancer AJCC v6 and v7|Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7|Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7|Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7|Stage IVB Laryngeal Verrucous Carcinoma AJCC v7|Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7|Stage IVB Major Salivary Gland Cancer AJCC v7|Stage IVB Oral Cavity Cancer AJCC v6 and v7|Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7|Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7|Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7|Stage IVC Laryngeal Verrucous Carcinoma AJCC v7|Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7|Stage IVC Major Salivary Gland Cancer AJCC v7|Stage IVC Oral Cavity Cancer AJCC v6 and v7|Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7|Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7|Tongue Carcinoma
|
August 8, 2008 | Phase 3 |
| NCT01007552 | Roswell Park Cancer Institute|Genentech, Inc. |
Cholangiocarcinoma
|
December 2009 | Phase 2 |
| NCT00301964 | National Cancer Institute (NCI)|Gynecologic Oncology Group |
Recurrent Endometrial Carcinoma
|
March 2006 | Phase 2 |
| NCT01442935 | UNICANCER |
Colorectal Cancer
|
February 2011 | Phase 2 |
| NCT02079519 | Hoffmann-La Roche |
Multiple Myeloma
|
May 2006 | Phase 2 |
| NCT04788381 | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Colorectal Cancer|Lung Cancer|Operation Wound; Infection|Bevacizumab
|
April 1, 2021 | |
| NCT05211323 | National Cancer Institute (NCI) |
Combined Hepatocellular Carcinoma and Cholangiocarcinoma|Stage III Liver Cancer|Stage IV Liver Cancer
|
February 11, 2022 | Phase 2 |
| NCT03844074 | Outlook Therapeutics, Inc. |
Age-related Macular Degeneration|Neovascular Age-related Macular Degeneration|Wet Macular Degeneration
|
October 1, 2018 | Phase 3 |
| NCT01633970 | Genentech, Inc. |
Cancer
|
July 11, 2012 | Phase 1 |
| NCT00337207 | Northwestern University|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
March 2006 | Phase 2 |
| NCT05063552 | National Cancer Institute (NCI) |
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Metastatic Head and Neck Squamous Cell Carcinoma|Metastatic Hypopharyngeal Squamous Cell Carcinoma|Metastatic Laryngeal Squamous Cell Carcinoma|Metastatic Lip and Oral Cavity Carcinoma|Metastatic Nasal Cavity Squamous Cell Carcinoma|Metastatic Nasopharyngeal Squamous Cell Carcinoma|Metastatic Pharyngeal Squamous Cell Carcinoma|Metastatic Sinonasal Squamous Cell Carcinoma|Recurrent Head and Neck Squamous Cell Carcinoma|Recurrent Hypopharyngeal Squamous Cell Carcinoma|Recurrent Laryngeal Squamous Cell Carcinoma|Recurrent Lip and Oral Cavity Squamous Cell Carcinoma|Recurrent Nasopharyngeal Squamous Cell Carcinoma|Recurrent Pharyngeal Squamous Cell Carcinoma|Recurrent Sinonasal Squamous Cell Carcinoma|Stage IV Hypopharyngeal Carcinoma AJCC v8|Stage IV Laryngeal Cancer AJCC v8|Stage IV Lip and Oral Cavity Cancer AJCC v8|Stage IV Nasopharyngeal Carcinoma AJCC v8|Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8|Stage IV Sinonasal Cancer AJCC v8
|
December 16, 2021 | Phase 2|Phase 3 |
| NCT03793400 | Changhua Christian Hospital |
Choroidal Neovascularization|Punctate Inner Choroidopathy
|
March 13, 2018 | |
| NCT03896074 | Fondazione Ricerca Traslazionale |
Non-small-cell Lung Cancer Patients
|
May 2019 | Phase 2 |
| NCT00866723 | Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute|Massachusetts General Hospital|Genentech, Inc. |
Ovarian Cancer|Primary Peritoneal Serous Cancer|Fallopian Tube Cancer
|
March 2009 | Phase 2 |
| NCT00856180 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Brigham and Women´s Hospital|Genentech, Inc. |
Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
|
February 2009 | Phase 2 |
| NCT00796757 | Hoffmann-La Roche |
Renal Cell Cancer
|
December 2008 | Phase 2 |
| NCT00999791 | Shahid Beheshti University of Medical Sciences |
Diffuse Diabetic Macular Edema
|
July 2009 | Phase 1 |
| NCT00698516 | GlaxoSmithKline |
Recurrent Small-cell Lung Cancer (SCLC)|Lung Cancer, Small Cell
|
July 2008 | Phase 2 |
| NCT00929058 | Radboud University Medical Center |
Hypertension|Cancer
|
June 2009 | Not Applicable |
| NCT02613208 | Hoffmann-La Roche |
Breast Cancer
|
December 9, 2015 | |
| NCT01309451 | Maturi, Raj K., M.D., P.C. |
Diabetic Macular Edema
|
March 2011 | Phase 4 |
| NCT01344824 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) |
Lung Cancer
|
March 2010 | Phase 2 |
| NCT01220154 | David O´Malley|Genentech, Inc.|Ohio State University Comprehensive Cancer Center |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|No Prior Chemotherapy
|
October 2010 | Phase 1 |
| NCT00970970 | University Medical Center Groningen|VHL Alliance |
Von Hippel-Lindau Disease|Hemangioblastoma|Renal Cell Carcinoma|Pheochromocytoma|Pancreatic Neuroendocrine Tumor
|
September 2009 | |
| NCT00949247 | Case Comprehensive Cancer Center |
Breast Cancer
|
December 2009 | Early Phase 1 |
| NCT00532909 | Branimir Sikic|AstraZeneca|Stanford University |
Anal, Colon, and Rectal Cancers|Colorectal Neoplasms|Colon+Rectal Cancer
|
July 2006 | Phase 1 |
| NCT02048540 | Chinese PLA General Hospital |
Locally Advanced Gastric Carcinoma
|
February 2009 | Phase 1|Phase 2 |
| NCT02054052 | Haihong Yang, MD, Pricipal investigator|Guangzhou Medical University |
Non-small Cell Lung Cancer|Malignant Pleural Effusion
|
January 2014 | Phase 2 |
| NCT01661946 | Queen´s University|The Physicians´ Services Incorporated Foundation |
Diabetic Macular Edema
|
August 2012 | Phase 3 |
| NCT04670978 | Shandong University |
Objective Response Rate
|
March 31, 2021 | Phase 2 |
| NCT02829931 | H. Lee Moffitt Cancer Center and Research Institute |
Malignant Glioma
|
August 22, 2016 | Phase 1 |
| NCT01504724 | Kyungpook National University Hospital |
Diabetic Retinopathy
|
August 2011 | Phase 4 |
| NCT02633189 | National Cancer Institute, Naples |
Non-squamous Non-small Cell Lung Cancer
|
April 2016 | Phase 3 |
| NCT01966913 | Assistance Publique - Hôpitaux de Paris |
Germ Cell Tumor
|
April 2012 | Phase 1|Phase 2 |
| NCT04812002 | Women´s Hospital School Of Medicine Zhejiang University |
Gestational Trophoblastic Neoplasia
|
April 15, 2021 | Phase 2 |
| NCT01894061 | Case Comprehensive Cancer Center|NovoCure Ltd.|National Cancer Institute (NCI) |
Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
|
June 12, 2013 | Phase 2 |
| NCT02366143 | Hoffmann-La Roche |
Carcinoma, Non-Small-Cell Lung
|
March 31, 2015 | Phase 3 |
| NCT00120172 | Geriatric Oncology Consortium|Sanofi |
Colorectal Cancer|Neoplasm Metastasis
|
May 2005 | Phase 2 |
| NCT01260506 | Vascular Biogenics Ltd. operating as VBL Therapeutics |
Glioblastoma Multiforme
|
December 2010 | Phase 1|Phase 2 |
| NCT01679327 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Colorectal Cancer
|
March 2012 | Phase 2 |
| NCT02399410 | University Hospital, Ghent |
Colorectal Neoplasms
|
December 2015 | Phase 2 |
| NCT01195298 | South Eastern European Research Oncology Group|Roche Pharma AG |
Breast Cancer|Metastasis
|
May 2010 | Phase 2 |
| NCT02985619 | University of Sao Paulo |
Diabetic Macular Edema
|
July 21, 2016 | Phase 2|Phase 3 |
| NCT04425681 | Second Affiliated Hospital of Nanchang University|Nanchang University |
Leptomeningeal Metastasis|Non-small Cell Lung Cancer|EGFR Activating Mutation
|
October 1, 2017 | Phase 2 |
| NCT02848443 | Institut de Recherches Internationales Servier|ADIR, a Servier Group company|Servier |
Metastatic Colorectal Cancer
|
May 2016 | Phase 1 |
| NCT00850577 | Bristol-Myers Squibb |
Non-small Cell Lung Cancer (NSCLC)
|
June 2009 | Phase 2 |
| NCT00820547 | UNICANCER |
Breast Cancer
|
January 2009 | Phase 2 |
| NCT01936974 | Western Regional Medical Center |
Ovarian Carcinoma|Fallopian Tube Carcinoma|Peritoneal Carcinoma
|
September 2013 | Phase 2 |
| NCT03353831 | AGO Research GmbH|Hoffmann-La Roche |
Recurrent Ovarian Carcinoma
|
September 11, 2018 | Phase 3 |
| NCT00091026 | National Cancer Institute (NCI) |
Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
|
July 2004 | Phase 2 |
| NCT00392392 | SCRI Development Innovations, LLC|Celgene Corporation|Genentech, Inc. |
Breast Cancer
|
October 2006 | Phase 2 |
| NCT01402531 | University of California, San Diego |
Hereditary Hemorrhagic Telangiectasia (HHT)
|
July 22, 2010 | Phase 2 |
| NCT00043004 | European Organisation for Research and Treatment of Cancer - EORTC|Arbeitsgruppe Lebermetastasen und Tumoren|Institute of Cancer Research, United Kingdom |
Colorectal Cancer|Metastatic Cancer
|
May 2002 | Phase 2 |
| NCT00588666 | Memorial Sloan Kettering Cancer Center |
Myeloproliferative Disorder|Urothelial Carcinoma|Cancer
|
May 2006 | Phase 2 |
| NCT02806817 | Centro Nacional de Investigaciones Oncologicas CARLOS III|Fundacion CRIS de Investigación para Vencer el Cáncer |
Breast Cancer|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Early-Stage Breast Carcinoma
|
July 2016 | Early Phase 1 |
| NCT04787289 | British Columbia Cancer Agency |
Ovarian Cancer|Platinum-resistant Ovarian Cancer
|
September 2021 | Phase 2 |
| NCT00433511 | National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group |
Breast Adenocarcinoma
|
November 2, 2007 | Phase 3 |
| NCT00418093 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Brigham and Women´s Hospital|Eli Lilly and Company|Sanofi-Synthelabo|Genentech, Inc. |
Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
|
September 2006 | Phase 2 |
| NCT00069095 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2003 | Phase 3 |
| NCT00517595 | Accelerated Community Oncology Research Network|Eli Lilly and Company|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
August 2007 | Phase 2 |
| NCT05357417 | Henan Cancer Hospital |
Breast Cancer
|
April 29, 2022 | Phase 2 |
| NCT00408772 | University of California, Davis|Sanofi |
Colorectal Cancer|Metastatic Cancer
|
June 2007 | Phase 2 |
| NCT01137968 | Geron Corporation |
Non-small Cell Lung Cancer
|
May 2010 | Phase 2 |
| NCT02039674 | Merck Sharp & Dohme LLC |
Non-small Cell Lung Carcinoma
|
February 21, 2014 | Phase 1|Phase 2 |
| NCT00870636 | Children´s Hospital Los Angeles |
Retinopathy of Prematurity
|
||
| NCT00446030 | Sanofi |
Breast Neoplasms
|
March 2007 | Phase 2 |
| NCT00127036 | H. Lee Moffitt Cancer Center and Research Institute|Roche Pharma AG |
Adenocarcinoma|Colon Cancer
|
October 2003 | Phase 2 |
| NCT00444535 | Novartis Pharmaceuticals|Novartis |
Neoplasms, Breast
|
February 27, 2007 | Phase 2 |
| NCT00369122 | National Cancer Institute (NCI)|Radiation Therapy Oncology Group |
Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Stage IB Cervical Cancer AJCC v6 and v7|Stage IIA Cervical Cancer AJCC v7|Stage IIB Cervical Cancer AJCC v6 and v7|Stage III Cervical Cancer AJCC v6 and v7
|
August 11, 2006 | Phase 2 |
| NCT01312376 | Abramson Cancer Center of the University of Pennsylvania |
Ovarian Carcinoma|Fallopian Tube Cancer|Primary Peritoneal Cancer
|
March 2011 | Phase 1 |
| NCT02754362 | NYU Langone Health|MOUNT SINAI HOSPITAL |
Glioblastoma|Glioma
|
November 2016 | Phase 2 |
| NCT02982694 | Vall d´Hebron Institute of Oncology|European Organisation for Research and Treatment of Cancer - EORTC |
MSI|ColoRectal Cancer|Chemotherapy|Resistance, APC
|
November 24, 2017 | Phase 2 |
| NCT02954172 | Innovent Biologics (Suzhou) Co. Ltd.|WuXi CDS Clinical Research (Shanghai) Co.Ltd. |
NSCLC
|
November 28, 2016 | Phase 3 |
| NCT00923936 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Sarcoma, Kaposi
|
April 23, 2009 | Phase 2 |
| NCT01163396 | Gruppo Oncologico del Nord-Ovest |
Colorectal Cancer Metastatic
|
July 2007 | Phase 2 |
| NCT01782976 | M.D. Anderson Cancer Center|Brain Tumor Trials Collaborative|EMD Serono |
Glioblastoma
|
June 2013 | Phase 2 |
| NCT00343291 | Eli Lilly and Company |
Non-Small Cell Lung Cancer
|
December 2006 | Phase 2 |
| NCT02106520 | Hospices Civils de Lyon |
Hereditary Hemorrhagic Telangiectasia|Epistaxis
|
April 2014 | Phase 2|Phase 3 |
| NCT01280643 | Fox Chase Cancer Center|National Cancer Institute (NCI) |
Metastatic Colorectal Cancer
|
March 2010 | Not Applicable |
| NCT00601926 | Paul Monk|Genentech, Inc.|Ohio State University Comprehensive Cancer Center |
Kidney Cancer
|
February 2008 | Phase 2 |
| NCT00072566 | National Cancer Institute (NCI) |
Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage IV Ovarian Cancer
|
December 2003 | Phase 2 |
| NCT01266031 | National Cancer Institute (NCI)|M.D. Anderson Cancer Center|Genentech, Inc.|Merck Sharp & Dohme LLC|Brain Tumor Trials Collaborative|Ohio State University Wexner Medical Center|Northwestern University Feinberg School of Medicine|UF Health Cancer Center at Orlando Health|Baylor Health Care System|MUSC Hollings Cancer Center|University of Utah Health System|University of Washington|Henry Ford Health System|Columbia University|Rush University Medical Center|NorthShore University HealthSystem|The Cleveland Clinic|University of North Carolina, Chapel Hill|Washington University School of Medicine|Texas Oncology-Austin|National Institutes of Health Clinical Center (CC) |
Malignant Glioma|Recurrent Glioblastoma
|
July 12, 2011 | Phase 1|Phase 2 |
| NCT03127124 | NantPharma, LLC |
Pancreatic Adenocarcinoma Metastatic
|
February 27, 2018 | Phase 1|Phase 2 |
| NCT04188145 | Centre Hospitalier Universitaire Dijon |
Metastatic Colorectal Cancer
|
January 27, 2020 | Phase 3 |
| NCT00393094 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
High-Grade Gliomas
|
September 2006 | Phase 2 |
| NCT00608972 | Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI) |
Metastatic Breast Cancer
|
May 2008 | Phase 2 |
| NCT00651482 | Sandy Srinivas|Genentech, Inc.|Novartis|Stanford University |
Kidney Neoplasms|Kidney (Renal Cell) Cancer
|
August 2008 | Phase 2 |
| NCT01264341 | Hellenic Cooperative Oncology Group |
Kidney Cancer
|
December 2010 | Phase 2 |
| NCT02054078 | Tang-Du Hospital |
Malignant Pleural Effusion
|
January 2012 | Phase 2 |
| NCT01564914 | Tracon Pharmaceuticals Inc.|The Cleveland Clinic|Case Comprehensive Cancer Center |
Glioblastoma|Glioblastoma Multiforme
|
May 2012 | Phase 2 |
| NCT00484939 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2007 | Phase 3 |
| NCT02013830 | Hoffmann-La Roche |
Liver Cancer
|
May 2005 | Phase 2 |
| NCT00483834 | University Health Network, Toronto|Hoffmann-La Roche |
Colorectal Cancer
|
December 2006 | Phase 2 |
| NCT00165568 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Brigham and Women´s Hospital |
Colorectal Cancer|Neoplasm Metastasis
|
July 2005 | Phase 2 |
| NCT00702819 | Vision Research Foundation |
Retinopathy of Prematurity
|
June 2008 | Phase 1 |
| NCT00370669 | Shahid Beheshti University of Medical Sciences |
Diabetic Macular Edema
|
November 2005 | Phase 3 |
| NCT00523809 | M.D. Anderson Cancer Center |
Breast Cancer|Ovarian Cancer
|
August 2007 | Phase 2 |
| NCT03395899 | Queen Mary University of London|Kliniken Essen-Mitte|MedSIR|Asan Medical Center|Hoffmann-La Roche |
Breast Cancer|Estrogen Receptor-positive Breast Cancer
|
December 21, 2017 | Phase 2 |
| NCT05491811 | Sun Yat-sen University|First Affiliated Hospital of Wenzhou Medical University|Second Affiliated Hospital, School of Medicine, Zhejiang University|Liaoning Cancer Hospital & Institute|Shenyang Chest Hospital|Harbin Medical University|Hebei Medical University Fourth Hospital|Handan Central Hospital|The First Affiliated Hospital of Soochow University|Jiangsu Cancer Institute & Hospital|The First Affiliated Hospital with Nanjing Medical University|Huai´an First People´s Hospital|Wuhan Union Hospital, China |
Non-Small Cell Lung Cancer
|
August 2022 | Phase 2 |
| NCT04516278 | Outlook Therapeutics, Inc. |
Age-related Macular Degeneration|Neovascular Age-related Macular Degeneration|Wet Macular Degeneration|BRVO - Branch Retinal Vein Occlusion|Diabetic Macular Edema
|
October 1, 2020 | Phase 3 |
| NCT03905317 | Sun Yat-sen University |
Lung Adenocarcinoma
|
March 1, 2019 | Phase 2 |
| NCT03925662 | Sherief Abd-Elsalam|Tanta University |
Colorectal Cancer
|
April 1, 2019 | Phase 3 |
| NCT00811993 | Hoffmann-La Roche |
Neoplasms
|
February 2009 | Phase 1 |
| NCT00555594 | Asociación para Evitar la Ceguera en México|National Council of Science and Technology, Mexico|Universidad Nacional Autonoma de Mexico |
Corneal Neovascularization
|
September 2006 | Phase 2|Phase 3 |
| NCT03792074 | Sinocelltech Ltd. |
Non-squamous Cell Non-small Cell Lung Cancer
|
February 2019 | Phase 3 |
| NCT05377034 | National Cancer Centre, Singapore|Hoffmann-La Roche|Sirtex Medical|Singapore Clinical Research Institute |
Locally Advanced Hepatocellular Carcinoma
|
August 25, 2022 | Phase 2 |
| NCT01918852 | Dutch Colorectal Cancer Group|Nordic Pharma SAS |
Colorectal Cancer|Metastases
|
December 2013 | Phase 3 |
| NCT00483782 | Medical Research Council|National Cancer Institute (NCI) |
Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
|
April 2006 | Phase 3 |
| NCT03708536 | Fujian Cancer Hospital |
Colorectal Adenocarcinoma
|
November 2018 | Phase 3 |
| NCT03686254 | Nanfang Hospital of Southern Medical University |
Colorectal Neoplasms Malignant
|
July 16, 2018 | Phase 2|Phase 3 |
| NCT01690325 | West German Study Group|Roche Pharma AG|Sanofi |
Breast Cancer
|
September 2012 | Phase 2 |
| NCT00611325 | Duke University|Millennium Pharmaceuticals, Inc.|Genentech, Inc. |
Glioblastoma|Gliosarcoma
|
May 2008 | Phase 2 |
| NCT02645734 | Shahid Beheshti University of Medical Sciences |
Diabetic Macular Edema
|
Phase 2|Phase 3 | |
| NCT00055861 | National Cancer Institute (NCI) |
Recurrent Breast Cancer|Stage IV Breast Cancer
|
July 2002 | Phase 2 |
| NCT01295944 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Ependymoma|Anaplastic Ependymoma
|
April 27, 2011 | Phase 2 |
| NCT00394251 | Celgene |
Breast Cancer
|
August 1, 2006 | Phase 2 |
| NCT02974621 | National Cancer Institute (NCI) |
Recurrent Glioblastoma
|
September 15, 2017 | Phase 2 |
| NCT00296816 | Sanofi |
Ovarian Cancer
|
March 2006 | Phase 2 |
| NCT00022659 | National Cancer Institute (NCI)|Gynecologic Oncology Group |
Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
|
April 2002 | Phase 2 |
| NCT02724878 | Dana-Farber Cancer Institute|Genentech, Inc. |
Advanced Non-Clear Cell Kidney Cancer
|
July 2016 | Phase 2 |
| NCT00892177 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Glioblastoma Multiforme
|
October 2009 | Phase 2 |
| NCT01207687 | National Cancer Institute (NCI) |
Vestibular Schwannoma|Neurofibromatosis Type 2
|
October 2010 | Phase 2 |
| NCT00121836 | Hoffmann-La Roche |
Breast Cancer
|
June 2005 | Phase 4 |
| NCT01625936 | Abramson Cancer Center of the University of Pennsylvania |
Renal Cell Carcinoma
|
June 2012 | Phase 1 |
| NCT05482516 | Georgetown University|Genentech, Inc.|Natera, Inc. |
Colon Adenocarcinoma|Rectal Adenocarcinoma|Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Hepatocellular Carcinoma|Adenocarcinoma of Biliary Tract|Gallbladder Adenocarcinoma
|
December 2022 | Phase 3 |
| NCT00115765 | Amgen |
Colorectal Cancer
|
June 1, 2005 | Phase 3 |
| NCT01626339 | University of Malaya |
Age Related Macular Degeneration
|
April 2012 | Not Applicable |
| NCT00993044 | Children´s Hospital Los Angeles |
Refractory Solid Tumors in Children
|
September 2009 | Phase 1 |
| NCT00085358 | National Cancer Institute (NCI)|Gynecologic Oncology Group |
Brenner Tumor|Fallopian Tube Cancer|Ovarian Carcinosarcoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
|
May 2004 | Phase 1 |
| NCT00557232 | Instituto de Olhos de Goiania |
Glaucoma|Rubeosis Iridis
|
November 2006 | Phase 4 |
| NCT00347698 | Asociación para Evitar la Ceguera en México |
Diabetic Retinopathy
|
March 2006 | Phase 2|Phase 3 |
| NCT04739670 | Peter MacCallum Cancer Centre, Australia |
Metastatic Triple Negative Breast Cancer
|
March 1, 2021 | Phase 2 |
| NCT00023920 | National Cancer Institute (NCI) |
Blastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive
|
July 2001 | Phase 2 |
| NCT00996502 | Columbia University|Genentech, Inc. |
Prostate Cancer
|
July 2006 | Phase 1|Phase 2 |
| NCT05141721 | Gritstone bio, Inc. |
Colorectal Neoplasms
|
February 12, 2022 | Phase 2|Phase 3 |
| NCT00466687 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) |
Melanoma
|
September 2004 | Phase 2 |
| NCT00845910 | Hoffmann-La Roche |
Breast Cancer
|
May 2009 | Phase 2 |
| NCT01468831 | National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC) |
Retinal Vein Occlusion
|
March 28, 2012 | Phase 1|Phase 2 |
| NCT03642132 | Pfizer |
Ovarian Cancer
|
July 19, 2018 | Phase 3 |
| NCT00600821 | Pfizer |
Non-Small-Cell Lung Carcinoma|Adenocarcinoma
|
April 2008 | Phase 2 |
| NCT00817284 | Ulrik Lassen|Rigshospitalet, Denmark |
Glioblastoma Multiforme
|
November 2008 | Phase 2 |
| NCT00623805 | Hoffmann-La Roche |
Colorectal Cancer
|
March 2008 | Phase 3 |
| NCT00366457 | Massachusetts General Hospital|Genentech, Inc.|Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute |
Pancreatic Cancer|Adenocarcinoma of the Pancreas
|
August 2006 | Phase 2 |
| NCT00955305 | National Cancer Institute (NCI) |
Large Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer|Bronchioloalveolar Lung Carcinoma
|
March 2010 | Phase 2 |
| NCT01004250 | Eli Lilly and Company |
Non-Small Cell Lung Cancer
|
October 2009 | Phase 2 |
| NCT01739218 | Hoffmann-La Roche |
Ovarian Cancer
|
February 1, 2013 | Phase 2 |
| NCT00941499 | M.D. Anderson Cancer Center |
Advanced Cancers
|
July 2009 | Phase 1 |
| NCT00556088 | SCRI Development Innovations, LLC|Novartis |
Solid Tumors
|
December 2007 | Phase 1 |
| NCT01383343 | National Cancer Institute (NCI) |
Recurrent Colon Carcinoma|Recurrent Rectal Carcinoma|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
|
August 2011 | Phase 1 |
| NCT03030430 | Bio-Thera Solutions |
NSCLC
|
March 15, 2016 | Phase 1 |
| NCT00200200 | Memorial Sloan Kettering Cancer Center |
Hepatic Metastases|Colon Cancer|Rectal Cancer
|
November 19, 2004 | Phase 2 |
| NCT05528952 | Centre Hospitalier Universitaire de Besancon|GERCOR - Multidisciplinary Oncology Cooperative Group |
Hepatocellular Carcinoma
|
September 27, 2022 | Phase 2 |
| NCT00347399 | Asociación para Evitar la Ceguera en México |
Age Related Macular Degeneration
|
March 2006 | Phase 2 |
| NCT02612077 | Hoffmann-La Roche |
Metastatic Colorectal Cancer
|
May 2008 | |
| NCT04741165 | Taizhou Hanzhong biomedical co. LTD |
Hepatocellular Carcinoma
|
January 7, 2021 | Phase 2 |
| NCT00883298 | Center for Neurosciences, Tucson|Genentech, Inc. |
Recurrent Glioblastoma Multiforme|Recurrent Gliosarcoma
|
April 2009 | Phase 2 |
| NCT00755170 | Hellenic Oncology Research Group|University Hospital of Crete |
Non Small Cell Lung Cancer
|
November 2008 | Phase 2 |
| NCT01027468 | Medical University of Vienna |
Neovascular Age-related Macular Degeneration
|
August 2009 | Not Applicable |
| NCT00929240 | Hoffmann-La Roche |
Breast Cancer
|
July 2009 | Phase 3 |
| NCT00569127 | National Cancer Institute (NCI) |
Atypical Carcinoid Tumor|Carcinoid Tumor|Colorectal Neuroendocrine Tumor G1|Gastric Neuroendocrine Tumor G1|Neuroendocrine Neoplasm
|
December 1, 2007 | Phase 3 |
| NCT03390673 | Prestige Biopharma Limited |
Healthy Volunteers
|
September 19, 2018 | Phase 1 |
| NCT05427305 | TOT Biopharm Co., Ltd. |
Efficacy
|
October 20, 2017 | Phase 3 |
| NCT00703235 | Isfahan Ophthalmology Research Center |
Macular Edema|Diabetic Retinopathy
|
Phase 2|Phase 3 | |
| NCT00100815 | Roswell Park Cancer Institute |
Pancreatic Cancer
|
August 2004 | Phase 2 |
| NCT04743661 | Pediatric Brain Tumor Consortium|National Cancer Institute (NCI)|Memorial Sloan Kettering Cancer Center|Y-mAbs Therapeutics, Inc |
Recurrent Medulloblastoma|Recurrent Ependymoma
|
April 4, 2022 | Phase 2 |
| NCT03611179 | Nada Hassan Salah|Assiut University |
Advanced Ovarian Cancer
|
September 1, 2018 | Phase 2 |
| NCT03635567 | Merck Sharp & Dohme LLC |
Cervical Cancer
|
October 25, 2018 | Phase 3 |
| NCT01674738 | Aktion Bronchialkarzinom e.V.|Roche Pharma AG|Eli Lilly and Company |
Carcinoma, Non-Small-Cell Lung
|
Phase 2 | |
| NCT00862342 | Asan Medical Center |
Metastatic Colorectal Cancer
|
January 2009 | Phase 2 |
| NCT00565656 | Centre Hospitalier Universitaire de Nice |
Myelodysplastic Syndromes
|
July 2007 | Phase 2 |
| NCT00371111 | Shahid Beheshti University of Medical Sciences |
Resistant Cystoid Macular Edema
|
August 2006 | Phase 1 |
| NCT00349336 | Hoffmann-La Roche |
Colorectal Cancer
|
August 2006 | Phase 3 |
| NCT00740168 | Technische Universität Dresden |
Cancer
|
May 2007 | |
| NCT04735861 | Tongji Hospital|Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology|Qilu Hospital of Shandong University|The First Affiliated Hospital of Zhengzhou University|Henan Cancer Hospital|Hubei Cancer Hospital|Shengjing Hospital|Anhui Provincial Cancer Hospital|Wuhan University|Jingzhou Central Hospital|The First People´s Hospital of Jingzhou|Xiangyang Central Hospital |
Ovarian Clear Cell Carcinoma
|
April 7, 2021 | Phase 2 |
| NCT02141295 | Hoffmann-La Roche |
Colorectal Cancer
|
June 30, 2014 | Phase 2 |
| NCT00802906 | Johann Wolfgang Goethe University Hospital |
Central Serous Chorioretinopathy
|
May 2007 | Not Applicable |
| NCT02997228 | National Cancer Institute (NCI)|NRG Oncology |
Metastatic Colorectal Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7
|
November 7, 2017 | Phase 3 |
| NCT03498521 | Hoffmann-La Roche|Foundation Medicine, Inc. |
Cancer of Unknown Primary Site
|
July 10, 2018 | Phase 2 |
| NCT05330429 | Gilead Sciences |
Metastatic Colorectal Cancer
|
July 8, 2022 | Phase 2 |
| NCT01999270 | Washington University School of Medicine |
Astrocytoma, Oligoastrocytoma, Mixed|Ganglioneuroma|Glioma|Ganglioglioma|Glioblastoma Multiforme Glioma
|
April 2013 | Phase 1 |
| NCT01649947 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Non-small Cell Lung Cancer|Advanced Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer
|
December 23, 2011 | Phase 2 |
| NCT00543842 | M.D. Anderson Cancer Center|Genentech, Inc. |
Rectal Cancer
|
December 2007 | Phase 1 |
| NCT00360360 | SCRI Development Innovations, LLC|Genentech, Inc. |
Neoplasm, Unknown Primary
|
July 2006 | Phase 2 |
| NCT03526432 | University of Oklahoma|Genentech, Inc. |
Endometrial Cancer
|
August 8, 2018 | Phase 2 |
| NCT03428958 | NuCana plc |
Colorectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma|Colorectal Tumors|Neoplasms, Colorectal
|
October 16, 2018 | Phase 1|Phase 2 |
| NCT00511992 | University of Oklahoma|Genentech, Inc. |
Advanced Ovarian Carcinoma|Primary Peritoneal Carcinoma|Ovarian Carcinosarcoma
|
July 2007 | Phase 2 |
| NCT05382442 | Akeso |
Metastatic Colorectal Cancer
|
July 27, 2022 | Phase 2 |
| NCT03396926 | University of California, San Francisco|Merck Sharp & Dohme LLC |
Microsatellite Stable|Mismatch Repair Protein Proficient|Stage III Colorectal Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7
|
April 18, 2018 | Phase 2 |
| NCT01743157 | California Pacific Medical Center Research Institute |
Metastatic Melanoma
|
December 2010 | Phase 1|Phase 2 |
| NCT03126799 | National Cancer Center, Korea|Roche Korea co.,Ltd. |
EGFR Positive Non-small Cell Lung Cancer
|
November 1, 2016 | Phase 2 |
| NCT00853021 | Jorge A. Garcia, MD|National Cancer Institute (NCI)|Case Comprehensive Cancer Center |
Kidney Cancer
|
December 2005 | Phase 2 |
| NCT01641406 | Auxilio Mutuo Cancer Center |
Infiltrating Duct and Lobular Carcinoma In Situ|Invasive Lobular Breast Carcinoma|Inflammatory Breast Carcinoma
|
March 2011 | Phase 2 |
| NCT01142778 | Hoffmann-La Roche |
Breast Cancer
|
May 19, 2010 | Phase 2 |
| NCT00028990 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|NCIC Clinical Trials Group|NSABP Foundation Inc |
Breast Cancer
|
December 2001 | Phase 3 |
| NCT00096967 | Genentech, Inc. |
Breast Cancer|Colorectal Cancer|Metastases
|
October 2002 | Phase 3 |
| NCT00507585 | M.D. Anderson Cancer Center |
Liver Cancer|Advanced Solid Tumors
|
June 2006 | Phase 1 |
| NCT01198548 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Stage IV Colon Cancer|Stage IV Rectal Cancer
|
August 2010 | Phase 2 |
| NCT05314101 | Fujian Cancer Hospital |
Immunotherapy|Colorectal Cancer
|
April 1, 2022 | Phase 2 |
| NCT03919448 | Laboratorios Richmond S.A.C.I.F.|FP Clinical Pharma S.R.L.|Syngene International Limited |
Pharmacokinetics|Safety Issues
|
April 1, 2019 | Phase 1 |
| NCT01217437 | National Cancer Institute (NCI) |
Central Nervous System Neoplasm|Pineoblastoma|Recurrent Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor|Refractory Medulloblastoma|Refractory Peripheral Primitive Neuroectodermal Tumor
|
November 22, 2010 | Phase 2 |
| NCT05510427 | M.D. Anderson Cancer Center|Helsinn Healthcare |
Cholangiocarcinoma|Liver Cancer
|
February 28, 2023 | Phase 1 |
| NCT00137813 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc.|Sanofi |
Esophageal Cancer|Gastric Cancer
|
August 2004 | Phase 2 |
| NCT04732598 | Japanese Foundation for Cancer Research|Chugai Pharmaceutical |
Breast Cancer
|
January 21, 2021 | Phase 3 |
| NCT04344782 | Assistance Publique - Hôpitaux de Paris |
COVID19 Pneumonia
|
April 15, 2020 | Phase 2 |
| NCT03991403 | Samsung Medical Center |
Non-small Cell Lung Cancer
|
August 27, 2019 | Phase 3 |
| NCT00612430 | Duke University|Genentech, Inc. |
Glioblastoma|Gliosarcoma
|
March 2007 | Phase 2 |
| NCT04677504 | Hoffmann-La Roche |
Biliary Tract Cancer
|
February 23, 2021 | Phase 2 |
| NCT02796183 | Neon Hospital|Ondokuz May?s University |
Diabetic Macular Edema
|
January 2015 | Not Applicable |
| NCT05512351 | Henan Provincial People´s Hospital |
Oligodendroglioma
|
December 23, 2022 | Phase 2 |
| NCT03573986 | Abramson Cancer Center of the University of Pennsylvania |
Recurrent Glioblastoma
|
April 18, 2018 | Phase 1 |
| NCT05009017 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Biosimilar
|
January 1, 2021 | |
| NCT00126633 | University of California, San Francisco|National Cancer Institute (NCI) |
Pancreatic Cancer
|
April 2004 | Phase 2 |
| NCT01364012 | Hoffmann-La Roche |
Non-Small Cell Lung Cancer
|
May 23, 2011 | Phase 3 |
| NCT00208546 | Dutch Colorectal Cancer Group|Koningin Wilhelmina Fonds|Sanofi|Roche Pharma AG|Immunicon |
Colorectal Cancer
|
June 2005 | Phase 3 |
| NCT00548418 | Washington University School of Medicine|GlaxoSmithKline|Genentech, Inc. |
Cervical Cancer
|
February 2007 | Phase 2 |
| NCT00911716 | Cancer Trials Ireland |
Breast Cancer
|
October 2008 | Not Applicable |
| NCT01231633 | Long Island Vitreoretinal Consultants |
Macular Edema|Central Retinal Vein Occlusion
|
September 2010 | Not Applicable |
| NCT00665990 | St. Jude Children´s Research Hospital |
Refractory Solid Tumors|Leukemia
|
November 2007 | Phase 1 |
| NCT00599820 | Asociación para Evitar la Ceguera en México |
Angioid Streaks|Choroidal Neovascularization
|
November 2005 | Phase 3 |
| NCT00544011 | Hopital Jean Minjoz|National Cancer Institute (NCI) |
Colorectal Cancer
|
April 2007 | Phase 2 |
| NCT03795311 | Centre Georges Francois Leclerc |
Colorectal Cancer
|
November 7, 2018 | Phase 1|Phase 2 |
| NCT00512876 | Walter Reed Army Medical Center|Massachusetts Eye and Ear Infirmary |
Corneal Neovascularization
|
August 2007 | Not Applicable |
| NCT01821859 | OHSU Knight Cancer Institute |
Ovarian Cancer|Peritoneal Cancer
|
January 2010 | Phase 2 |
| NCT02138617 | UNC Lineberger Comprehensive Cancer Center |
Colon Cancer
|
May 2014 | Phase 2 |
| NCT05611645 | Huashan Hospital |
Glioma|Recurrent Glioma
|
October 1, 2022 | Phase 2 |
| NCT00972335 | SCRI Development Innovations, LLC|Genentech, Inc.|Novartis |
Intracranial Meningioma
|
January 2010 | Phase 2 |
| NCT00559936 | Massachusetts Eye and Ear Infirmary |
Corneal Neovascularization
|
February 2007 | Phase 1 |
| NCT03024437 | Roberto Pili|Genentech, Inc.|Syndax Pharmaceuticals|Indiana University |
Metastatic Cancer|Renal Cancer
|
June 29, 2017 | Phase 1|Phase 2 |
| NCT04553510 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
Nasopharyngeal Carcinoma|Adverse Effect of Radiation Therapy|Brain Injuries
|
January 1, 2016 | Phase 2 |
| NCT05022927 | Chugai Pharmaceutical |
Hepatocellular Carcinoma (HCC)
|
June 1, 2021 | Phase 1 |
| NCT01954030 | Annick Desjardins|Tactical Therapeutics, Inc.|Duke University |
Malignant Glioma (WHO Grade III or IV)
|
October 2013 | Phase 1 |
| NCT00281840 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) |
Head and Neck Cancer
|
September 2005 | Phase 2 |
| NCT04982237 | Akeso |
Cervical Cancer
|
August 27, 2021 | Phase 3 |
| NCT04406272 | Dana-Farber Cancer Institute|Vascular Biogenics Ltd. operating as VBL Therapeutics |
Glioblastoma|Recurrent Glioblastoma
|
August 1, 2020 | Phase 2 |
| NCT01775644 | Hoffmann-La Roche |
Colorectal Cancer
|
December 14, 2012 | |
| NCT01496742 | Genentech, Inc. |
Non-Squamous Non-Small Cell Lung Cancer
|
April 2012 | Phase 2 |
| NCT00109057 | Genentech, Inc. |
Cancer
|
February 1998 | Phase 2 |
| NCT01167725 | Walter Reed Army Medical Center|National Cancer Institute (NCI) |
Colorectal Cancer
|
August 2010 | Phase 3 |
| NCT00580333 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Genentech, Inc. |
Breast Cancer
|
September 2007 | Phase 2 |
| NCT00384176 | AstraZeneca |
Colorectal Cancer
|
August 30, 2006 | Phase 2|Phase 3 |
| NCT00887822 | Hoffmann-La Roche |
Gastric Cancer
|
March 2009 | Phase 3 |
| NCT04034459 | Ludwig-Maximilians - University of Munich |
Metastatic Colorectal Cancer
|
November 25, 2016 | Phase 2 |
| NCT00674011 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital |
Breast Cancer
|
January 2008 | |
| NCT01367028 | Austrian Breast & Colorectal Cancer Study Group|Hoffmann-La Roche|Cephalon |
Breast Cancer
|
June 2011 | Phase 2 |
| NCT00684853 | Federal University of São Paulo |
Macular Degeneration
|
November 2007 | Phase 2 |
| NCT03762018 | ETOP IBCSG Partners Foundation|Hoffmann-La Roche |
Pleural Mesothelioma Malignant Advanced
|
April 30, 2019 | Phase 3 |
| NCT04954014 | Maimónides Biomedical Research Institute of Córdoba |
ARDS, Human|Coronavirus Infection
|
September 1, 2020 | Phase 2 |
| NCT01434147 | Austrian Breast & Colorectal Cancer Study Group|Hoffmann-La Roche |
Rectal Cancer
|
October 2011 | Phase 2 |
| NCT00468585 | Memorial Sloan Kettering Cancer Center |
Breast Cancer
|
June 2005 | Phase 1|Phase 2 |
| NCT00660621 | Kentuckiana Cancer Institute|Eisai Inc. |
Glioma
|
April 2008 | Phase 2 |
| NCT00569335 | Taiho Pharmaceutical Co., Ltd. |
Colorectal, Cancer
|
October 2007 | Phase 2 |
| NCT03869892 | Institut de Recherches Internationales Servier|ADIR, a Servier Group company|Servier |
Metastatic Colorectal Cancer
|
March 21, 2019 | Phase 3 |
| NCT00373256 | Pfizer |
Breast Neoplasms
|
November 2006 | Phase 3 |
| NCT01314066 | Weill Medical College of Cornell University |
Severe Sepsis|Acute Respiratory Distress Syndrome
|
July 2010 | Phase 2 |
| NCT05512325 | Henan Provincial People´s Hospital |
Genetic Change
|
December 17, 2022 | |
| NCT00847119 | Institut Català d´Oncologia|Hoffmann-La Roche |
Rectal Cancer
|
September 2007 | Phase 2 |
| NCT00016094 | National Cancer Institute (NCI) |
Anaplastic Large Cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Mantle Cell Lymphoma
|
April 2001 | Phase 2 |
| NCT00052559 | National Cancer Institute (NCI) |
Adenocarcinoma of the Rectum|Stage II Rectal Cancer|Stage III Rectal Cancer
|
August 2002 | Phase 1 |
| NCT03167177 | ImmunityBio, Inc. |
Melanoma
|
December 2017 | Phase 1|Phase 2 |
| NCT03032484 | The University of Texas Health Science Center at San Antonio |
Astrocytoma
|
May 18, 2017 | Phase 2 |
| NCT00491855 | M.D. Anderson Cancer Center |
Peritoneal Cancer
|
June 2007 | Phase 1 |
| NCT04931342 | Hoffmann-La Roche|GOG Foundation|European Network of Gynaecological Oncological Trial Groups (ENGOT) |
Ovarian Cancer
|
October 7, 2021 | Phase 2 |
| NCT00733408 | University of Washington|National Cancer Institute (NCI) |
Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer
|
April 23, 2008 | Phase 2 |
| NCT00550927 | Eli Lilly and Company|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
November 2006 | Phase 1 |
| NCT05411757 | Shandong Public Health Clinical Center|Imbioray (Hangzhou) Biomedicine Co., Ltd. |
Advanced Primary Liver Cancer
|
June 30, 2022 | Early Phase 1 |
| NCT00520403 | Hoffmann-La Roche |
Renal Cell Cancer
|
September 2007 | Phase 2 |
| NCT00271505 | M.D. Anderson Cancer Center|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
December 5, 2005 | Phase 2 |
| NCT00800917 | Rigshospitalet, Denmark|University of Copenhagen|Wyeth is now a wholly owned subsidiary of Pfizer|Roche, Copenhagen |
Glioblastoma Multiforme
|
November 2008 | Phase 2 |
| NCT00324870 | National Cancer Institute (NCI) |
Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer
|
February 2006 | Phase 1|Phase 2 |
| NCT05007106 | Merck Sharp & Dohme LLC |
Uterine Cervical Neoplasms|Endometrial Neoplasms|Squamous Cell Carcinoma of Head and Neck|Gallbladder Neoplasms|Cholangiocarcinoma|Esophageal Neoplasms|Triple Negative Breast Neoplasms|Hepatocellular Carcinoma|Urinary Bladder Neoplasms|Ovarian Neoplasms|Stomach Neoplasms
|
September 16, 2021 | Phase 2 |
| NCT04837716 | M.D. Anderson Cancer Center |
Metastatic Lung Non-Small Cell Carcinoma|Recurrent Lung Non-Small Cell Carcinoma|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8
|
March 18, 2021 | Phase 1 |
| NCT01787669 | University of Sydney|Allergan |
Diabetes|Diabetic Macular Oedema|Diabetic Macular Edema|Diabetic Retinopathy
|
June 2013 | Phase 2 |
| NCT00804830 | Region Skane |
Thyroid Neoplasms|Carcinoma|Thyroid Cancer|Metastatic Cancer
|
April 2008 | Phase 2 |
| NCT01296815 | Centro de Investigación en. Enfermedades Infecciosas, Mexico |
Kaposi´s Sarcoma
|
September 2010 | Phase 2 |
| NCT05514925 | Khairallah Moncef|University Hospital Fattouma Bourguiba |
Proliferative Diabetic Retinopathy|Vitreous Hemorrhage|Tractional Retinal Detachment
|
November 21, 2017 | Phase 4 |
| NCT03668054 | Laboratorio Elea Phoenix S.A. |
Age-Related Macular Degeneration
|
February 7, 2017 | Phase 3 |
| NCT02753127 | Sumitomo Pharma Oncology, Inc. |
Colorectal Cancer
|
June 2016 | Phase 3 |
| NCT00954642 | Genentech, Inc. |
Solid Cancers
|
August 2009 | Phase 1 |
| NCT04564898 | Gruppo Oncologico del Nord-Ovest |
Colorectal Cancer Metastatic
|
January 25, 2022 | Phase 1|Phase 2 |
| NCT00548548 | Genentech, Inc.|Hoffmann-La Roche|Chugai Pharmaceutical |
Adenocarcinoma
|
September 2007 | Phase 3 |
| NCT03609307 | Shahid Beheshti University of Medical Sciences |
Age Related Macular Degeneration
|
September 2018 | Phase 2|Phase 3 |
| NCT00159432 | University of Southern California|Hoffmann-La Roche|Genentech, Inc. |
Colorectal Cancer
|
February 2005 | Phase 2 |
| NCT00217425 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) |
Lymphoma
|
July 2006 | Phase 2 |
| NCT01437618 | Azienda Ospedaliero, Universitaria Pisana |
Metastatic Colorectal Cancer
|
June 2009 | |
| NCT00675597 | Memorial Sloan Kettering Cancer Center|Sanofi |
Lung Cancer
|
May 2008 | Not Applicable |
| NCT00700180 | Hoffmann-La Roche |
Non-Small Cell Lung Cancer
|
September 2008 | Phase 2 |
| NCT01803282 | Gilead Sciences |
Pancreatic Cancer|Non-small Cell Lung Cancer|Esophagogastric Cancer|Colorectal Cancer|Breast Cancer
|
March 29, 2013 | Phase 1 |
| NCT00387374 | National Cancer Institute (NCI) |
Adenosquamous Cell Lung Cancer|Drug+Agent Toxicity by Tissue+Organ|Hemoptysis|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
|
October 2006 | Phase 2 |
| NCT00875147 | University of Zurich |
Colorectal Liver Metastases
|
April 2009 | |
| NCT02271464 | Azienda Ospedaliero, Universitaria Pisana |
Metastatic Colorectal Cancer
|
March 2012 | Phase 2 |
| NCT00612339 | Duke University|Genentech, Inc.|Schering-Plough |
Glioblastoma|Gliosarcoma
|
August 2007 | Phase 2 |
| NCT01186991 | Genentech, Inc.|Hoffmann-La Roche |
Breast Cancer
|
March 2011 | Phase 2 |
| NCT01097746 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Fallopian Tube Carcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|FIGO Stage III Ovarian Cancer|FIGO Stage IIIA Ovarian Cancer|FIGO Stage IIIA1 Ovarian Cancer|FIGO Stage IIIA1(i) Ovarian Cancer|FIGO Stage IIIA1(ii) Ovarian Cancer|FIGO Stage IIIA2 Ovarian Cancer|FIGO Stage IIIB Ovarian Cancer|FIGO Stage IIIC Ovarian Cancer|FIGO Stage IVA Ovarian Cancer|FIGO Stage IVB Ovarian Cancer|Malignant Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Carcinoma|Primary Peritoneal Serous Adenocarcinoma
|
April 14, 2010 | Phase 2 |
| NCT01351415 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
June 25, 2011 | Phase 3 |
| NCT01532089 | Academic and Community Cancer Research United|National Cancer Institute (NCI) |
EGFR Exon 19 Deletion Mutation|EGFR NP_005219.2:p.L858R|Lung Non-Squamous Non-Small Cell Carcinoma|Stage IV Lung Non-Small Cell Cancer AJCC v7
|
March 16, 2012 | Phase 2 |
| NCT02336165 | Ludwig Institute for Cancer Research|MedImmune LLC|Cancer Research Institute, New York City|Cure Brain Cancer Foundation, Australia |
Glioblastoma
|
February 26, 2015 | Phase 2 |
| NCT00597402 | Duke University|Genentech, Inc.|Schering-Plough |
Glioblastoma|Gliosarcoma|Brain Tumor
|
July 2007 | Phase 2 |
| NCT01262859 | University of Pittsburgh|Genentech, Inc. |
Head and Neck Neoplasms
|
December 2010 | Phase 2 |
| NCT02076152 | Massachusetts General Hospital|National Cancer Institute (NCI) |
Recurrent Glioblastoma
|
February 2014 | Not Applicable |
| NCT00602602 | Abramson Cancer Center of the University of Pennsylvania|National Cancer Institute (NCI) |
Pancreatic Cancer
|
March 2007 | Phase 2 |
| NCT01386710 | Northwell Health |
Glioblastoma Multiforme|Anaplastic Astrocytoma
|
September 2011 | Phase 1|Phase 2 |
| NCT01705184 | Intergroupe Francophone de Cancerologie Thoracique |
Non-small Cell Lung Cancer Metastatic|Nonsquamous Nonsmall Cell Neoplasm of Lung
|
December 2012 | Phase 2 |
| NCT01303679 | ARCAGY+ GINECO GROUP |
First Line Metastatic Breast Cancer
|
June 2010 | Phase 3 |
| NCT02316327 | Fundacion Clinic per a la Recerca Biomédica |
Non-Small Cell Lung Cancer (NSCLC)
|
July 2013 | Phase 4 |
| NCT00448591 | Hoffmann-La Roche |
Breast Cancer
|
September 2006 | Phase 3 |
| NCT00943826 | Hoffmann-La Roche |
Glioblastoma
|
June 29, 2009 | Phase 3 |
| NCT01471470 | Asan Medical Center|Roche Pharma AG |
Advanced Gastric Cancer
|
July 2010 | Phase 2 |
| NCT01301716 | Genentech, Inc. |
Solid Cancers
|
September 2011 | Phase 1 |
| NCT00433927 | PD Dr. med. Volker Heinemann|Merck KGaA, Darmstadt, Germany|Ludwig-Maximilians - University of Munich |
Neoplasm Metastasis|Colorectal Cancer
|
January 2007 | Phase 3 |
| NCT00826540 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
|
September 2009 | Phase 2 |
| NCT00070122 | National Cancer Institute (NCI) |
Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
|
April 2004 | Phase 3 |
| NCT00242502 | M.D. Anderson Cancer Center|Genentech, Inc. |
Hepatocellular Carcinoma|Liver Cancer
|
October 2005 | Phase 2 |
| NCT00353262 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2005 | Phase 1 |
| NCT00370851 | Shahid Beheshti University of Medical Sciences |
Retinal Disease
|
August 2006 | Phase 3 |
| NCT00217581 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) |
Esophageal Cancer|Gastric Cancer
|
October 2004 | Phase 2 |
| NCT01473251 | Vitreo-Retinal Associates, Michigan|Van Andel Research Institute |
Exudative Macular Degeneration|Diabetic Macular Edema
|
November 2011 | Not Applicable |
| NCT00503906 | University of Miami |
Breast Cancer
|
June 2007 | Phase 2 |
| NCT05110118 | Shandong Boan Biotechnology Co., Ltd |
Metastatic Colorectal Cancer|Non Small Cell Lung Cancer Metastatic|Non Small Cell Lung Cancer Recurrent
|
August 4, 2020 | Phase 1 |
| NCT03836157 | University of Oklahoma|ImmunoGen, Inc. |
Endometrial Cancer|Endometrial Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma
|
May 31, 2019 | Phase 2 |
| NCT04988607 | Guangdong Association of Clinical Trials |
Lung Cancer
|
August 2021 | Phase 2 |
| NCT04781270 | Fudan University |
Colorectal Carcinoma|Liver Metastases
|
April 15, 2021 | Phase 3 |
| NCT05253651 | Seagen Inc.|Merck Sharp & Dohme LLC |
Colorectal Neoplasms
|
November 30, 2022 | Phase 3 |
| NCT00085111 | National Cancer Institute (NCI) |
Unspecified Childhood Solid Tumor, Protocol Specific
|
December 2003 | Phase 1 |
| NCT03367871 | University of Miami|Merck Sharp & Dohme LLC |
Cervical Cancer
|
September 6, 2018 | Phase 2 |
| NCT02842294 | Centre Hospitalier Universitaire de Besancon |
Metastatic Colorectal Cancer|Quality of Life
|
May 2013 | |
| NCT02248571 | iOMEDICO AG|Arbeitsgemeinschaft fur Internistische Onkologie|Novartis Pharmaceuticals |
Breast Cancer Recurrent|HER2+Neu-negative Carcinoma of Breast|Hormone Receptor Positive Malignant Neoplasm of Breast
|
August 2014 | Phase 4 |
| NCT05489211 | AstraZeneca|Daiichi Sankyo, Inc. |
Endometrial Cancer|Gastric Cancer|Metastatic Castration-resistant Prostate Cancer|Ovarian Cancer|Colorectal Cancer
|
September 6, 2022 | Phase 2 |
| NCT03778957 | AstraZeneca |
Hepatocellular Carcinoma
|
November 30, 2018 | Phase 3 |
| NCT00778102 | Hoffmann-La Roche |
Colorectal Cancer
|
October 2008 | Phase 2 |
| NCT00253526 | National Cancer Institute (NCI) |
Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage I Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer
|
Phase 2 | |
| NCT01330524 | Shahid Beheshti University of Medical Sciences |
Acute Nonarteritic Anterior Ischemic Optic Neuropathy
|
January 2010 | Phase 1|Phase 2 |
| NCT01554059 | Sixth Affiliated Hospital, Sun Yat-sen University |
Rectal Adenocarcinoma
|
March 2012 | Phase 2 |
| NCT05503667 | Shanghai Pulmonary Hospital, Shanghai, China |
Lung Adenocarcinoma Stage III|Lung Adenocarcinoma Stage IV|EGFR Gene Mutation
|
February 1, 2022 | Phase 2 |
| NCT00321646 | Mary-Ellen Taplin, MD|Beth Israel Deaconess Medical Center|Duke University|Genentech, Inc.|Sanofi|Dana-Farber Cancer Institute |
Prostate Cancer|Adenocarcinoma of the Prostate
|
June 2006 | Phase 2 |
| NCT00079040 | National Cancer Institute (NCI) |
Extensive Stage Small Cell Lung Cancer
|
January 2006 | Phase 2 |
| NCT00118235 | National Cancer Institute (NCI) |
Extensive Stage Small Cell Lung Cancer
|
December 2004 | Phase 2 |
| NCT03275506 | ARCAGY+ GINECO GROUP |
Ovarian Cancer Stage IV
|
February 26, 2018 | Phase 2 |
| NCT04091217 | Hoffmann-La Roche |
Melanoma
|
November 25, 2019 | Phase 2 |
| NCT02469987 | Mylan Inc.|Mylan GmbH|Viatris Inc. |
Healthy
|
April 2015 | Phase 1 |
| NCT03117972 | Centre Hospitalier Universitaire de Besancon |
Metastatic Colorectal Cancer
|
August 4, 2017 | Phase 2 |
| NCT02563002 | Merck Sharp & Dohme LLC |
Colorectal Carcinoma
|
November 30, 2015 | Phase 3 |
| NCT02591667 | Medical University of Vienna |
Colorectal Cancer|Peritoneal Metastasis
|
March 2016 | Phase 2 |
| NCT01760746 | University of British Columbia |
Proliferative Diabetic Retinopathy (PDR)
|
July 2012 | |
| NCT04148898 | Second Affiliated Hospital of Nanchang University|Nanchang University |
Leptomeningeal Metastasis|Non-small Cell Lung Cancer|EGFR Activating Mutation
|
November 1, 2019 | Phase 2 |
| NCT02386826 | SCRI Development Innovations, LLC|Novartis |
Glioblastoma Multiforme|Gliosarcoma|Colorectal Cancer|Renal Cell Carcinoma
|
September 22, 2015 | Phase 1 |
| NCT01121939 | SCRI Development Innovations, LLC|Genentech, Inc. |
Neuroendocrine Carcinoma
|
May 2010 | Phase 2 |
| NCT00006786 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) |
Colorectal Cancer
|
November 2000 | Phase 2 |
| NCT05502991 | Henan Provincial People´s Hospital |
Glioblastoma
|
December 11, 2022 | Phase 2 |
| NCT00260364 | Royal Marsden NHS Foundation Trust|Professor Cunningham´s Clinical Research Fund|Hoffmann-La Roche |
Pancreatic Cancer
|
November 2005 | Phase 1|Phase 2 |
| NCT03462212 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS|Istituto Di Ricerche Farmacologiche Mario Negri|Foundation Medicine |
Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
|
March 17, 2021 | Phase 1|Phase 2 |
| NCT03586869 | ImmunityBio, Inc. |
Pancreatic Cancer
|
July 28, 2018 | Phase 1|Phase 2 |
| NCT00790010 | Dana-Farber Cancer Institute|Genentech, Inc.|Bristol-Myers Squibb |
Melanoma
|
February 26, 2009 | Phase 1 |
| NCT04679064 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS|GlaxoSmithKline |
Ovarian Cancer
|
December 1, 2020 | Phase 3 |
| NCT01705392 | Haukeland University Hospital|The Norwegian Melanoma Group|Norwegian Cancer Society |
Metastatic Malignant Melanoma|Unresectable Malignant Melanoma
|
January 2013 | Phase 2 |
| NCT03882424 | Zhejiang Teruisi Pharmaceutical Inc. |
Healthy
|
June 12, 2018 | Phase 1 |
| NCT00737243 | SCRI Development Innovations, LLC|Genentech, Inc. |
Carcinoma
|
August 2008 | Phase 2 |
| NCT00496405 | Asociación para Evitar la Ceguera en México |
Diabetic Macular Edema|Diabetic Retinopathy
|
April 2007 | Phase 4 |
| NCT01610557 | National Eye Institute (NEI)|The Emmes Company, LLC|National Institutes of Health Clinical Center (CC) |
Diabetic Macular Edema
|
May 2012 | Phase 2 |
| NCT05290948 | Shahid Beheshti University of Medical Sciences |
Macular Edema
|
March 12, 2022 | Phase 2 |
| NCT00923130 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Renal Cell Carcinoma
|
January 7, 2009 | Phase 2 |
| NCT02842580 | Federation Francophone de Cancerologie Digestive |
Colorectal Neoplasms
|
September 2016 | Phase 2 |
| NCT00719797 | Gruppo Oncologico del Nord-Ovest |
Colorectal Cancer
|
July 2008 | Phase 3 |
| NCT03576651 | JHL Biotech, Inc. |
Healthy Male Subjects
|
March 24, 2018 | Phase 1 |
| NCT02157103 | Emory University |
Glioblastoma
|
January 2014 | Phase 2 |
| NCT01921790 | Sun Yat-sen University|Hoffmann-La Roche|Eli Lilly and Company |
Extranodal NK+T-cell Lymphoma, Nasal Type
|
August 2013 | Phase 2 |
| NCT04345146 | Sun Yat-sen University |
Non-squamous Non-small Cell Lung Cancer
|
January 1, 2020 | Phase 2 |
| NCT01186406 | Duke University|Genentech, Inc.|Eisai Inc. |
Glioblastoma Multiforme|Gliosarcoma
|
April 2011 | Phase 2 |
| NCT00385021 | Southwestern Regional Medical Center |
Colorectal Neoplasms
|
October 2006 | Phase 2 |
| NCT04512430 | Fundación GECP |
Non Small Cell Lung Cancer|EGFR Gene Mutation
|
December 2, 2020 | Phase 2 |
| NCT05116189 | Merck Sharp & Dohme LLC |
Ovarian Cancer|Carcinoma, Ovarian Epithelial|Fallopian Tube Neoplasms
|
December 13, 2021 | Phase 3 |
| NCT02010606 | Cedars-Sinai Medical Center |
Glioblastoma|Glioblastoma Multiforme|Glioma|Astrocytoma|Brain Tumor
|
January 8, 2014 | Phase 1 |
| NCT03552770 | University Hospital of Ferrara|Regione Emilia-Romagna |
Age-Related Macular Degeneration
|
November 23, 2014 | Phase 4 |
| NCT00673296 | National Taiwan University Hospital |
Diabetic Retinopathy With Premacular Hemorrhage
|
January 2007 | Not Applicable |
| NCT00984438 | University of Cincinnati|Eisai Inc. |
Glioblastoma Multiforme
|
June 2009 | Phase 1|Phase 2 |
| NCT00728845 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Lung Cancer
|
June 16, 2008 | Phase 1|Phase 2 |
| NCT00508625 | Amgen|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
June 2006 | Phase 2 |
| NCT04592029 | Second Affiliated Hospital of Guangzhou Medical University |
Hepatocellular Carcinoma Non-resectable
|
September 27, 2020 | Phase 1 |
| NCT01884740 | Weill Medical College of Cornell University |
Glioblastoma Multiforme|Fibrillary Astrocytoma of Brain|Glioma of Brainstem|Anaplastic Astrocytoma|Pilomyxoid Astrocytoma|Mixed Oligodendroglioma-Astrocytoma|Brain Stem Glioma|Diffuse Intrinsic Pontine Glioma
|
June 2013 | Phase 1|Phase 2 |
| NCT03596281 | Gustave Roussy, Cancer Campus, Grand Paris |
Ovarian Cancer
|
December 5, 2018 | Phase 1 |
| NCT01249638 | Ludwig-Maximilians - University of Munich|Roche Pharma AG |
Colorectal Cancer Metastatic
|
December 2010 | Phase 3 |
| NCT00390026 | St. Erik Eye Hospital |
Age-Related Macular Degeneration
|
November 2006 | Phase 3 |
| NCT00906516 | Bradmer Pharmaceuticals Inc. |
Brain Tumors
|
May 2009 | Phase 2 |
| NCT00293332 | University of California, San Francisco|National Cancer Institute (NCI) |
Lung Cancer
|
December 2005 | Phase 2 |
| NCT05158062 | Kosei Hasegawa, MD, PhD|Saitama Medical University International Medical Center |
Carcinoma, Ovarian Epithelial
|
April 20, 2022 | Phase 2 |
| NCT00754351 | University Hospital of Crete |
Breast Cancer
|
September 2008 | Phase 2 |
| NCT04634604 | Jaeb Center for Health Research|Pediatric Eye Disease Investigator Group|National Eye Institute (NEI) |
Retinopathy of Prematurity
|
April 27, 2022 | Phase 3 |
| NCT00655850 | University of Alabama at Birmingham|Genentech, Inc. |
Non-Small Cell Lung Cancer
|
March 2008 | Phase 2 |
| NCT00426829 | M.D. Anderson Cancer Center|Genentech, Inc. |
Liver Cancer|Hepatocellular Carcinoma|Cholangiocarcinoma
|
May 2007 | Phase 1 |
| NCT01508000 | European Organisation for Research and Treatment of Cancer - EORTC|Amgen|Roche Pharma AG |
Colorectal Cancer Metastatic|Liver Metastases|KRAS Wild Type Colorectal Cancer
|
June 2013 | Phase 2 |
| NCT00585377 | University of Utah|Genentech, Inc. |
Cancer
|
August 2007 | Phase 2 |
| NCT03828227 | GERCOR - Multidisciplinary Oncology Cooperative Group |
Elderly Patients|Metastatic Colorectal Cancer|Quality of Life
|
June 7, 2019 | Phase 3 |
| NCT00513786 | David O´Malley|Genentech, Inc.|Ohio State University Comprehensive Cancer Center |
Endometrial Cancer
|
August 1, 2007 | Phase 2 |
| NCT05110209 | Novartis Pharmaceuticals|Novartis |
Age-related Macular Degeneration (AMD)
|
July 15, 2020 | |
| NCT01478594 | AVEO Pharmaceuticals, Inc. |
Colorectal Cancer
|
December 2011 | Phase 2 |
| NCT01223235 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. |
Fallopian Tubes Cancer|Ovarian Cancer|Peritoneal Cancer
|
October 2010 | Not Applicable |
| NCT01932125 | Hoffmann-La Roche |
Ovarian Neoplasms|Peritoneal Neoplasms|Fallopian Tube Neoplasms
|
December 5, 2018 | Phase 4 |
| NCT00543504 | M.D. Anderson Cancer Center |
Advanced Cancer
|
October 10, 2007 | Phase 1 |
| NCT00333775 | Hoffmann-La Roche |
Breast Cancer
|
March 2006 | Phase 3 |
| NCT05398861 | Henan Cancer Hospital|Qilu Pharmaceutical Co., Ltd.|Beijing Biostar Technologies, Ltd |
HER-2 Negative Breast Cancer
|
June 1, 2022 | Phase 2 |
| NCT01356290 | Medical University of Vienna |
Medulloblastoma Recurrent|Ependymoma Recurrent|ATRT Recurrent
|
April 2014 | Phase 2 |
| NCT05364489 | The First Affiliated Hospital of Zhengzhou University |
Advanced Colorectal Cancer
|
June 15, 2022 | Phase 2 |
| NCT00192075 | Eli Lilly and Company |
Colorectal Cancer
|
June 2003 | Phase 2 |
| NCT02348008 | Arkadiusz Z. Dudek, MD|Merck Sharp & Dohme LLC|Big Ten Cancer Research Consortium |
Clear Cell Renal Carcinoma
|
March 2015 | Phase 1|Phase 2 |
| NCT05170594 | The Second Affiliated Hospital of Shandong First Medical University |
Ovarian Cancer
|
December 24, 2021 | Phase 2 |
| NCT02446431 | Miller Children´s & Women´s Hospital Long Beach|Children´s Hospital of Orange County |
Solid Tumor
|
July 2014 | Early Phase 1 |
| NCT00531076 | Amsterdam UMC, location VUmc |
Toxicity
|
October 2007 | Phase 1 |
| NCT01744756 | Instituto de Olhos de Goiania |
Recurrent Pterygium
|
February 2012 | Phase 2|Phase 3 |
| NCT04213222 | Peking University People´s Hospital |
Colon Cancer|Rectal Cancer|Liver Metastases
|
October 2020 | |
| NCT00520975 | National Cancer Institute (NCI) |
Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast Cancer
|
November 2007 | Phase 3 |
| NCT05097911 | National University Hospital, Singapore |
Advanced Hepatocellular Carcinoma
|
August 2, 2021 | Phase 1 |
| NCT02695641 | Mayo Clinic |
End Stage Renal Disease|Hemodialysis Vascular Access Failure
|
August 1, 2019 | Early Phase 1 |
| NCT02462304 | The University of Hong Kong|Nagoya City University|Asahikawa Medical College|University of Fukui|Eguchi Eye Clinic|Kyoto University|Nagasaki University|Osaka Medical College|Kyushu University|Tokyo Medical University Hachioji Medical Centre|Hokkaido University|Kyorin University|Inje University|Pusan National University|Kyungpook National University Hospital|Chungnam National University Hospital|Sun Cheon Hyang University|Kyunghee University|Yeungnam University Hospital|Korea University|National University Hospital, Singapore|Yamagata University |
Diabetic Macula Edema
|
June 2015 | Phase 4 |
| NCT01492673 | Memorial Sloan Kettering Cancer Center|Genentech, Inc.|Children´s Mercy Hospital Kansas City|Penn State University|University of Colorado, Denver|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Phoenix Children´s Hospital Center for Cancer & Blood Disorders|Alberta Children´s Hospital|MD Anderson Cancer Center Orlando|M.D. Anderson Cancer Center |
Neuroblastoma|Sarcoma
|
December 2011 | Phase 2 |
| NCT05185505 | The Methodist Hospital Research Institute|Genentech, Inc. |
Hepatocellular Carcinoma|Hepatocellular Cancer
|
March 17, 2022 | Phase 4 |
| NCT03149003 | Sumitomo Pharma Oncology, Inc. |
Glioblastoma
|
December 8, 2017 | Phase 3 |
| NCT00112918 | Hoffmann-La Roche|National Cancer Institute (NCI) |
Colorectal Cancer
|
December 2004 | Phase 3 |
| NCT00393068 | SCRI Development Innovations, LLC|Genentech, Inc. |
Esophageal Cancer
|
February 2007 | Phase 2 |
| NCT02776683 | Boehringer Ingelheim |
Colorectal Neoplasms
|
June 8, 2016 | Phase 3 |
| NCT00557492 | Amer Zureikat|University of Pittsburgh |
Pancreatic Cancer
|
December 2006 | Phase 2 |
| NCT01959490 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) |
Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
|
September 24, 2013 | Phase 2 |
| NCT00988897 | Sanofi |
Colorectal Neoplasms
|
October 2009 | Phase 2 |
| NCT00410774 | University of California, San Francisco|National Cancer Institute (NCI) |
Pancreatic Cancer
|
July 2006 | Phase 1|Phase 2 |
| NCT04753216 | Northwestern University|Ipsen Biopharmaceuticals|National Cancer Institute (NCI) |
Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Refractory Fallopian Tube Carcinoma|Refractory Ovarian Carcinoma|Refractory Primary Peritoneal Carcinoma
|
March 16, 2021 | Phase 2 |
| NCT00139360 | Haukeland University Hospital|Norwegian Cancer Society|Hoffmann-La Roche |
Metastatic Melanoma
|
May 2005 | Phase 2 |
| NCT04094688 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Colorectal Adenocarcinoma
|
September 30, 2019 | Phase 3 |
| NCT00622726 | The University of Texas Health Science Center, Houston |
Retinopathy of Prematurity
|
March 2008 | Phase 2 |
| NCT00632541 | Hoosier Cancer Research Network|Genentech, Inc.|Bayer|Amgen |
Metastatic Breast Cancer
|
October 2007 | Phase 2 |
| NCT02005120 | Zhejiang University |
Non Small Cell Lung Cancer
|
December 2013 | Phase 2 |
| NCT00448136 | Hoffmann-La Roche |
Neoplasms
|
July 2007 | Phase 2 |
| NCT05029973 | Tianjin Medical University Cancer Institute and Hospital |
Hepatocellular Carcinoma
|
May 10, 2021 | Phase 2 |
| NCT02200354 | Kobe City General Hospital |
Advanced Non-small Cell Lung Cancer
|
July 2014 | Phase 2 |
| NCT05444088 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Advanced Hepatocellular Carcinoma
|
August 1, 2022 | Phase 1|Phase 2 |
| NCT00095225 | Genentech, Inc. |
Non-Small-Cell Lung Carcinoma|Neoplasm Recurrence, Local
|
July 2004 | Phase 2 |
| NCT04563338 | University Health Network, Toronto|Hoffmann-La Roche |
Hepatocellular Carcinoma|Non-small Cell Lung Cancer Metastatic|Liver Metastases
|
June 4, 2021 | Phase 2 |
| NCT00391092 | Hoffmann-La Roche |
Breast Cancer
|
September 2006 | Phase 3 |
| NCT03676192 | Celltrion |
Adenocarcinoma of Lung
|
December 19, 2018 | Phase 3 |
| NCT00609622 | Pfizer |
Colorectal Neoplasms
|
April 2008 | Phase 2 |
| NCT01130519 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
HLRCC|Sporadic Papillary Renal Cell Cancer
|
May 6, 2010 | Phase 2 |
| NCT01308684 | Hoffmann-La Roche |
Glioblastoma Multiforme
|
May 2011 | Phase 1 |
| NCT00418938 | Amgen |
Cancer|Colon Cancer|Colorectal Cancer|Metastatic Cancer|Rectal Cancer|Metastatic Colorectal Cancer
|
November 1, 2006 | Phase 2 |
| NCT04575415 | Guangdong Association of Clinical Trials |
NSCLC
|
October 7, 2020 | |
| NCT03148132 | Universidad Autonoma de San Luis Potosí|Hospital Central Dr. Ignacio Morones Prieto |
Retinopathy of Prematurity Both Eyes|Retinal Disease|Premature Birth|Eye Diseases
|
May 23, 2017 | Phase 4 |
| NCT00707889 | AbbVie (prior sponsor, Abbott)|Genentech, Inc.|AbbVie |
Advanced Colorectal Cancer|Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum
|
October 2008 | Phase 2 |
| NCT00946712 | Southwest Oncology Group|National Cancer Institute (NCI) |
Recurrent Large Cell Lung Carcinoma|Recurrent Lung Adenocarcinoma|Recurrent Squamous Cell Lung Carcinoma|Stage IV Large Cell Lung Carcinoma|Stage IV Lung Adenocarcinoma|Stage IV Squamous Cell Lung Carcinoma
|
July 15, 2009 | Phase 3 |
| NCT00400803 | Masonic Cancer Center, University of Minnesota|Eli Lilly and Company|Genentech, Inc. |
Carcinoma, Non-Small-Cell Lung
|
March 2007 | Phase 2 |
| NCT01069328 | Bayer |
Carcinoma, Non-Small-Cell Lung|Lung Cancer
|
July 2006 | Phase 1 |
| NCT03829410 | Cardiff Oncology |
Metastatic Colorectal Cancer|KRAS Gene Mutation
|
May 6, 2019 | Phase 1|Phase 2 |
| NCT00442637 | Dutch Colorectal Cancer Group|Koningin Wilhelmina Fonds|Sanofi|Hoffmann-La Roche |
Colorectal Cancer Metastatic
|
January 2007 | Phase 3 |
| NCT01516216 | Dana-Farber Cancer Institute |
Metastatic Colorectal Cancer
|
April 13, 2012 | Phase 2 |
| NCT00438204 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) |
Lung Cancer
|
May 2006 | Phase 2 |
| NCT00060411 | National Cancer Institute (NCI) |
Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage IIIA Colon Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
|
June 2003 | Phase 1 |
| NCT00314353 | NSABP Foundation Inc|Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute |
Colorectal Neoplasms
|
March 2006 | Phase 2 |
| NCT00523640 | University of Chicago|Genentech, Inc.|Eli Lilly and Company |
Carcinoma, Renal Cell
|
March 2005 | Phase 2 |
| NCT02047214 | Cortice Biosciences, Inc. |
Glioblastoma Multiforme
|
January 2014 | Phase 2 |
| NCT00005061 | European Organisation for Research and Treatment of Cancer - EORTC |
Unspecified Adult Solid Tumor, Protocol Specific
|
December 1999 | Phase 1 |
| NCT00951496 | National Cancer Institute (NCI)|NRG Oncology |
Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Malignant Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Clear Cell Adenocarcinoma|Primary Peritoneal Endometrioid Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Primary Peritoneal Transitional Cell Carcinoma|Primary Peritoneal Undifferentiated Carcinoma|Stage II Fallopian Tube Cancer AJCC v6 and v7|Stage II Ovarian Cancer AJCC v6 and v7|Stage IIA Fallopian Tube Cancer AJCC v6 and v7|Stage IIA Ovarian Cancer AJCC V6 and v7|Stage IIB Fallopian Tube Cancer AJCC v6 and v7|Stage IIB Ovarian Cancer AJCC v6 and v7|Stage IIC Fallopian Tube Cancer AJCC v6 and v7|Stage IIC Ovarian Cancer AJCC v6 and v7|Stage III Ovarian Cancer AJCC v6 and v7|Stage III Primary Peritoneal Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7
|
August 11, 2009 | Phase 3 |
| NCT00970684 | Nathan Pennell, MD, PhD|National Cancer Institute (NCI)|Case Comprehensive Cancer Center |
Lung Cancer
|
September 2009 | Phase 2 |
| NCT01837862 | Julie Krystal|Janssen Pharmaceuticals|Northwell Health |
Pilomyxoid Astrocytoma|Pilocytic Astrocytoma|Glioma, Astrocytic|Optic Nerve Glioma|Pleomorphic Xanthoastrocytoma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliosarcoma|Diffuse Intrinsic Pontine Glioma|DIPG|Low-grade Glioma|Brainstem Glioma
|
October 22, 2013 | Phase 1|Phase 2 |
| NCT00642759 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Celgene Corporation|Genentech, Inc. |
Non-small Cell Lung Cancer
|
April 2008 | Phase 2 |
| NCT04681677 | Xoft, Inc.|Icad, Inc. |
Glioblastoma|Recurrent Glioblastoma|GBM|Recurrent GBM
|
November 2, 2021 | Phase 2 |
| NCT01077713 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
February 2010 | Phase 2 |
| NCT01271166 | Novartis Pharmaceuticals|Novartis |
Advanced Colorectal Cancer
|
October 2007 | Phase 1 |
| NCT00859222 | Patrick Y. Wen, MD|Brigham and Women´s Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Northwestern University|University of Virginia|Genentech, Inc.|Novartis|Dana-Farber Cancer Institute |
Malignant Glioma
|
March 2009 | Phase 1|Phase 2 |
| NCT05518994 | Henan Provincial People´s Hospital |
Astrocytoma of Brain
|
December 1, 2022 | Phase 2 |
| NCT03380689 | Fujian Cancer Hospital |
Metastatic Colorectal Cancer
|
January 5, 2018 | Phase 1 |
| NCT00469443 | Hellenic Oncology Research Group|University Hospital of Crete |
Colorectal Cancer
|
December 2006 | Phase 3 |
| NCT01122966 | Samsung Medical Center |
Glaucoma
|
March 2010 | Phase 2|Phase 3 |
| NCT00654836 | Loyola University|Genentech, Inc.|Celgene Corporation |
Breast Cancer
|
October 2007 | Phase 2 |
| NCT00748657 | National Cancer Institute (NCI)|NRG Oncology |
Malignant Ovarian Epithelial Tumor|Ovarian Granulosa Cell Tumor|Ovarian Gynandroblastoma|Ovarian Sertoli-Leydig Cell Tumor|Ovarian Sex Cord Tumor With Annular Tubules|Ovarian Sex Cord-Stromal Tumor|Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types|Ovarian Steroid Cell Tumor
|
September 22, 2008 | Phase 2 |
| NCT02142803 | National Cancer Institute (NCI) |
Adult Glioblastoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Cancer|Solid Neoplasm|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7
|
May 20, 2014 | Phase 1 |
| NCT01853813 | Gruppo Italiano per lo studio dei Carcinomi dell´Apparato Digerente|Azienda Ospedaliero, Universitaria Ospedali Riuniti |
Colorectal Cancer Stage II
|
May 2013 | Phase 2 |
| NCT01254526 | Genentech, Inc. |
Breast Cancer
|
December 2010 | Phase 1 |
| NCT00313768 | Pfizer |
Carcinoma, Non-Small-Cell Lung
|
December 2005 | Phase 2 |
| NCT05588297 | Shanghai Changzheng Hospital |
Colorectal Cancer Liver Metastases
|
October 2022 | Phase 2 |
| NCT00150657 | St. John Providence Health System|Genentech, Inc.|Eli Lilly and Company |
Non-Small Cell Lung Cancer
|
November 2004 | Phase 2 |
| NCT03813394 | National University Hospital, Singapore|Merck Sharp & Dohme LLC |
Locally Recurrent Cancer|Metastatic Nasopharyngeal Cancer
|
May 1, 2019 | Phase 1|Phase 2 |
| NCT03178552 | Hoffmann-La Roche |
Non-Small Cell Lung Cancer
|
September 22, 2017 | Phase 2|Phase 3 |
| NCT01640444 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Roche Pharma AG |
Colorectal Cancer Metastatic
|
July 2012 | Phase 2 |
| NCT00369889 | Indiana University School of Medicine|Genentech, Inc.|Indiana University |
Thymic Cancer|Thymoma
|
August 2006 | Phase 2 |
| NCT00464347 | National Eye Institute (NEI)|QLT Inc. |
Age-Related Macular Degeneration
|
January 2007 | Phase 2 |
| NCT00723125 | William Sikov MD|Yale University|Brown University |
Breast Cancer
|
September 2008 | Phase 2 |
| NCT01137604 | Eisai Inc. |
Glioma
|
November 9, 2010 | Phase 2 |
| NCT04919629 | Roswell Park Cancer Institute |
Fallopian Tube Carcinosarcoma|Fallopian Tube Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Ovarian Carcinosarcoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
|
December 15, 2022 | Phase 2 |
| NCT03193190 | Hoffmann-La Roche |
Pancreatic Adenocarcinoma
|
July 5, 2017 | Phase 1|Phase 2 |
| NCT04099836 | Duke University |
Non Small Cell Lung Cancer
|
July 9, 2020 | Phase 2 |
| NCT02348918 | Allegro Ophthalmics, LLC|Trial Runners, LLC|Duke University |
Diabetic Macular Edema
|
October 13, 2014 | Phase 2 |
| NCT04981509 | National Cancer Institute (NCI) |
Advanced Papillary Renal Cell Carcinoma|Advanced Renal Cell Carcinoma|Hereditary Leiomyomatosis and Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Sporadic Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8
|
September 17, 2021 | Phase 2 |
| NCT00628810 | Federation Francophone de Cancerologie Digestive |
Colorectal Cancer
|
January 2007 | Phase 2 |
| NCT00405405 | Sidney Kimmel Cancer Center at Thomas Jefferson University|Genentech, Inc.|Thomas Jefferson University |
Head and Neck Cancer|Parotid Gland Cancer|Thyroid Gland Cancer|Melanoma|Stage IV Head and Neck Cancer
|
December 2006 | Phase 1 |
| NCT00508872 | M.D. Anderson Cancer Center|Sanofi |
Colorectal Liver Metastases
|
November 2005 | Phase 2 |
| NCT00271609 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Recurrent High-Grade Gliomas|Malignant Gliomas
|
December 2005 | Phase 2 |
| NCT00684996 | National Cancer Institute (NCI) |
Recurrent Renal Cell Cancer|Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer
|
June 2008 | Phase 1|Phase 2 |
| NCT00813059 | Mount Sinai Hospital, Canada |
Non-arteritic Anterior Ischemic Optic Neuropathy
|
February 2009 | Phase 2 |
| NCT00779311 | Accelerated Community Oncology Research Network|Bayer |
Metastatic Colorectal Cancer
|
October 2008 | Phase 1 |
| NCT00423930 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Genentech, Inc. |
Head and Neck Cancer
|
October 2006 | Phase 2 |
| NCT02308527 | University of Birmingham|Cancer Research UK|Roche Pharma AG|Imagine for Margo|EUSA Pharma, Inc. |
Neuroblastoma
|
July 2013 | Phase 2 |
| NCT04958811 | Georgetown University|Genentech, Inc. |
Non-squamous Non-small-cell Lung Cancer
|
December 21, 2021 | Phase 2 |
| NCT03779191 | Instituto Nacional de Cancerologia de Mexico|Roche Pharma AG |
ALK Gene Rearrangement Positive|Non-Squamous Non-Small Cell Neoplasm of Lung
|
April 8, 2020 | Phase 2 |
| NCT00614822 | Christiana Care Health Services|Eli Lilly and Company |
Non Small Cell Lung Cancer
|
November 2007 | Phase 2 |
| NCT00975897 | Medical Research Council|National Cancer Institute (NCI) |
Colorectal Cancer
|
July 2009 | Phase 2|Phase 3 |
| NCT03133546 | ETOP IBCSG Partners Foundation|AstraZeneca|Hoffmann-La Roche |
Non Small Cell Lung Cancer Metastatic
|
May 31, 2017 | Phase 2 |
| NCT00530868 | University of Alabama at Birmingham|Genentech, Inc.|Breast Cancer Research Foundation |
Breast Cancer|Cancer of the Breast|Breast Neoplasm
|
October 8, 2007 | Phase 2 |
| NCT01077739 | Hoffmann-La Roche |
Colorectal Cancer
|
July 2009 | Phase 2 |
| NCT01495988 | Melanoma Research Foundation Breakthrough Consortium|Genentech, Inc. |
Melanoma|Metastatic Melanoma
|
August 2013 | Phase 2 |
| NCT00406172 | Asociación para Evitar la Ceguera en México |
Cystoid Macular Edema
|
Phase 3 | |
| NCT01311960 | Chulalongkorn University |
Pterygium|Bevacizumab|VEGF|Anti-VEGF
|
December 2010 | Phase 3 |
| NCT00722865 | Massachusetts General Hospital|Genentech, Inc. |
Hodgkin Lymphoma
|
September 2008 | Phase 2 |
| NCT03740165 | Merck Sharp & Dohme LLC|European Network of Gynaecological Oncological Trial Groups (ENGOT)|Gynecologic Oncology Group |
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms
|
December 18, 2018 | Phase 3 |
| NCT01588704 | Si-Yu Wang|Sun Yat-sen University |
Lung Cancer
|
April 2012 | Phase 2 |
| NCT01181609 | Hoffmann-La Roche |
Colorectal Cancer
|
June 2005 | Phase 2 |
| NCT00469976 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) |
Lung Cancer
|
June 2007 | Phase 2 |
| NCT00596297 | University of Sao Paulo |
Diabetic Retinopathy|Vitreous Hemorrhage
|
November 2007 | Phase 1|Phase 2 |
| NCT00448019 | M.D. Anderson Cancer Center|Genentech, Inc. |
Chronic Lymphocytic Leukemia
|
February 2007 | Phase 2 |
| NCT00047762 | Genentech, Inc. |
Colorectal Cancer
|
October 2002 | Phase 1 |
| NCT00583622 | M.D. Anderson Cancer Center |
Ovarian Cancer
|
December 2007 | Phase 2 |
| NCT02511405 | Vascular Biogenics Ltd. operating as VBL Therapeutics |
Glioblastoma
|
August 2015 | Phase 3 |
| NCT00642824 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
May 2007 | Phase 2 |
| NCT04829383 | Howard S Hochster|Genentech, Inc.|Rutgers Cancer Institute of New Jersey|Big Ten Cancer Research Consortium |
Unresectable Hepatocellular Carcinoma
|
March 22, 2021 | Phase 2 |
| NCT00976573 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Melanoma (Skin)
|
April 2010 | Phase 2 |
| NCT00356031 | Massachusetts General Hospital|National Institutes of Health (NIH)|National Cancer Institute (NCI) |
Soft Tissue Sarcoma|Fibrous Histiocytoma|Liposarcoma|Leiomyosarcoma|Fibrosarcoma|Synovial Sarcoma
|
July 2006 | Phase 2 |
| NCT02020707 | Mayo Clinic|National Cancer Institute (NCI) |
Cervical Adenocarcinoma|Cervical Adenosarcoma|Cervical Adenosquamous Carcinoma|Cervical Carcinosarcoma|Cervical Squamous Cell Carcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma|Endometrial Mixed Cell Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Undifferentiated Carcinoma|Fallopian Tube Adenocarcinoma|Fallopian Tube Carcinosarcoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Squamous Cell Carcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Malignant Female Reproductive System Neoplasm|Malignant Ovarian Clear Cell Tumor|Malignant Ovarian Endometrioid Tumor|Malignant Ovarian Epithelial Tumor|Malignant Ovarian Mucinous Tumor|Malignant Peritoneal Neoplasm|Malignant Solid Neoplasm|Ovarian Carcinosarcoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian High Grade Serous Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Platinum-Sensitive Ovarian Carcinoma|Primary Peritoneal Carcinosarcoma|Primary Peritoneal Clear Cell Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Primary Peritoneal Transitional Cell Carcinoma|Primary Peritoneal Undifferentiated Carcinoma|Stage IV Cutaneous Melanoma AJCC v6 and v7|Unresectable Melanoma|Uterine Corpus Carcinosarcoma
|
February 3, 2014 | Phase 1 |
| NCT01251926 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Neoplasms
|
November 15, 2010 | Phase 1 |
| NCT03574779 | Tesaro, Inc. |
Ovarian Neoplasms
|
November 15, 2018 | Phase 1|Phase 2 |
| NCT03711240 | National Cheng-Kung University Hospital |
Colorectal Cancer
|
January 8, 2019 | Phase 2 |
| NCT01852409 | Peking University |
Refractory Malignant Ascites
|
May 2013 | Phase 1 |
| NCT05617430 | Wuhan Union Hospital, China |
Hepatocellular Carcinoma
|
November 2, 2022 | Phase 2 |
| NCT01749384 | National Cancer Institute (NCI) |
Solid Neoplasm
|
December 6, 2012 | Phase 1 |
| NCT01814163 | Spanish Lung Cancer Group |
Nonsquamous Nonsmall Cell Neoplasm of Lung
|
February 2011 | |
| NCT02873195 | Academic and Community Cancer Research United|National Cancer Institute (NCI) |
Metastatic Colorectal Carcinoma|Recurrent Colorectal Carcinoma|Refractory Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7
|
July 7, 2017 | Phase 2 |
| NCT00671970 | Duke University|Genentech, Inc. |
Glioblastoma|Gliosarcoma
|
February 2007 | Phase 2 |
| NCT00642603 | Hoffmann-La Roche |
Colorectal Cancer
|
May 2008 | Phase 2 |
| NCT01017250 | Duke University|Genentech, Inc. |
Malignant Glioma
|
December 2009 | Not Applicable |
| NCT04627363 | Sun Yat-sen University|Second Affiliated Hospital of Guangzhou Medical University |
Hepatocellular Carcinoma|Bevacizumab|Liver Neoplasms|Toripalimab|Oxaliplatin
|
January 1, 2021 | Phase 2 |
| NCT00961415 | Hoffmann-La Roche |
Non-Squamous Non-Small Cell Lung Cancer
|
August 2009 | Phase 3 |
| NCT00679029 | University of Nebraska|National Cancer Institute (NCI) |
HER2-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
|
May 2008 | Phase 2 |
| NCT00462865 | Brown University|Women and Infants Hospital of Rhode Island|Rhode Island Hospital|The Miriam Hospital|Memorial Hospital of Rhode Island|University of New Mexico Cancer Center |
Breast Cancer
|
November 2007 | Phase 2 |
| NCT01022918 | Centre Georges Francois Leclerc|National Cancer Institute, France|Association de Neuro-Oncologues d´Expression Francaise|UNICANCER|Hoffmann-La Roche|Pfizer |
Naive Unresectable Glioblastoma
|
January 2009 | Phase 2 |
| NCT00386828 | British Columbia Cancer Agency |
Advanced Colorectal Cancer
|
October 2006 | Phase 2 |
| NCT00556348 | Instituto de Olhos de Goiania |
Age Related Macular Degeneration
|
November 2005 | Phase 4 |
| NCT00708448 | University of Utah |
Cancer|Non Small Cell Lung Cancer
|
March 28, 2008 | Phase 1 |
| NCT02663271 | University of Florida|NovoCure Ltd. |
Glioblastoma Multiforme|Glioblastoma|Malignant Glioma|GBM
|
December 19, 2016 | Phase 2 |
| NCT02574663 | TG Therapeutics, Inc.|SCRI Development Innovations, LLC |
Pancreatic Cancer|Colorectal Cancer|Rectal Cancer|Gastric Cancer|Esophageal Cancer|Gastrointestinal Stromal Tumor (GIST)
|
September 11, 2015 | Phase 1 |
| NCT00301990 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) |
Kidney Cancer
|
September 2005 | Phase 2 |
| NCT00932438 | University of Louisville|Biocompatibles UK Ltd |
Colon Cancer With Metastases to the Liver
|
June 2009 | Phase 1|Phase 2 |
| NCT00968240 | Northwell Health |
Glioblastoma Multiforme|Anaplastic Astrocytoma
|
July 2009 | Phase 1 |
| NCT01740258 | Duke University|Genentech, Inc. |
Malignant Glioma|Grade 4 Malignant Glioma|Glioblastoma|Gliosarcoma
|
January 2013 | Phase 2 |
| NCT00290615 | Herbert Hurwitz|National Cancer Institute (NCI)|Duke University |
Colorectal Cancer
|
January 2006 | Phase 2 |
| NCT00873275 | City of Hope Medical Center|National Cancer Institute (NCI) |
Colorectal Cancer
|
March 11, 2009 | Phase 1 |
| NCT03929666 | Zymeworks Inc. |
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
|
August 29, 2019 | Phase 2 |
| NCT01408030 | James Gossage|HHT Foundation International|Augusta University |
Telangiectasia, Hereditary Hemorrhagic|Epistaxis
|
August 2011 | Phase 2 |
| NCT00516295 | National Cancer Institute (NCI) |
Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Peripheral Primitive Neuroectodermal Tumor|Recurrent Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor
|
February 2008 | Phase 2 |
| NCT05217680 | Laboratorios Sophia S.A de C.V. |
Diabetic Macular Edema
|
May 17, 2021 | Phase 3 |
| NCT03391219 | Shahid Beheshti University of Medical Sciences |
Retinal Vein Occlusion
|
January 2018 | Phase 2|Phase 3 |
| NCT00193219 | SCRI Development Innovations, LLC|Bristol-Myers Squibb |
Colon Cancer
|
July 2005 | Phase 2 |
| NCT04135898 | Shanghai Institute Of Biological Products |
Healthy Male
|
October 30, 2019 | Phase 1 |
| NCT04674254 | Cairo University |
Proliferative Diabetic Retinopathy|Vascular Endothelial Growth Factor Overexpression|Diabetic Retinopathy
|
March 30, 2021 | Phase 4 |
| NCT02305615 | Hoffmann-La Roche |
Colorectal Cancer
|
January 13, 2015 | |
| NCT00776763 | Ophthalmological Association Edelweiss|University of Cologne |
Proliferative Diabetic Retinopathy|Age Related Macular Degeneration
|
October 2008 | Phase 2 |
| NCT02075086 | Grupo Hospital de Madrid |
Colorectal Cancer
|
July 2011 | Phase 2 |
| NCT04247984 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Beijing Hospital|Henan Cancer Hospital|Liaoning Tumor Hospital & Institute|Jiangsu Cancer Institute & Hospital |
Metastatic Colorectal Cancer
|
May 1, 2018 | Phase 2 |
| NCT01091896 | University of Sao Paulo |
Vitreous Hemorrhage Secondary to PDR
|
January 2010 | Phase 2 |
| NCT05325229 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Platinum-resistant Recurrent Ovarian Cancer
|
August 18, 2022 | Phase 2 |
| NCT01854593 | Nihon University |
Proliferative Diabetic Retinopathy|Diabetic Traction Retinal Detachment|Vitreous Hemorrhage
|
May 2012 | Phase 4 |
| NCT01090830 | Holy Cross Hospital, Florida |
Non-Small-Cell Lung Carcinoma
|
April 2010 | Phase 1|Phase 2 |
| NCT00458315 | Rigshospitalet, Denmark |
Unknown Primary Tumors
|
May 2007 | Phase 2 |
| NCT02490878 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Genentech, Inc. |
Radionecrosis|Brain Metastases
|
April 2016 | Phase 2 |
| NCT01180959 | M.D. Anderson Cancer Center|Genentech, Inc.|OSI Pharmaceuticals |
Liver Cancer
|
April 14, 2011 | Phase 2 |
| NCT00805064 | Johann Wolfgang Goethe University Hospital |
Retinal Vein Occlusion
|
January 2006 | Phase 3 |
| NCT00334815 | National Cancer Institute (NCI) |
Lung Adenocarcinoma|Lung Adenosquamous Carcinoma|Lung Large Cell Carcinoma|Lung Squamous Cell Carcinoma|Minimally Invasive Lung Adenocarcinoma|Stage IIIA Lung Non-Small Cell Cancer AJCC v7|Stage IIIB Lung Non-Small Cell Cancer AJCC v7
|
June 15, 2006 | Phase 2 |
| NCT00461773 | Yale University|Novartis|Genentech, Inc. |
Hormone-Sensitive Breast Cancer|Breast Cancer
|
March 2007 | Phase 2 |
| NCT04551950 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany|EMD Serono |
Cervical Cancer
|
October 19, 2020 | Phase 1 |
| NCT02876224 | Hoffmann-La Roche |
Colorectal Cancer
|
September 30, 2016 | Phase 1 |
| NCT00395434 | Mateon Therapeutics |
Tumors
|
September 2006 | Phase 1 |
| NCT00356889 | National Cancer Institute (NCI) |
Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Gastrointestinal Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
|
May 2006 | Phase 2 |
| NCT01227707 | Hoffmann-La Roche |
Colorectal Cancer
|
November 2005 | Phase 2 |
| NCT04511715 | Shahid Beheshti University of Medical Sciences |
Non-proliferative Diabetic Retinopathy
|
September 1, 2020 | Phase 2|Phase 3 |
| NCT00635050 | University of Alabama at Birmingham|Ortho Biotech, Inc.|Genentech, Inc. |
Invasive Breast Cancer
|
March 2008 | Phase 2 |
| NCT04595266 | Grupo Espanol Multidisciplinario del Cancer Digestivo |
Colorectal Cancer Metastatic|Liver Metastasis Colon Cancer
|
June 29, 2021 | Phase 2 |
| NCT01094184 | Hoffmann-La Roche |
Breast Cancer
|
March 2010 | Phase 4 |
| NCT05359861 | Surface Oncology |
Hepatocellular Carcinoma
|
April 12, 2022 | Phase 2 |
| NCT00671645 | Austrian Breast & Colorectal Cancer Study Group|Hoffmann-La Roche |
Rectal Cancer
|
July 2008 | Phase 2 |
| NCT01321957 | Martin-Luther-Universität Halle-Wittenberg|Roche Pharma AG |
Metastatic Colorectal Cancer
|
May 2011 | Phase 2 |
| NCT01650428 | University College, London|Cancer Research UK|Hoffmann-La Roche |
Rectal Cancer
|
April 2013 | Phase 2 |
| NCT01269853 | Northwell Health|Feinstein Institute for Medical Research |
Glioblastoma Multiforme|Anaplastic Astrocytoma
|
October 2010 | Phase 1|Phase 2 |
| NCT00083031 | Dana-Farber Cancer Institute|National Cancer Institute (NCI)|Genentech, Inc. |
Breast Cancer
|
July 2003 | Phase 2 |
| NCT00109070 | Genentech, Inc. |
Colorectal Cancer
|
September 2000 | Phase 3 |
| NCT01055028 | Stanford University|Genentech, Inc. |
Angiosarcomas|Soft Tissue Sarcoma
|
February 2010 | Phase 2 |
| NCT00861419 | Amgen |
Advanced Solid Tumors
|
December 2005 | Phase 1 |
| NCT02665416 | Hoffmann-La Roche |
Advanced+Metastatic Solid Tumors
|
January 25, 2016 | Phase 1 |
| NCT00408070 | UConn Health|Genentech, Inc. |
Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Stage 3 Cancer|Stage 4 Cancer
|
October 2006 | Phase 2 |
| NCT02841332 | University Hospital, Toulouse |
Glioblastoma
|
May 2013 | Not Applicable |
| NCT02256800 | Jaw-Yuan Wang, MD, PhD|Kaohsiung Medical University Chung-Ho Memorial Hospital |
Metastatic Colorectal Cancer
|
August 13, 2014 | Not Applicable |
| NCT00276575 | Herbert Hurwitz, MD|National Cancer Institute (NCI)|Duke University |
Unspecified Adult Solid Tumor, Protocol Specific
|
March 2005 | Phase 1 |
| NCT02743221 | Institut de Recherches Internationales Servier|ADIR, a Servier Group company|Servier |
Metastatic Colorectal Cancer
|
April 29, 2016 | Phase 2 |
| NCT01343901 | Hoffmann-La Roche |
Colorectal Cancer
|
September 30, 2010 | |
| NCT00782756 | Memorial Sloan Kettering Cancer Center|Genentech, Inc.|National Institutes of Health (NIH) |
Brain Cancer|Malignant Glioma
|
October 28, 2008 | Phase 2 |
| NCT03170284 | Hoffmann-La Roche |
Carcinoma, Non-Small-Cell Lung
|
June 17, 2008 | |
| NCT00598156 | Lund University Hospital|Hoffmann-La Roche |
Metastatic Colorectal Cancer
|
June 2007 | Phase 3 |
| NCT00464646 | NSABP Foundation Inc|Genentech, Inc.|International Drug Development Institute |
Breast Cancer
|
May 2007 | Phase 2 |
| NCT01951482 | Sun Yat-sen University |
Non Squamous Non-small Cell Lung Cancer|Brain Metastases|Bevacizumab
|
June 2013 | Phase 2 |
| NCT00467142 | Institut Bergonié |
Colorectal Cancer
|
January 23, 2007 | Phase 2 |
| NCT02007174 | Instituto de Oftalmología Fundación Conde de Valenciana|National Council of Science and Technology, Mexico |
Recurrent Pterygium
|
March 2012 | |
| NCT01263834 | Prince of Songkla University |
Glaucoma
|
December 2010 | Phase 2|Phase 3 |
| NCT04689347 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
Metastatic Colorectal Cancer
|
January 1, 2021 | Phase 1 |
| NCT02664961 | Tracon Pharmaceuticals Inc. |
Gestational Trophoblastic Neoplasia|Choriocarcinoma|Placental Site Trophoblastic Tumor|Epithelioid Trophoblastic Tumor
|
March 2016 | Phase 2 |
| NCT02118831 | California Retina Consultants |
Age-related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion
|
March 2012 | Phase 1|Phase 2 |
| NCT03786081 | Seagen Inc.|Genmab|European Network of Gynaecological Oncological Trial Groups (ENGOT)|Belgian Gynaecological Oncology Group|Gynecologic Oncology Group|Merck Sharp & Dohme LLC |
Cervical Cancer
|
February 27, 2019 | Phase 1|Phase 2 |
| NCT01707745 | Sivakami A Pai|Dubai Health Authority |
Stage 2&addition; or Stage 3&addition; Retinopathy of Prematurity in Zone I or Zone II.
|
January 2010 | Not Applicable |
| NCT00096148 | National Cancer Institute (NCI) |
Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Childhood Acute Basophilic Leukemia|Childhood Acute Eosinophilic Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
|
October 2004 | Phase 2 |
| NCT00691379 | Hellenic Oncology Research Group|University Hospital of Crete |
Breast Cancer
|
April 2008 | Phase 1|Phase 2 |
| NCT00979017 | Katy Peters|Genentech, Inc.|Duke University |
Glioblastoma Multiforme|Gliosarcoma
|
November 2009 | Phase 2 |
Appearance
Liquid
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
References
- [1] Tan H, et al. 99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of treatment in ApoE-/-mice. Sci Rep. 2017 Jun 14;7(1):3504.
- [2] Wang Q, et al. Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC Biotechnol. 2014 Feb 27;14:17.
- [3] Di Mauro C, et al. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers. Br J Cancer. 2017 May 23;116(11):1425-1435.
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.